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SUMMARY
Treatment of human milk fat globules with pronase gave a 
soluble sialoglycopeptide mixture which was fractionated on Sephadex G-50 
to give two major hexose-sialic acid peaks I and II. Material 
corresponding to peak II was treated with alkaline borohydride 
when an oligosaccharide component was released. Purification and 
gas chromatographic analysis of the released carbohydrate showed 
it to contain sialic acid; galactose, N-acetylglucosamine and 
N-acetylgalactosamine in the ratio 3:3.5:2:1.
Sialoglycopeptides I and II both showed epithelial mem­
brane antigenic activity in the radioimmunoassay of Ormerod and 
Steele. Further fractionation of peaks I and II by ion-exchange led, 
in the case of peak II, to a sialic acid-rich glycopeptide with 
increased antigenic activity. Papain digestion of human milk fat 
globule membrane gave a crude sialoglycopeptide mixture which also 
showed strong epithelial membrane antigenic activity.
An investigation was made of means for selectively 
removing carbohydrate from glycopeptides. Hydrogen fluoride in 
pyridine was found to remove 67% of the total carbohydrate from 
fetuin at 45°C but very little at 0°C. In order to assess the 
effect of hydrogen fluoride and other deglycosylating agents on 
the structure and conformation of a polypeptide chain, a radio­
immunoassay was developed for the antigenicity of IgG. Treat­
ment of IgG with hydrogen fluoride at 45°C destroyed the anti­
genicity whereas treatment of IgG with a mixture of glycosidases 
from Trichomonas foetus caused no loss of antigenicity indicating 
that the glycosidases but not hydrogen fluoride can remove carbo­
hydrate without affecting the polypeptide chain.
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sialoglycopeptide II was treated with a mixture of exo- 
and endo-glycosidases from Diplococcus pneumoniae which removed 
60% of the carbohydrate and led to a five-fold loss in epithelial 
membrane antigenic activity. Removal of sialic acid alone caused 
little affect indicating that the antigenic activity of 




Early in the nineteenth century the biological cell was known 
to be bound by a membrane. This was defined by Carl NUgeli in 1855 
and was described by Wilhelm Pfeffer (1897) as "the plasma membrane".
It was not until the advent of electron microscopy in the mid 1950's,
however, that eukaryotic cells were found to contain, in addition to
the plasma membrane, a mass of intracellular membranes such as the 
nuclear membrane, Golgi membranes and the endoplasmic reticulum 
(Fig. 1), These interior membranes are found only in eukaryotic cells 
e.g. cells of higher organisms such as protozoa, fungi and algae, but 
not in prokaryotic cells such as blue-green algae and bacteria.
2. Origin of the plasma membrane and membrane flow
All the membranes of the cell are composed of lipids and 
proteins with less amounts of asymetrically distributed carbohydrates 
and other prosthetic groups. The present ideas regard membrane bio­
genesis as an integral part of the activities of the cell and envisage 
membrane constituents as being assembled primarily in the endoplasmic 
reticulum before being transferred to their designated sites.
The idea of preliminary assembly of membrane components in 
the endoplasmic reticulum followed by further structural adjustments 
in the Golgi apparatus has been developed into the concept of membrane 
flow in which membranes are seen as progressing from site to site 
through the cell, being continuously modified and differentiated en 
route.(Morré & Ovtracht, 1977) possibly even after incorporation into 
the plasma membrane itself (Shur &. Roth, 1975).
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Fig. 1. The living cell. After Porter & Bonneville (1973) 
Plasma membrane (PM), Endoplasmic reticulum (ER), 
Nuclear envelope (NE), Golgi membranes (G), Mito­
chondria (M), Free ribosomes (R), Nucleus (N), 
Dense granular chromatin (C).
" 3 . ................
The flow of membrane components is not restricted to 
providing new membranes in periods of cell growth. Biogenic processes 
are also observed during homeostasis and in situations where net 
increases in total membrane content do not occuro These observations 
suggest a dynamic situation involving continuous degradation and turn­
over of membrane constituents mediated by formation, migration and 
fusion of membrane vesicles (Grove et al., 1968; Dauwalder et al.,
1972; Hirano et al., 1972; Whaley et al., 1972; Whaley 1975; Morré 
and Vanderwoude, 1974; Morr^, 1975, 1977) and are largely summarised 
in the complex scheme of Morré et al., (1979) which is shown in Fig. 2.
Fig. 2 concentrates on the production aspects of membrane 
turnover about which much more data are available than about recycling 
processes. The nuclear envelope is shown as exhibiting continuity 
with the rough endoplasmic reticulum in a complex system of membranes 
associated with microsomes (1). Transition vesicles bud off from the 
endoplasmic reticulum and go to form new Golgi cisternae (2) or 
possibly contribute directly to condensing vacuoles (3a), to the plasma 
membrane (3b) or to lysosomes (3c). Corresponding transition vesicles 
may also originate from what appears to be clearly the nuclear envelope 
itself (4). Presumably after undergoing further additions or modi­
fications, patches of membrane leave the Golgi apparatus to form 
condensing vacuoles and thence secretory vesicles, which may appear 
with (6) or without (5) a 'bristle coat' in electron micrographs.
The secretory vesicles then fuse with the plasma membrane (7,8) in 
exocytotic processes resulting in incorporation of new plasma membrane 
material. Loss of plasma membrane can occur by budding processes in 
special cases such as milk fat globule secretion (see later section) 



















Schematic representation of the flow differentiation of membranes and
the interier origin of the plasma membrane 
Adapted from Morré D.J. et al (1979).
The numbers placed in the Fig. corresponding to the numbers in page 3
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plasma membrane may be internalized by endocytotic processes (10,11,12) 
among which phagocytosis and pinocytosis will be included.
However, despite the conceptual framework provided by the 
above hypothesis of membrane flow and differentiation, many details of 
the mechanisms of formation of plasma membrane remain poorly understood 
or conjectural. In fact, alternative mechanisms involving insertion of 
membrane constituents directly from the non-membranous cytosol and 
simultaneous (single step) assembly of membrane components have also 
been extensively discussed (McMurray & Magee, 1972; Bretscher, 1973; 
Singer & Rothfield, 1973; Bluemink & Delaat, 1977; Holtzman et al., 
1977). Others have reported compositional differences between plasma 
membranes and endomembranes. Meldolsi (1974) for example, compared 
fractions enriched in plasma membrane with fractions enriched in mem­
branes of secretory granules. These and other studies (e.g. Palade,
1975) have led to a concept of cyclic membrane flow in which the 
vesicle membrane material makes no permanent contribution to the plasma 
membrane but rather is taken up by endocytosis and is reutilized in 
subsequent secretory cycles. Morré et al (1979) have emphasized that 
this "shuttle" concept Should not be confused with compensatory endo­
cytotic recycling processes in which excess membrane, not necessarily 
that newly derived by exocytosis, becomes internalized and is reulil- 
ized by one of several possible pathways" (see Fig. 2).
3. Development of the ideas of plasma membrane structure
The structure and the molecular architecture of biological 
membranes have been studied since the last century. Early ideas about 
the composition and structure of membranes were based upon what could
6.
be gleaned from histological examination under the light microscope. 
More accurate knowledge of their composition, and further insight into 
their detailed structure depended upon the discovery of more specific 
histochemical techniques and progress in the development of the 
electron microscope.
The development of ideas on molecular organization of the 
plasma membrane began in 1855 when Carl NSgeli reported that a 
discrete boundary membrane existed at cell surfaces. He reached this 
conclusion on the basis of his studies of pigment penetration into 
intact and damaged cells and from direct microscopic examination of 
the cell boundary, which he termed the plasma membrane. He also 
suggested that the plasma membrane was responsible for the osmotic 
properties of the cell. Pfeffer*s (1897) experiments on the osmotic 
behaviour of plant cells, supported NMgeli*s suggestion and two years 
later Overton (1899) proposed the idea of a lipid membrane suggesting 
that cholesterol and other lipids were involved in the control of 
penetration of substances into the protoblast. These early studies 
together with other chemical, histochemical and physiological data 
were re-evaluated by Gorter and Grendel in 1925. They were the first 
to suggest that membrane lipids exist in the form of a bimolecular 
leaflet with the polar ends of molecules facing outwards towards the 
equeous phase (Fig. 3). They reached this conclusion largely from 
the observation that if the total lipid of erythrocytes was spread as 
a coherent monolayer, it occupied twice the surface area of the cells 
from which it was extracted. This concept was later the subject of 
extensive criticism by Winkler & Bungenberg De Jong (1941) and by 
Hoffman (1962) who showed that these results had two inherent errors; 
not only the incomplete extraction of membrane lipids, but also the
7.
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Fig. 4. After Danielli & Davson
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underestimated area of the erythrocyte surface. Davson (1962) 
subsequently repeated this work and found that the two errors cancelled 
each other out.
In fact, the first hypothesis concerning the overall structure 
of biological membranes was presented by Danielli and Davson (1935) 
who envisaged the membrane lipid as forming a bimolecular leaflet, 
coated on both its ionic surfaces with a layer of protein (Fig. 4).
Their idea of outer protein layers was based on indirect evidence 
derived from surface tension measurements. They observed that the 
surface tension of natural membranes in aqueous media was much lower 
than that of artificial lipid films (Harvey, 1931), and protein, with 
its well known capacity for reducing the surface tension of aqueous 
solution appeared to be ap attractive candidate as a coat for the 
lipid. This proposal was later found also to have been based on a 
misconception, as phospholipids alone can produce the low surface 
tensions shown by natural membranes (Haydon & Taylor, 1963).
Nevertheless these membrane models were later supported 
and developed by the "Unit membrane model" of Robertson (1959) 
who, on the basis of electron microscopy commented that "cells of 
widely different types in vertebrates and invertebrates have been 
found to be bounded by a unit membrane structure which appears in 
every respect the same as that which bounds Schwann cells and axons." 
Robertson (1964) found that biological membranes showed a typical 
railway-line appearance with dimensions compatible with those esti­
mated by physical techniques and observed that the protein appeared 
to consist of two asymmetric layers (Fig. 5).
9,
The Davson-Danielli-Robertson model of biological membrane 
structure was subject to criticism in a number of ways. Thus the model 
did not explain the fact that the hydrophilic portions of membrane 
phospholipids are accessible to enzymic attack and are not extensively 
complexed to the membrane protein (Lenard & Singer, 1966). Moreover, 
Korn (1966) pointed out that much of the. support for the Davson-Danielli- 
Robertson model was based on early electron micrographs of myelin, the 
interpretation of which was questionable.
A further problem concerned the permeability of biological 
membranes to certain molecules, which would not be expected to cross 
a continuous lipid barrier. Intensive studies on membrane transport 
were carried out in the 1950*s and two basic concepts of transport 
processes were being considered. Firstly carriers were envisated as 
unidentified molecules with affinity for lipid which operated a shuttle
Fig. 5. After Robertson (1964)
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service across the relatively thick membrane. Thus Hokin & Hokin 
(1961) discovered that certain lipids such as phosphatidic acid and 
phosphatidylinositol underwent a relatively rapid turnover during 
stimulation of active permeation. Such lipids were seen as shuttle 
molecules tumbling in the lipid layer becoming orientated first to 
one side of the membrane and then to the other. Secondly pore structures 
were suggested which would allow the passage of certain small molecules 
through the lipid membrane and in fact Stein and Danielli (1956) 
attempted to reconcile permeability evidence with the basic Danielli- 
Davson model by incorporating protein-lined pores into the bimolecular
layer of lipid (Fig. 6).
/WWVWV? Pore
ProteinFig. 6. After Stein & Danielli (1956)
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In the light of the above objections to the Davson-Danielli- 
Robertson model and with the improvement in electron microscope 
resolution and the advent of new techniques like nuclear magnetic 
resonance, optical rotatory dispersion, circular dichroism and x-ray 
diffraction, alternative models of biological membrane structure began 
to appear in the I960’s.-
Important among such alternative models was the subunit 
concept. Improved electron micrographs suggested the presence of 
large globular repeating units, particularly in mitochondrial membranes 
(see Sjostrand, 1963) and these observations led Benson (1966) and 
Green et al (1967) to propose that membranes were construetured. of 
globular lipoprotein subunits in which lipid acyl tails were inter­
calated into the membrane protein complexes. This proposal endeavoured 
to explain the fact that the hydrophilic parts of lipids and proteins 
are probably exposed to the aqueous phase and stabilized by polar 
environments. Furthermore, this proposal concurred with that of Lucy 
(1964) who suggested that the lipid in biological membranes might be 
in the form of small globular micelles (Fig. 7). A little later 
Sjdstrand (1968) represented these suggestions in the form of globular 
structural units (Fig. 8).
The subunit model was based on electron microscopic studies 
of mitochondrial membranes, and fitted many experimental observations 
derived from these membranes. However this model was incompatible 
with the considerable body of evidence for a lipid bilayer structure, 
particularly that obtained from x-ray diffraction studies and Thompson 
et al (1968) were unable to find any indications of globular structure
12.




Fig. 3. After Sjostrand (1968)
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by means of these methods.
Nevertheless nuclear magnetic resonance (Chapman et al., 1966), 
optical rotatury dispersion and circular dichroism evidence (Lenard 
and Singer 1966) from erythrocyte membrane indicated the probability 
of substantial non-polar interaction between lipid and protein in the 
membrane structure and Lenard and Singer (1966) proposed an alternative 
model incorporating such lipid-protein interactions and a lipid bilayer 
(Fig. 9) of which they said "this model is radically different from 
the Danielli-Davson-Robertson model in several respects, and in our 
opinion is more consistent with the principles of macromolecular 
structure as they are currently understood." In fact this model is 
not very different from the modified bilayer model of Stein &
Danielli (Fig. 6) and is generally supported by the improved x-ray 
diffraction data (Finean et al., 1962; Wilkins, et al., 1971) and by 
electron microscope studies associated with freeze-dtching techniques, 
which, as Branton (1969) pointed out, suggest that not only lipid 
hydrocarbon but also some globular protein molecules occupy the centre 
of the membrane in the Davson-Danielli model. The mosaic model of 
Lenard and Singer (1966) regards the protein molecule, like the 
phospholipids, as amphipathic with at least one highly polar end, 
exposed to the aqueous phase, and with non polar portions which are 
embedded in the hydrophobic interior of the membrane. This model 
satisfies the physicochemical data and is thermodynamically sound in 
that the polar areas of both lipid and protein are in direct contact 
with the aqueous environment while their hydrophobic portions are 
embedded in the centre of the bilayer away from the structured mass 
of water molecules. The mosaic model is not only thermodynamically 
sound but also provides a pathway for polar molecules through the
14.
lipid bilayer (via transmembrane proteins) without the need for 
ad hoc modifications such as the protein-lined pores of the modified 
bilayer model of Stein and Danielli (Fig. 6). The model is supported 
by chemical labelling of membrane proteins and also by freeze-etching 
or freeze fracture electron microscopy. Bretscher (1971) used a membrane- 
impermeable reagent - FMMP, to label membrane protein in both
erythrocyte chosts and in the intact erythrocyte. Double-labelled 
proteins were found following extraction from ghosts but not from 
intact membranes. Freeze-etching has been used to study most functional 
membranes, including plasmalemmal, vacuolar, chloroplast, mitochondrial, 
and bacterial membranes (Branton, 1969; Bayer & Remson, 1970) and 
particular attention has been given to erythrocyte membranes (Pinto 
da Silva & Branton, 1970; Tillack & Marchesi, 1970; Pinto da Silva & 
Nicolson, 1974). Most biological membranes show a mosaic-like 
structure consisting of a smooth matrix interrupted by a large number
integral proteins 
4-
Fig. 9. After Lenard & Singer (1966) and Singer (1971)
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of particles of uniform size that is characteristic for a particular
o
membrane (for example 85 - A diameter for erythrocyte membrane).
It has been demonstrated that the lipids of biological 
membranes, under physiological conditions, are in a fluid rather 
than a crystalline state. This has been shown by means of spin- 
labelling experiments (Hubbell et al., 1968; Kieth et al., 1968), 
differential scanning calorimetry (Stein et al., 1969; Melchoir et al.,
1970) and X-ray diffraction studies (Engelman, 1970; Wilkins et al.,
1971). The fluidity concept was introduced to the mosaic model by 
Singer & Nicolson (1972) in the form of the fluid mosaic model 
(Fig. 10) which regards the membrane as a solution of integral 
proteins in a two-dimensional, viscous solvent system of phospho­
lipids. The viscosity of the membrane lipid matrix has been estimated 
by several methods, such as fluorescence polarisation (Rudy & Coilter
1972), electron spin resonance (Lang et al., 1974) and flash photo­
lysis (Poo & Cone, 1974). Edidin (1974) has pointed out that bio­
logical membranes have the apparent viscosity of light machine oil.
The fluid mosaic model allows the lateral movement of
membrane components. Paramagnetic and nuclear magnetic resonance
studies have shown that phospholipid molecules move rapidly in the
plane of the membrane with diffusion coefficients of the order of 
—8 2
10 Cm /S (Kornberg & McConnell, 1971; Scandella et al., 1972;
Devaux & McConnell, 1972) and similar results have been obtained 
from other techniques such as partitioning of isotopically-labelled 
hydrophobic compounds (Rigand et al., 1972), fluorescence polari­






Fig. 10. After Singer & Nicholson (1972)
fluorescent eximer formation (Galla & Sackman, 1974)
Considerable interest was aroused by findings (Inbar et al.,
1973), based on fluorescence polarization, that transformed cells 
showed increased membrane fluidity relative to normal controls.
However subsequent workers have found comparable or even lower 
fluidity in transformed cells when these were examined by a range of 
techniques including fluorescence polarization (Nicolan et al., 1978), 
e.s.r. spectroscopy (Gaffney, 1975; Hatten et al., 1978; Lee & 
Scandella, 1979), resonance energy transfer (Ferandez & Berlin,
1976), excimer formation rates (Edwards et al., 1976; Burleson 
et al., 1978) and fluorescence photobeaching recovery (Eldridge 
et al., 1980).
17.
The effect of lipid composition on the lateral mobility 
of membrane components was studied by Axelrod et al., (1980) who 
manipulated the lipid composition of cells grown in culture 
(Horwitz, 1977) and measured the lateral mobility and distribution 
of fluorescence-labelled membrane components (Axelrod et al., 1976; 
Koppel et al., 1976). They pointed out that "Substantial membrane 
lipid fatty acyl changes in primary cultures of myotubes from chick 
did not substantially affect the lateral mobility of either a 
membrane lipid probe or of the acetylcholine receptor, an integral 
membrane protein."
Integral membrane proteins generally have been found not 
only to rotate about an axis perpendicular to the plane of the 
membrane (Brown, 1972; Cone, 1972) but also to diffuse laterally 
within the plane of the membrane. Frye and Edidin (1970) first 
demonstrated this in a classic experiment wing cell fusion. They 
differentially labelled protein components of mouse and human cells 
before using Sendai virus to cause membrane fusion giving hybrid 
cells. After 40 minutes at 37°C the components of the two membranes 
were completely intermixed. The lateral diffusion coefficient of 
membrane proteins in this experiment was estimated by Frye and 
Edidin to be approximately 2 x 10 Cm^/S. Diffusion coefficients 
of a number of membrane proteins have since been determined, for 
example Poo and Cone (1974) have followed the redistribution of 
rhodopsin molecules after bleaching of part of the retinal rod mem­
brane and arrived at a diffusion coefficient for rhodopsin of 
3.5 X 10 ^ cm^/S.
18.
Despite the evidence for lateral mobility of both membrane 
lipids and proteins there are also indications that structural res­
traints can operate to impede the mobilities of certain membrane 
components and attention has recently been directed towards these 
restraints. Lateral movement can be restricted by several mechanisms 
which can be classified into two categories.
I - Intramembrane restraints
Among the mechanisms which restrict the lateral mobility of 
membrane components is the association of the components themselves. 
Lipid-lipid or protein-protein interactions can be mediated by non- 
covalent forces leading to the formation of aggregates or paracrys- 
talline arrays. Oesterhelt & Stoeckenius (1971), using bacterial 
systems, have studied the non-covalent association of membrane com­
ponents into paracrystalline aggregates in the plane of the bilayer.
A similar type of ordering of membrane components has been observed 
in mammalian cells at cell junctions (McNutt & Weinstein, 1973;
Gilula, 1974). Another mechanism has been shown in the sequestration 
or exclusion of membrane components to (or from) specific lipid 
domains. Kleeman et al. (1974) and Kleeman & McConnell (1974) have 
shown that fluid-solid lateral separations can occur, at critical 
transition temperatures, in bacterial membranes from fatty acid 
auxotrophes (bacteria in which the lipid composition of the membrane 
can be experimentally manipulated). Furthermore Steir & Sackman 
(1973), from their work on liver microsomal membranes, have demonstrated 
the existence of quasi-crystalline aggregates. They showed that 
the cytochrome P450 - cytochrome P450 reductase complex of the 
liver microsomal membrane is entrapped in a halo of lipid molecules
19.
which remain rigid at temperatures where the rest of the hilayer is 
fluid. It has been shown that lipids in the annulus (the nearest 
neighbours) around a protein (Marcelja, 1976) are more ordered than 
bulk lipids, because of steric restrictions to their rotational free­
dom. Second and third lipid neighbours could also be affected but to
a much smaller extent. A particularly well-studied system is 
2+ 2+
(Ca , Mg )-ATPase of sarcoplasmic reticulum (see Lee, 1977 for 
review) in which both rotation freedom and activity are controlled 
by the fluidity of the lipid annulus, this in turn being controlled 
by the nature of interactions between the lipid and the protein.
When the ATPase is reconstituted in a model membrane with dipalmitoyl 
phosphatidylcholine, the fatty acyl chains of dipalmitoyl phosphatidyl­
choline in the annulus around the ATPase are highly immobilized 
Xi.e, they have relatively little rotational freedom), at temperatures 
below approx. 32°C, and the rigidity of the lipid microenvironment 
prevents the normal operation of the ATPase. Above 32°C, however, 
the fluidity of the annular lipids begins to increase allowing 
increasing ATPase activity. The presence of immobilized lipid has 
also been suggested around cytochrome oxidase (Jost et al., 1973) 
and cytochrome-b (Dehlinger et al., 1974).
II - Peripheral membrane restraints
Restraining forces can also result from the presence of 
peripheral lattices of protein extending across large portions of 
the inner or outer surfaces. These lattices or networks may link 
specific components and impede their lateral mobilities. Weiss & 
Subjeck (1974) have pointed out that myosin is a component of both 
the inner and the outer surface of membranes. This peripheral com­
ponent may effect a fine control over membrane components by
20.
linking specific membrane domains.
A particular protein network has been clearly demonstrated 
in human red cell membrane (Lux, 1979a), This network functions 
like a membrane skeleton which imposes extrinsic stability to the 
membrane and may be a major determinant of red cell shape (Lux et al.,
1977), deformability, and membrane structural integrity. Spectrin 
and actin (see protein section, page 45) are major components of 
this system and have been found to be vital for maintenance of normal 
erythrocyte shape. Sheetz and Singer (1977) found that ghosts of 
normal erythrocytes are echinocytic in isotonic media but gradually 
resume a biconcave shape, in the presence of Mg ATP, a process 
which can be accelerated by small amounts of bivalent antispectrin 
antibodies. The authors have suggested that the antibodies facili­
tate the shape change process by promoting polymerization of the 
membrane skeleton. Birchmeier & Singer (1977) showed that unpolymer­
ised muscle G-actin inhibits the shape change, presumably by compet­
ition for the spectrin components with endogenous erythrocyte actin. 
The shape change has also been shown to be inhibited by cytochalasins 
which show a binding affinity for the P-spectrin-actin complex 
(Lin & Lin, 1978a; 1978b). The association of spectrin dimers or 
tetramers with actin has shown a requirement for other components 
such as, for example, band 4.1 (see protein section). Fowler &
Taylor (1978) have reported that oligomeric complexes of spectrin, 
actin and band 4.1, extracted from red cell membrane cause actin to 
gel and that purified spectrin dimers or tetramers lack this 
activity, suggesting a requirement for band 4.1. Ungewickell et al. 
(1979) have observed that, at physiological ionic strength, pelelle- 
table ternary complexes and, in some cases, gel are formed only
21.
from spectrin tetramers, F-actin (polymerized) and band 4.1 but not 
from binary mixtures of these proteins or from ternary mixtures if 
the actin is unpolymerised (G-actin),
The lateral mobility of red cell membrane proteins 
(Benett & Branton, 1977; Benett, 1978) and lipids (Mombers et al., 
1977; Haest et al., 1978) is now generally accepted to be restricted 
by interactions with the inner membrane cytoskeleton. There is 
convincing evidence that the point of linkage involves a binding 
protein called "ankyrin" that is probably band 2.1 (see protein 
section)(Bennett & Stenbuck 1979a; Luna et al., 1979). Bennett & 
Stenbuck (1979b) have reported that ankyrin is firmly linked to 
some band 3 molecules, (10-20% of the total) in detergent extracts 
of spectrin-depleted red cell membranes. They also noted that band 
4.2 protein is also associated with band 3 in these extracts.
A general model for the cytoskeleton of animal cells has 
been described (Nicolson, 1976 ). This includes microfilaments, 
which contain actin and thick filaments similar to polymerized 
myosin. Another component comprises microtubles which are poly­
meric complexes of the protein tubulin (Fig, 11). On the basis 
of the actions of the drugs colchicine and cytochalasin B, which 
disrupt microtubules and microfilaments respectively, Yahara & 
Edelman (1973),(1975) and Poste et al., (1975) have suggested that 
microtubules àhd mictofilaments act in opposition to control move­
ment of intrinsic membrane proteins.
The function of microfilaments, containing actomyosin- 
like fibres, is envisaged as being mainly contractile, serving to 
direct intrinsic protein within the plane of the membrane. Micro-
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tubules may serve as an anchoring system which, when required, 
opposes the above function.
Microfilaments have been detected by negative-stain 
electron microscopy which indicates that the cytoskeleton is 
organised as a two-dimensional web of irregular, beaded microfilaments 
either 35A° (Liu et al., 1978) or 80-120A° wide (for reference see 
Lux, 1979a). X-ray diffraction studies by Pape et al (1977) supported 
the 35A° dimension and indicated that the protein layer on the cyto­
plasmic membrane surface is about 40A° thick on average.
Despite many recent advances in the study of the cyto­
skeleton certain general points remain to be established, and many 
structural details must still be pursued. We have a fairly clear 
picture of how the principal skeletal proteins are organized. Lux 
(1979b) has suggested an organisation involving "long, flexible, 
bifunctional, spectrin tetramer strands crosslinked at each end 
through interactions with actin and band 4.1" (Fig. 12). Nevertheless, 
Lux emphasized that the true skeleton is undoubtedly more complicated 
than the model shown in Fig. 12 as "Skeletal proteins like bands 4.2, 
4.9 and 7 are not included in the model since too little is known 
about their location and function. Band 4.1 must attach to the 
bilayer in some way since most of it remains on the membrane when 
spectrin and actin are extracted at low ionic strength, and spectrin 
chains must often cross each other since the average spacing between 
ankyrin linked band 3 dimers (*\* 375-530A°) is considerably less 
than the average length of a spectrin tetramer (*v 2000A°)".
23.
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Fig. 12. After Lux (1979b)
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4. Plasma Membrane Components 
4.-A. Lipids
Membrane lipids are polar lipids containing both a hydro- 
phobic tail (aliphatic chains of fatty acids, aldehydes or alcohols) 
and a hydrophobic head within the molecule.
In the generally-accepted bilayer structure of biological
membranes (Fig, 13) the long hydrophobic tail groups are sequestered
within the interior of the membrane and all the hydrophilic head
groups face the aqueous environment. The major driving force for
the assocation of these hydrophobic tails results from entropie
factors rather than from specific apolar-apolar interactions. The
development of this picture of membrane structure has been discussed
in an earlier section (page 5 ). It is, however, noteworthy that
Van Meer (1980), having considered the results of De Krüjff et al.
(1978) and Steir et al (1978), pointed out that "application of 
31p-NMR revealed that some of the phospholipid molecules experience 
a high isotropic motion indicating that part of the phospholipids 
in these membranes are not arranged in a classical bilayer."
The hydrophobic and hydrophilic regions are linked by 
bridging moieties which can be glycerol, sphinganine derivatives 
or a sterol molecule (Fig, 14) and cutting across these classi­
fications are the three main categories of lipids namely, phospho­
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Phospholipids are the most polar of the lipids and result 
when a phosphate moiety is attached, via an ester band, at c-1 of 
either glycerol (to form glycerophospholipids) or to a sphinganine 
derivative (to form phosphosphingolipids)(Fig. 14).
Glycerophospholipids contain the Sn-glycerol 3-phosphate 
moiety either as a monoester (Fig. 15, X * H) or as diester linked to 
one of the remaining X groups listed in Fig. 15).
A considerable range of hydrophilic head groups occurs 
among the glycerophospholipids, differing not only in size but also 
in shape, polarity and charge. For example phosphatidic acid has a 
phosphate acidic grouping with PK^ 1-2 with a negative charge at 
neutral pH, whereas both phosphatidylcholine and phosphatidylethanol- 
amine are neutral at pH 7.0 because they both have, additionally, 
aminogroups with pKa 13 and 10 respectively. Phosphatidylserine, 
phosphatidylglycerol and phosphatidylinositol on the other hand are 
negatively charged at physiological pH ranges.
The hydrophobic tails of glycerophospholipids are usually 
made up of fatty acyl chains linked by ester bands to the glycerol 
moiety. Analogues of these diacyl compounds carrying 0-alkyl or 
0-1 alkenyl chains also occur. In addition, monoacyl derivatives 
such as lysophosphatidylcholine, and to a lesser extent lysophos- 
phatidylethanolamine, have been reported as minor components of many 
membranes. There is some evidence that these latter compounds arise 
from specific phospholipase action. Such action has been shown by 
Nilson et al (1977) who reported that "Phospholipase A^ treatment of 
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been suggested that lysophospholipids, which are often produced as a 
result of snake venom phospholipases are instrumental in membrane 
lysis but recently Van Meer et al (1980) pointed out-that although 
lysophospholipids arise from phospholipase-induced hydrolysis of 
membrane phospholipids, there is little evidence of resulting damage 
or of significant changes in the phospholipid bilayer configuration 
of the membrane.
The second major class of phospholipids the phosphosphingo­
lipids are based on one of three main structural types of sphingoids 
(sphinganine derivatives) which are: sphinganine, sphingosine (trans- 
4-sphengenine) and phytosphingosine (4-D-hydroxysphinganine)
(Fig. 16 a, b and c respectively). The first two derivatives occur, 
in low and large amounts respectively, in animals. The third derivative 
exists in plants and fungi. Bacteria were thought not to contain 
phosphosphingolipids but some sphinganine-containing lipids have now 
been characterized in Bacteroides melaninogenicus (Rizza et al., 1970).
The compound derived from combination of a sphinganine 
derivative with a fatty acid via an amide linkage is known as a cera- 
mide (Fig. 17, I) and the commonest phosphosphingolipid is sphingo­
myelin (ceramide 1-phosphocholine) itself derived from ceramide by 
addition of a phosphocholine head group (Fig. 17, II). Sphingomyelin 
occurs in relatively high concentrations in mammalian plasma membranes. 
Ceramide 1-phosphoinositol (Fig. 17, III) is a further naturally- 
occurring phosphosphingolipid that is found in plants and fungi.
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The distribution of phospholipids between the two monolayers
of biological membranes has been studied by means of a number of
techniques including the use of phospholipases (Op den Kamp, 1979),
31P-n.m.r. (Van Meer et al., 1980) and phospholipid-exchange proteins 
(Wirtz & van Deenan, 1977; Machida & Ohnishi, 1980). The earliest 
results were obtained from erythrocyte membranes. Verklej et al. (1973) 
used phospholipases to demonstrate that choline-containing phospholipids 
are located mainly in the outer monolayer of erythrocyte membranes 
whereas amino phospholipids are largely confined to the inner monolayer. 
These results have been confirmed by other groups (Kahlenberg et al., 
1974; Zwaal et al., 1975) working with 'right side-out* and 'inside- 
out* resealed erythrocyte ghosts and by the chemical studies of 
Bretscher (1972), Gordersky & Marinetti (1973) and Whitby & Berg 
(1974). Asymmetry of phospholipids has also been demonstrated in 
virus membranes (Rothman & Lenard, 1977) in which the detailed distrib­
ution of individual phospholipids differs markedly from that in the 
erythrocyte membrane (Fig. 18). Despite the accumulation of consider­
able evidence for membrane assymetry derived from specific systems it 
has been emphasized by Op den Kamp (1979) that "it is too early, 
however, to declare it as a firmly established general phenomenon."
The means by which membrane asymmetry is maintained are 
unclear. Membrane-bound enzymes, themselves asymmetrically located, 
are often surrounded by specific phospholipids (De Pierre et al., 1975) 
and.the different chemical environments of the two sides of the membrane 
may well be expected to lead to specific localization of the various 
phospholipids (Op den Kamp, 1979). It has been suggested that 
eukaryotic cells exposed to serum such as erythrocytes (Giordesky &
33,
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Fig. 18. Assymetric distribution of phospholipids in membranes of 
human erythrocytes (a) and of influenza virus grown in 
bovine kidney cells (b). After Rothman and L e n a r d ( l 9 7 7 )
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Marinetti, 1973; Renooij et al., 1976), hépatocytes (Nilsson & Dallner,
1977) and fibroblasts (Mark-Malchoff et al., 1977) may show asymmetric 
distribution of lipids as a direct result of exchange of serum lipid 
components with the surface membrane. Fontain and Schroder (1979), 
however, have studied the distribution of aminophospholipids in a 
tumourigenic, transformed murine fibroblast grown in the absence of 
serum, lipids or proteins and showed clear asymmetric distribution of 
the membrane phospholipids suggesting that such asymmetry may be an 
intrinsic property of eukaryotic cell membranes.
It has been claimed that spectrin (see protein section page 45  ^
can help to maintain phospholipid asymmetry in erythrocyte membranes 
and that crosslinking or damaging of spectrin allows the inner membrane 
phospholipids, phosphatidylserine and phosphatidylethanolamine to "flip- 
flop" to the outer lipid layer (Haest et al., 1978).
A functional role for lipid asymmetry is also questionable. 
Asymmetry of phospholipids has been implicated in platelet aggregation 
(Zwaal et al., 1977), sickle cell anaemia (Giordesky et al., 1972) cell 
transformation (Mark-Malchoff et al., 1977) and coupling of the 3“ 
receptor with adenylate cyclase (Hirata & Axelrod, 1978) while 
Schroeder, (1978) suggested that phospholipid asymmetry may also 
account for differences in fluidity between the two halves of tumour 
cell plasma membranes. The questions both of the generality of lipid 
asymmetry and of its function remain open and await more data before 
they can be solved.
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Glycolipids
Glycolipids result when a mono or oligosaccharide complex is 
glycosidically linked to c-1 of glycerol (Fig. 14a) or a sphinganine 
derivative (Fig. 14b). The attachment of carbohydrate molecules is 
believed to proceed in a stepwise manner and to be catalysed by 
specific glycosyl transferases. The carbohydrate moiety of the glyco- 
lipid is exposed only to the external environment (Gahmberg &
Hakomory, 1973). Mammalian glycolipids are largely based on sphingosine. 
Cerebrosides (Fig. 19)-are ceramide monosaccharides occurring most 
abundantly in the myelin sheath of nerves. On hydrolysis they yield 
one molecule of sphingosine, a fatty acid, and hexose (galactose or, 
less commonly, glucose). More complex glycolipids in mammalian membranes 
occur which contain several additional monosaccharide units. These can 
include N-acetylgalactosamine, N-acetylglucosamine, and N-acetylneuraminic 
acid. When ^ -acetylneuraminic acid is a component, the glycolipids are 
commonly referred to as gangliosides. Fig. 20 shows the structures of 
the major gangliosides of mammalian tissues.
It is well established that substances responsible for the 
ABO blood group specificities are glycolipids and a number of such 
glycolipids have been isolated from the membranes of erythrocytes.
The first to be characterised were sphingolipids with short carbo­
hydrate chains of 5-10 sugar molecules (Koscielack, 1973). More 
complex glycolipids, the so-called poly (glycosyl) ceramides, with 
about 60 carbohydrate units per molecule of sphingosine have recently 
been reported as blood-group active materials present on the surface 
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Fig. 20. Structures of the major gangliosides of mammalian tissues.
G = ganglioside, M = monosialo, D = disialo, T = trisialo, 
and arabic numerals indicate sequence of migration in 
thin-layer chromatograms. After Harrison & Lunt (1980)
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Sterols
The third of the three major classes of membrane polar lipids 
is that of the sterols. The most abundant sterol in animal tissues is 
cholesterol, the structure of which is shown in Fig. 14c. Cholesterol 
contains a hydrophilic hydroxyl group substituted at c-3 of a hydro- 
phobic molecule. Neutron diffraction experiments with selectively 
deuteriated cholesterol indicate that cholesterol is deeply embedded 
in the hydrocarbon region of the lipid bilayer so that the cholesterol 
OH group is positioned in the vicinity of the glycerol backbone of 
neighbouring phospholipids (Worcester & Franks, 1976). Therefore the 
incorporation of cholesterol into a lipid bilayer influences mainly the 
packing of the hydrocarbon chains of phospholipids and direct inter­
action with the polar head group at and beyond the phosphate segment
can probably be excluded. This conclusion has been supported by 
31
measuring P chemical shielding anisotropy in pure lipid/water 
mixtures with and without cholesterol (Cullis, 1976; Brown & Seelig
1978).
It is believed that the hydrophobic molecule interacts 
with the first 10 carbon atoms of neighbouring phospholipid molecules 
in a lipid bilayer (Demel & Kruyff, 1976) and so restricts the mobility 
and increases the stability of biological membranes. However 
Cherry et al. (1980) have reported that "It is well established that 
cholesterol either decreases or increases ’fluidity* depending on 
whether the temperature is above or below the chain melting temperature 
(Tc ) of the lipid." Therefore the addition of cholesterol to 
phosphatidylcholine bilayers at temperatures above 23.8°C, the chain- 
melting transition temperature, decreases the fluidity of the bilayer 
whereas at temperatures below 23.8°C it increases the fluidity (for
38.
reviews see Rubenstein et al., 1979 and refs, cited therein). It 
has been suggested (Inbar et al., 1974; Inbar & Shinitzky, 1974; 
Shinitzky & Inbar, 1974; Inbar, 1976) that a relatively low cholesterol/ 
phospholipid ratio is the main reason for the apparently increased 
fluidity of leukaemic and lymphoma lymphocytes. Later workers, 
however, have attributed these reported differences in fluidity to 
inadequate purification (Pagano et al., 1977; Johnson & Nicolau, 1977; 
Johnson & Kramers 1978) or to differences in the concentration of 
free fatty acids and glycerides rather than to a low cholesterol 
concentration (Johnson & Robinson, 1979). The influence of choles­
terol on membrane fluidity has been considered from an immunochemical 
point of view by Brulet & McConnell (1977) who found that cholesterol 
affects complement fixation at low hapten concentrations. This may be 
by way of enhancing hapten exposure to antibody binding sites, thereby 
promoting antibody binding and so facilitating complement fixation.
In the single bilayer vesicle, the simplest system for study­
ing the localization of lipid components in biological membranes, the 
localization of cholesterol and various phosphatidylcholine species 
has been determined indirectly by De Kruijiff et al. (1976) who pointed 
out that at concentrations of below 30 mol %, cholesterol is equally 
distributed between the halves of the bilayer whereas it shows a 
preference for the inner monolayer at higher concentrations. A more 
direct approach based on cholesterol exchange between 1:0.9 dipalm- 
itoyllecithin-cholesterol vesicles and red-cell ghosts (Poznansky & 
Lange, 1976) indicated the presence of 71% exchangeable and 29% 
non-exchangeable cholesterol pools in the vesicles. These results 
correlate well with the evidence of Huang (1974) that 70% of the 
total membrane cholesterol is located on the outer half of the bilayer.
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More recently Poznansky & Lange (1978) have confirmed that twice as much 
as cholesterol is located in the outer monolayer as in the inner layer 
and that this ratio is little influenced by the nature of the phosphatidyl­
choline present.
Cholesterol is a minor sterol component of membranes of higher 
plants in which the major sterols are frequently sitosterol (Fig. 21) 
and stigmasterol (Fig. 22).
7-Dehydrocholesterol (with a second double bond at C-7) is 
a minor component of some mammalian intracellular membranes. Ergo- 
sterol (Fig. 23) is a major sterol of membranes, in eukaryotic micro­
organisms, and has been shown to stabilize yeast plasma membranes 
against osmotic lysis. Similar results have been obtained for stig­
masterol, also present in many microorganisms, whereas sterols lacking 
the c-22 double bond are less effective in this respect.
24
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Fig. 21. Sitosterol Fig. 22. Stigmasterol Fig. 23. Ergosterol
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Phase transitions
When a lipid-water system is heated, a liquid crystalline- 
gel phase transition of the bilayer form occurs at the so-called 
transition temperature (below the melting point of pure lipid).
The phase transition can be defined as a two dimensional co­
operative transition which is normally caused by raising the temper­
ature but can also be induced by changing the ionic strength or the 
pH of the surrounding aqueous medium (Trëuble & Eibl, 1974; Simon 
et al., 1975; Trëuble et al., 1976). While the endothermie phase 
transition of a single lipid system (a pure complex lipid of single 
fatty acid species) is sharp, it is broader for lipids of mixed 
fatty acid composition. Many factors can effect the two character­
istics of the phase transition (temperature and enthalpy of trans­
ition). These include the chain length of the hydrocarbon chains, 
nature of the phospholipid head group and the ionic strength of 
the surrounding medium (Blum, 1979). It has also been reported 
that the temperature of the phase transition is dependent on the 
pressure of dispersion (i.e. the higher the pressure of dispersion, 
the higher the temperature of the phase transition) indicating an 
increase in molecular volume during the transition (Srinivansan 
et al., 1974; Liu & Kay, 1977). The transition temperature is 
also dependent on the addition of other lipids such as choles­
terol, the effect of which is to decrease the fluidity of the 
liquid-crystalline membrane state (see page 37 ) and even to
eliminate the phase transition in lipid membranes. Such effects
31of cholesterol have been shown by using p NMR in erythrocyte 
membranes (Cullis, 1976) and also by means of differential scanning 
calorimetry in pure lipid membranes (Phillips, 1972). Addition of
4l.
equimolar concentrations of cholesterol to phosphatidylcholine and 
phosphatidylethanolamine eliminates the phase transition and small 
changes in the head group structure occur with increasing choles­
terol concentrations (Brown & Seelig, 1978).
The biological relevance of the thermally-induced phase 
transition is discussed by Gruen (1980) who stated that "In bio­
logical tissues at ambient temperatures, the lipids in cell membranes 
are at a temperature above the transition temperature (Tc ). It is 
important, if model systems are to be relevant to biology, that 
their behaviour above Tc should correspond as closely as possibly to 
the real system."
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Studies carried out using p NMR (Cullis & De Kruijff, 1978), 
X-ray (Reiss-Husson, 1967; Rand et al., 1971) and freeze-fracture 
techniques (see Cullis & De Kruijff^ 1979)have resulted in observations 
which indicate that non-bilayer structures may occur in biological 
membranes. Cullis & DeKruijff (1978) have reported that mixtures 
of Soya bean lipids exhibit polymorphic phase behaviour in which 
the bilayer phase is observed at temperature below -10°C but at 
higher temperatures (0-50°C) the hexagonal (H^^) phase is observed 
(Fig. 24). Other non-bilayer configurations, the inverted micellar 
and cubic or rhombic phases (Fig. 24), have also been reported by 
the latter authors who proposed that "the bilayer structure of 
lipids in biomembranes may be in dynamic equilibrium with other 
available phases. In the light of such possibilities a mechanism 
of "flip-flop" phenomena in biological membranes is suggested,"
These observations are supported by other data (Rand et al., 1972;
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Corresponding P NMP spectra
50 p.p.m. H->
Fig. 24. After Cullis, P.R. et al. (1979)
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however, noteworthy that unsaturated phosphatidylethanolamines, which 
show a preference for the hexagonal (H^^) phase (Cullis & De Kruijff,
1978), are found in high concentrations in the membranes of Gram 
negative bacteria ^.g. Escherichia coli, where phosphatidylethanol­
amine makes up 85% of the outer membrane phospholipid (TrMuble & 
Overath, 1973)^ and are major components of other bacterial and 
mammalian cell membranes (for ref. see Cullis & De Kruijff, 1978).
Temperature-dependent phase transitions which indicate 
the occurrence of non-bilayer configurations inside the bilayer, 
and also rapid exchange, "flip-flop", between these phases and the 
bilayer have also been observed in endoplasmic reticulum membranes 
derived from bovine and rabbit liver (De Kruijff et al., 1978;
Stier et al., 1978) and from intact rat liver (De Kruijff et al.,
1979). De Kruijff and others have reported that at 37°C microsomal
preparations (isolated vesicular fragments of the endoplasmic
31reticulum) give rise to p NMR spectra indicating isotropic motion 
which is consistent with the occurrence of inverted micellar or 
(short) cylindrical arrangements of lipid inside the bilayer, 
and suggesting that membrane lipids experience rapid exchange 
between these structures and the bilayer lipid.
...........  44..
4"B. Proteins
Proteins of biological membranes have been divided into 
two broad categories (Singer &' Nicolson, 1972; Capaldi and 
Vanderkooi, 1972). Firstly, extrinsic (or peripheral) proteins 
are weakly associated with the membrane and are predominantly 
bound by electrostatic interactions (Rosenberg and Guidotti,
1969; Hoogeveen et al., 1970; Clarke 1971; Maddy, Dunn and Kelly, 
1972). These proteins are soluble in aqueous media and are relat­
ively easily dissociated from the membrane by mild treatments such 
as manipulations of ionic strength or pH. Peripheral proteins are 
believed to be associated with the polar head groups on the outer 
faces of the lipid bilayer, so that they appear to be exposed 
either to the extracellular or to the cytoplasmic environment.
In view of reversible associations between some cytosol proteins 
and plasma membranes ^.g. liver plasma membrane (Emmelot & Bos, 
1972)]] certain peripheral proteins have been considered to be 
cytoplasmic contaminants. However peripheral proteins do 
resemble soluble cytoplasmic proteins not only in the composition 
and sequence of their amino acids but also in their three dimen­
sional structure and their solubility in aqueous systems.
Examples of peripheral proteins are found in the red cell 
membrane (Fig. 25) (Marchesi & Steers, 1968; Marchesi et al., 
1970; Nicolson et al., 1971; Marchesi et al., 1976; Lux, 1979a) 
and include spectrin, actin, band 4 (4.1, 4.2 and 4.9), ankyrin 
(bands 2.1, 2.2, 2.3, 2.6) and band 6 components all of which are 
in physical contact with the cytoplasmic side of the membrane 
although bands 2.1, 2.2 and 2.3 have been labelled at both mem­
brane surfaces (Stares & Richards, 1974; Staros et al., 1975).
45.




Fig. 25. Schematic representation of the major polypeptides of 
the human erythrocyte membrane Glycophorin A (PAS 2), 
Glycophorin B (PAS 3), band 3 polypeptide (3), 
Spectrin (1 and 2), band 4.1 polypeptide (4.1), 
band 4.2 polypeptide (4.2), ankyrin polypeptides (2) 
and band 6 polypeptide (6).
After Harrison & Lunt (1980)
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All these proteins (except bands 2.6, 4,2 and 6) have been found 
to remain after extraction of ghosts (Yu et al., 1973) or intact 
red cells (Sheetz et al., 1978) with nonionic detergent such as 
Triton X-100. Lux et al. (1976) have shown that spectrin is the 
major component of these residual proteins, and that it accounts 
for 76% of the skeletal protein. Spectrin has been found to be 
composed of two large subunits, band 1 (240.000 daltons) and 2 
(220.000 daltons) which are structurally similar but not 
identical (Aderson, 1979). Tn fact purified spectrin heterodimers 
(bands 1 + 2) and heterotetramers (band 1 + 2)^ have been isolated 
and sized (Ralston, 1976; Kam et al., 1977). Ungewickell & Gratzer 
(1978) have defined the equilibrium relationships of these mole­
cules and pointed out that the tetramer is the physiological
species. Recently Shotton et al. (1979) have shown that spectrin
o o
dimers are long (*V/ 1000 A), Slender (*v 50 A), worm-like molecules
in which the two subunits are aligned in parallel and variably
coiled about each other. When these dimers join end to end, they
form tetramers. This confirms the work of Ralston (1976) and
Kam et al. (1977) which indicates that the dimers join head to head,
Actin (band 5), which accounts for approximately 5%-10% 
of the membrane skeletal protein, has been found to have the same 
molecular weight as muscle actin (Tilney & Detmers, 1975), and 
forms functional actomyosin hybrids with muscle myosin (Ohnishi, 
1977; Puszkin et al., 1977). It can be purified from ghosts by 
muscle actin extraction procedures (Tilney & Detmers, 1975; Sheet 
et al., 1976; Ohnishi, 1977).
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The association of band 4.1 with the spectrin-actin com­
plex has been discussed in an earlier section (page 20 ) in which 
it was mentioned that other proteins might also be involved.
Cross linking studies indicate that band 4.9 protein also is 
physically close to band 2 of spectrin (Palek & Liu 1979) and 
band 7 has been shown to be present in equimolar quantities with 
spectrin in skeletons prepared from intact red cells. This com­
ponent is not as prominent in skeletons prepared from ghosts 
(Lux et al., 1976).
Other examples of peripheral protein are shown by the 
basic protein of myelin (Eng et al., 1968) and cytochrome C, which 
is associated with the outer surface of the inner mitochondrial 
membrane (Schneider et aî., 1972). Recently, peripheral proteins, 
with molecular wèights of 84,000 and 50,000-60,000 have been 
extracted with urea from AH-66 Hepatoma Aseites cells, and have 
been shown, by iodination with lactoperoxidase labelling to be 
located on the outer surface of the membrane (Kishi et al., 1980).
Intrinsic (or integral) proteins are much less easily 
dissociated from the membrane. They penetrate deeply into the 
lipid bilayer, being tightly anchored in the hydrophobic domain. 
For example, rhodopsin, found in the retinal rod outer-segment 
membrane, has its carbohydrate portion (Heller and Lowrence,
1970; Steineman and Stryer, 1973) exposed at the surface of the 
membrane and its hydrophobic segment buried in a fluid lipid 
domain (Blaurock and Wilkins, 1972; Steineman and Stryer, 1973). 
Another example of an intrinsic protein is cytochrome b^ which was 
shown by Strittmatler et al. (1972) to be an amphipathic molecule
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in which the C-terminal 48 amino acid segment is a hydrophobic 
fragment that is largely embedded in the membrane, whereas the 
N-terminal 104 amino acid segment is a hydrophilic fragment pro­
truding from the membrane and susceptible to proteolytic 
cleavage. Most of the information concerning membrane proteins 
and glycoproteins has been obtained from studies on the glyco- 
peptides of human erythrocytes (Marchesi et al., 1976; Marchesi,
1978). Glycophorin is an integral glycoprotein of this membrane 
which it spans (Fig. 25); The glycoprotein comprises a poly­
peptide chain of B1 amino acid residues (Fig. 26) the N-terminal 
80 residues of which carry carobhydrate in the form of 16 oligo­
saccharide side chains. 15 of these are 0-glycosidically linked 
and one is N-glycosidically-bound (see the glycoprotein section). 
This is the external hydrophilic segment and is linked to a 
hydrophobic segment, of about 22 amino acid residues, which spans 
the thickness of the membrane. This is in turn attached to an 
internal hydrophilic sequence extending to the C-terminus of the 
chain. The overall amino acid composition of glycophorin is not 
greatly different from that of many soluble glycoproteins and 
does not alone explain its ability to strongly associate with 
membrane lipids. However, the amino acid sequence of glycophorin 
is distinct from that of soluble glycoproteins in that there is 
a high proportion of charged amino acids at both ends of the mole­
cule with predominantly hydrophobic amino acids arranged, probably 
in the form of an a-helix, in between. Another integral protein 
in the human erythrocyte is the band 3 component, which appears 
to be organized with glycophorin into an oligomer-glycoprotein 
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This glycoprotein is shown diagramatically in Fig, 25.
Recently, studies on the major human histocompatibility 
(HLA) antigens have shown some structural similarities with 
glycophorin A. The C-terminal region of the 44,000 dalton HLA 
glycoprotein chain consists of a hydrophobic region followed by 
a cluster of basic amino acids terminating with a relatively 
hydrophobic sequence (Robb et al., 1978). Nakojo et al. (1979) and 
Kishi et al.(1980) have demonstrated another example of an 
intrinsic protein which was isolated from the plasma membrane 
of AH-66 cells by Funakoshi and Yamashina (1976). This was shown 
to resemble glycophorin of human erythrocyte membranes in chemical 
composition, but to have a significantly higher molecular weight.
The general arrangements of integral proteins have been 
discussed by Singer (1974), who described two possible forms 
(Fig. 27). The first of these is monodispersed protein in which 
a hydrophilic segment protrudes from the membrane and a hydrophobic 
segment is embedded in it. These two segments are linked by a 
region of the chain. An example of this form is cytochrome b^.
The second form would be a subunit-aggregate form which might have 
a narrow water-filled channel running down its central axis.
Singer suggested that glycophorin A might constitute an example 
of this second type, although band 3, with its anion-transporter 
function, is probably more likely to exist in such a form.
A more complex arrangement has been reported in the 
lipoprotein of the outer membrane of E. coli (Braun & Bosch,
1972; Braun, 1973; Ihouye, 1974; Braun et al., 1976; Lee et al., 
1977; DiRienzo et al., 1978) in which an a-helix, with one
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hydrophobic face, can be formed involving the hydrophobic amino 
acids of the lipoprotein chain, A suitable arrangement of six 
such helices would make up a polymeric complex with a hydro- 
phobic outer shell and an interior hydrophilic channel which 
might serve a transport function.
- ^ +
0000
ooooo Ô O O O O
a, A single-chain monodisperse
00000
b. A subunit aggregate structure
Fig. 27. After Singer (1974)
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Labelling and separation of membrane proteins
In order to characterize membrane proteins and to define 
their location within the membrane complex, it is necessary to 
have available techniques for their isolation and also for their 
labelling by reagents having differential access to various parts 
of the membrane.
Proteins exposed on the outer surfaces of cell membranes 
can be specifically labelled in a number of ways (Carraway, 1975; 
Juliano, 1975; Hubbard et al., 1976). The lactoperoxidase- 
catalysed iodination procedure (Phillips & Morrison, 1971;
Hubbard & Cohn, 1972) involves or ^^^I-labelling of tyrosyl
and histidyl residues of proteins. Provided that short reaction 
times are used, the size of the enzyme (approx, 78,000 molecular 
weight) precludes its penetration of the cell membrane and res­
tricts labelling to its outer surface. Other non-penetrating 
reagents such as formylmethionylsulphonemethylphosphate
(Bretscher, 1971) or [^^s]-sulphonic acid diazonium salt 
(Bender et al., 1971) have been used to label the amino groups 
of proteins exposed on the outer surface of cell membranes, while 
Rifkin et al. (1972) have reported the use of borohydride
to reduce Schiff's bases formed between aldehydes and protein 
amino groups.
Labelling of cell surface carbohydrate residues is 
commonly achieved by periodate oxidation of cis diol groupings 
(particularly on sialic acid) followed by [fn] borohydride 
reduction of the resulting aldehyde groupings (Blumenfeld et al., 
1972). Alternatively, galactose oxidase can be used to oxidise
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specifically galactosyl or N-acetylgalactosaminyl residues prior 
to tritiated borohydride reduction (Gahmberg & Hakomori, 1973) 
or labelling with [^^s]-methioninesulphone hydrazide (Itaya 
et al., 1975).
Selective labelling of proteins exposed on the inner 
surface of the membrane is less easy but has been possible in a 
number of cases. Thus identification of proteins exposed on the 
cytoplasmic surfaces of erythrocyte membranes has been facilitated 
by the availability of sealed inside-out vesicles (Steck, 1972). 
Latex-filled phagosomes have also been used as a source of 
inside-out plasma membrane to identify transmembrane proteins in 
cultured mouse cells (Hunt et al., 1975; Evans et al.,(1977).
More recently it has been shown that plasma membranes isolated 
on either polylysine-coated polyacrylamide beads (Jacobson et al., 
1977; Cohen et al., 1977) or polylysin-coated glass beads 
(Kalish et al., 1978) are equivalent to inside-out vesicles with 
respect to the transmembrane proteins. Accordingly, Cohen et al. 
(1980) showed that double-label experiments, in which labelling by 
galactose oxidase borohydride treatment was performed first
for intact HeLa cell membranes and again after isolation on 
polylysine-coated polyacrylamide bead, identified several 
proteins which may span the membrane.
Analysis of membrane proteins, whether labelled or not, 
has been made very much easier by the development of polyacrylamide 
gel electrophoresis in sodium dodecyl sulphate (SDS). SDS disrupts 
non-covalent associations in proteins causing dénaturation. The 
result is an extended rod-like molecule to which the amphipathic
54.
SDS units are attached via hydrophobic interactions with their 
charged residues externally disposed. In general, unit length of 
extended polypeptide chain binds a constant number of SDS molecules 
giving SDS-protein complexes of equivalent shape and with electro­
phoretic mobility characteristic of their size (Steinhardt & 
Reynolds, 1969). SDS-polyacrylamide gel electrophoresis 
accordingly allows rapid determination of molecular weights of 
membrane proteins (Shapiro et al., 1967; Weber & Osborn, 1969) 
and identification of particular labelled species. Moreover the 
denaturing conditions employed ensure that not only are intrinsic 
membrane proteins freed from lipid interactions but are also 
obtained in disaggregated form.
The separation of intrinsic membrane proteins is a 
general problem and entails the use of detergents or other agents 
capable of disrupting the hydrophobic interactions within the 
membrane. Standard protein fractionation procedures can be 
employed but must be carried out in the continued presence of 
the solubilizing agent. Otherwise aggregation and precipitation 
of the protein will result. Non-ionic detergents particularly 
have been used to solubilize integral membrane proteins from a 
range of membrane systems without loss of membrane function or 
apparently denaturing the protein (Helenious & Simons, 1975; 
Tanford, 1976). The non-ionic detergent Triton X-100 has 
recently been used to remove all non-interacting membrane lipids 
and proteins in attempts to study the attachment of integral 
membrane proteins to peripheral proteins of the cell cyto- 
skeleton (Koch et al., 1978; Sheetz et al., 1978).
Peripheral membrane proteins behave essentially as normal 
soluble non-membrane proteins and need no special procedures for 
their isolation and characterisation.
4.C Glycoproteins
_ Glycoproteins are proteins with covalently-bound carbo­
hydrate side chains arranged in linear or branched structures 
(Finne et al., 1978). The carbohydrate component comprises 
1-80% by weight of the glycoprotein molecule and can contain up 
to 60 or more residues. Both peripheral and intrinsic membrane 
proteins can be glycoproteins and isolation of the water-soluble 
peripheral membrane glycoproteins proceeds by standard biochemical 
procedures. Intrinsic membrane glycoproteins, on the other hand, 
are commonly insoluble in aqueous solutions and, as has been 
discussed in an earlier section (page 54)» must be released from 
the membrane lipid bilayer by organic solvents, detergents or 
chaotropic reagents. Purification then proceeds by gel filtration, 
ion-exchange chromatography etc. in the presence of detergent 
to prevent aggregation. Proteolytic digestion of the purified 
intrinsic glycoprotein will often lead to release of water- 
soluble peptides containing the carbohydrate residues which can 
then be analysed by standard techniques.
Iternatively, proteolytic enzymes can be used to cleave 
surface peptides directly from the intact cell. The resulting 
water-soluble glycopeptides containing all the carbohydrate of 
the membrane glycoproteins can then be purified and analysed by 
standard means. Affinity chromatography using immobilized lectins
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(see page 66) is a particularly powerful tool in the fractionation 
of glycoproteins or glycopeptides and can also be carried out in 
the presence of detergent when necessary.
C.a Oligosaccharide structures of plasma membrane glycoproteins
Carbohydrate complexes commonly found in animal cell 
glycoproteins contain N-acetylneuraminic acid (sialic acid) the 
neutral sugars fucose, mannose and galactose and the amino sugars, 
N-acetylglucose amine and N-acetylgalactosamine. These sugars 
are grouped together in oligosaccharide complexes which are 
joined to the polypeptide chain by covalent linkages. A number of 
carbohydrate-polypeptide linkages have been reported (Marshal &
Neuberger 1970) but the most commonly encountered linkages are 
of two types. The first comprises an N-glycosidic bond (Fig. 28a) between 
the reducing end of N-acetylglucosamine and the g-amide group of 
asparagine (Marshall & Neuberger, 1970). This type of linkage 
is often found in soluble plasma glycoproteins and is sometimes 
referred to as "plasma type" (Kreamer 1971). The second type of 
linkage is the 0-glycosidic bond between the reducing end of N- 
acetylgalactosamine and the hydroxyl group of serine or threonine (Fig. 28b) 
Such 0-glycosidic linkages are abundant in mucin and have been 
called "mucin type". However it has been pointed out that this 
is not a satisfactory classification as both types often occur in 
membranes on the same polypeptide chain (Winzler 1969; Pepper and 
Jamieson, 1969; Jackson & Seaman, 1972).
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It is well established that the N-glycosidic linkage is 
relatively stable to hydrolysis by alkali whereas the 0-glycosidic 
linkage is labile to mild alkaline treatment. Mild alkaline 
treatment of the whole glycoproteins or glycopeptide can 
accordingly be used to release the 0-glycosidically linked 
oligosaccharide complexes for further structural studies. Alkali 
cleavage involves B-elimination of the glycosidically-linked 
sugar moieties as shown in Fig. 29.
Treatment is usually carried out with alkaline boro­
hydride rather than with alkali alone. This has two advantages. 
Firstly, the released N-acetylgalactosamine is protected from 
alkaline degradation by reduction to N-acetylgalactosaminitol. 
Secondly, the double-bonded amino acids 2-aminoacrylic acid 
(from serine) and 2-aminocrotonic acid (from threonine) are 
reduced to the more stable alanine and 2-aminobutyric acids 
respectively. Moreover the appearance of these latter amino 
acids can be monitored to detect the original points of linkage.
Release of the N-glycosidically-linked sugar complex 
is less easy and a number of approaches to this problem will be 
dealt with in a later section (page 64).
N-glycosidically-linked oligosaccharides of soluble 
glycoproteins generally possess a core sequence containing mannose 
and N-acetylglucosamine. The latter is usually attached to 
asparagine, in the sequence Asp- GlcNAc.- Glc NAc to which 
branched chains of mannose are coupled. Two basic types of 
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1 - A high mannose type which contains several
mannose residues peripheral to the Man -»
(Glc NAc)2 Core. An example of this type is 
the thyroglobulin unit A (Ito et al., 1977) 
which is shown in Fig. 28aI.
2 - A complex type in which chains containing Gal Glc
NAc - sequences are attached to the internal 
branched mannose residues. The non-reducing ends 
of the chains are completed by neuraminic acid 
residues. Such complex type oligosaccharides are 
found for example in human serum transferrin 
(Fig. 2Sa II) (Spik et al. , 1975) .
The N-glycosidically-linked oligosaccharide structures 
of membrane glycoproteins appear to conform to the general patterns 
described above. Thus many workers have shown analogous structures 
in membranes of different cells such as mouse spleen cells 
(H-2 alloantigens) (Nathenson, 1974), human fibroblasts (Muramtsu 
et al., 1976a), rat brain (Krusius, et al., 1976) and ascites 
hepatoma cells (Nakada et al., 1976).
The O^glycosidically linked blogisaccharides usually 
contain some or all of the sugars L-fucose, D-galactose, N-acetyl 
D-galactosamine and N-acetylneuraminic acid, and such chains are 
commonly smaller than those of the alkali-stable oligosaccharides. 
An exception to the above statement is found in the case of the 
blood group substances (Fig. 30) for which Kornfeld & Kornfeld 










































































































The alkali-labile oligosaccharides of membrane glyco­
protein often contain a core structure, Gal-gl-3-GalNAc, linked 
to serine or threonine via N-acetyl D-galactosamine. It is 
commonly found that N-acetyl neuraminic acid substitutes this 
disaccharide giving trisaccharides (Fig. 31a) or a tetrasaccharide 
(Fig. 31b). The trisaccharide (Fig.. 31a(i),) has been reported in 
human erythrocyte membranes (Thomas & Winzler, 1969), in delipid- 
ized total rat brain (Finne, 1975), in TA-3 mammary carcinoma 
cell surface epiglycanine (Codington et al., 1975) and in bovine 
milk fat globule membrane (Farrar & Harrison, 1978). The alter­
native trisaccharide (Fig. 31a(ii), on the other hand, has only 
been demonstrated in bovine milk fat globule membrane (Farrar & 
Harrison, 1978) and in rat brain membrane (jamefelt et al., 1978).
The tetrasaccharide (Fig. 31b) was first reported in 
glycopeptides from human erythrocyte by Thomas & Winzler (1969) 
on the basis of periodate oxidation data. This technique was 
also used, in combination with alkaline degradation, by Newman 
et al. (1976a) to demonstrate the presence of the tetrasaccharide 
on bovine milk fat globule membrane and by Glbckner et al. (1976) 
who identified the same structure on membranes of horse, sheep 
erythrocytes.
Further evidence for occurrence of the tetrasaccharide 
structure has been obtained from the application of serological 
and chemical methods to membrane glycoproteins from pig lympho­
cytes (Newman et al., 1977). Recently, the combination of méthy­
lation, gas liquid chromatography and mass spectrometry allowed 
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delipidized rat brain (Finne, 1975) and from glycopeptides
derived from bovine milk fat globule membrane (Farrar & Harrison, 1978)
C.b Analytical techniques used in the study of membrane glycoproteins 
A number of approaches have been developed for the study 
of the carbohydrate portions of membrane glycoproteins which are 
generally present in only very low amounts. The fractionation 
and purification of small quantities of material has been in 
many cases facilitated by growing cells in the presence of radio- 
actively-labelled sugars (e.g. j^lT]-fucose (Muramatsu, 1971;
Ogata-Arakawa, 1977), [fll] mannose (Koide et al., 1979),
or -D-galactose (Prujansky-Jacobovit et al., 1979))
and so obtaining radiolabelled glycoproteins which can be 
easily followed through separation procedures (Li et al., 1978).
Following the isolation of a specific glycoprotein, 
analysis of the carbohydrate component usually requires its 
separation from the protein chain. This can readily be achieved 
for 0-glycosidically-linked oligosaccharides by mild alkaline 
treatment (see page 58 ). N-Glycosidically-linked sugar com­
plexes are less easy to isolate. In this case, one approach has 
been to treat the glycoprotein extensively with proteolytic 
enzymes which tend to leave the carbohydrate complexes attached 
to a small residual peptide chain (Thomas & Winzler, 1969). 
Alternatively, methods have more recently been developed for 
chemical cleavage of the N-glycosidic glycopeptide linkage by 
hydrazine which releases intact carbohydrate complexes from the 
fragmented polypeptide (Kobata et al., 1979). Endoglycosidases 
specific for glycosidic linkages near the oligosaccharide-pep-
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tide junction have become available in the last ten years 
(Flowers & Sharon, 1978) but these will only cleave oligosaccharides 
of certain maximum size (see page yo ) and so are of limited use 
in structural analysis of more complex carbohydrate complexes.
Once an oligosaccharide complex relatively free from 
amino acids has been isolated then standard carbohydrate analy­
tical techniques can be applied. These include acid hydrolysis 
and periodate oxidation (Marshall & Neuberger, 1972) coupled with 
gas chromatography (and possibly also mass spectrometry) of 
alditol acetate or trimethylsilyl ether derivatives of mono­
saccharide components (Cook, 1976). Sequential action of 
specific exoglycosidases can also be used to elucidate the 
organisation of sugar units within the complex and again gas 
chromatography can be used in parallel with this approach.
Apart from rigorous chemical analysis of oligosaccharide 
complexes attached to membrane glycoproteins it is often to deter­
mine to what extent specific sugar residues are exposed on the 
surfaces of intact cell membranes particularly in the context of 
their participation in recognition events (see pages 75-104).
In this respect the lectins have become very important. Lectins 
are proteins, usually of plant origin, that carry specific binding 
sites for certain simple carbohydrates, and are accordingly of 
use, not only in detection of cell surface sugars but also in the 
fractionation of glycoproteins by means of affinity chromatography.
Many recent reviews (Lis & Sharon, 1973; Nicolson, 1974; 
Sharon & Lis, 1975; Lis & Sharon, 1977; Goldstein & Hayes, 1978; 
Lotan & Nicolson, 1979) have reported detailed information on
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lectin purification, properties and their biological effects on 
cells. These reviews describe lectins as saccharide-binding 
proteins and glycoproteins which bind mono- or oligosaccharides 
with great specificity through complementary sugar-binding sites. 
Their interactions with carbohydrate-containing molecules and cells 
resemble those of antibodies, involving at least two saccharide- 
binding sites per molecule. Binding of lectins to cell surfaces 
often accordingly results in cell agglutination.
Almost all of the lectins that have been isolated and 
characterized exhibit specificities for saccharides on the surface 
of erythrocytes (Lotan & Nicolson, 1979) and haemagglutination of 
animal or human erythrocytes by lectins has become established as 
a technique for studying lectins. The presence of lectins in 
plant extracts, animal tissue homogenates or serum can be detected 
by these means and their specificities can be determined by 
inhibition of the lectin-induced haemagglutination by using simple 
carbohydrates of known structure. Many lectins have been charact­
erised in this way and their binding specificities have been 
established. For instance concanava1in A (Con A) binds specifically 
to a-D-mannose or a-D-glucose, soybean agglutinin (SEA) to D- 
galactose and N-acetyl-D-galactosamine, wheat germ agglutination 
(WGA) to N-acetyl-D-glucosamine, peanut lectin to the disaccharide 
galactoryl Bl*^3-^-acetylgolactosamine, anti-H lectin (Ulex 
europaeus) to L-fucose and di-N-acety1-chitobiose (for refs, see 
Sharon & Lis, 1972) and lectin from Bandeiraea simplicifolia binds 
to a-D-galactose (Hayes, 1974). Several observations suggest that
6 7 • . ,
WGA may also bind N-acetylneuraminic acid (Redwood & Polefka (1976); 
Jordan et al., 1977; Bhavanandan, 1978; Sheik Fareed et al., 1978). 
Recently Sabnis & Hart (1978) reported that one of the wellr 
characterized major proteins of the phloem exudate of the pumpkin 
(cucurbita maxima) and also of other membranes of cucurbitacae 
was a lectin. Also Allen (1979) has reported the presence of a 
lectin in the marrow (cucurbita pepa)-fruit exudate and in related 
species. This latter lectin has been demonstrated to be specif­
ically inhibited by an NN -diacetyldiaminodisaccharide, and is 
therefore similar in specificity to the lectins from wheat-germ 
(Allen et al., 1973), the potato tuber (Allen & Neuberger, 1973) 
and thomapple (Datura Stramonium) (Pardoe et al., 1970;
Pardoe et al., 1970; Kilpatrick & Yeoman, 1978).
Many reviews (Lis & Sharon, 1973; Goldstein & Hayes,
1978) have pointed out that although the commonest source of plant 
lectins has been the seeds of legumes, lectins are also found in 
plants of other families. Moreover lectins are found not only 
in seeds but also in roots, leaves and tubers. Recent studies 
have begun to define the physiological role of lectins in plants 
(Kbhle and Kauss, 1979).
Relatively little information is available concerning
lectins from animal sources. A g-galactoside-binding lectin
activity has detected in tissue of electric fish (Teichberg et al.,
1975), and a few other mammalian lectins have been purified and
characterized. For example, a plasma membrane component of
2+
hepatocytes has been described which requires Ca for binding to 
sialoglycoproteins and erythrocytes (Hudgin, 1974; Stockert et al..
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1974) and De Waard et al. (1976) have purified a g-Galactoside 
binding lectin from cal heart and lung.
Lectins of known saccharide-binding specificities have
been employed for demonstrating the presence of sugars exposed on
the surfaces of various erythrocytes and cells. Both direct
and indirect techniques have been used for such studies. Binding
of fluorescent and electron-dense lectin derivatives to the
surface of various cell types has been observed using light and
electron microscopy, respectively (Nicolson, 1976; Nicolson, 1978;
Roth, 1978; Lotan, 1979). Horisberger et al. (1977) using electron
microscopy have shown the ability of certain gold-labelled lectins
to bind in a specific manner to the surface of human and bovine
milk fat globules. Quantitative binding of radioactivity-labelled
lectins to cells has indicated the presence of 10^-10^ binding
sites per cell on the surfaces of various cells with binding
6 7 - 1
affinities ranging from 10 to 5.10 M (Sharon and Lis, 1975;
Lis and Sharon 1977).
More recently lectin-induced agglutination of intact human 
and bovine milk fat globules has been used by Farrar et al. (1980) 
to demonstrate the sugars exposed on the surface of milk fat 
globules.
In direct evidence concerning the exposure of specific 
sugars on cells has been obtained from hapten-inhibition experi­
ments in which the ability of mono- and oligosaccharides of known 
structure to inhibit the agglutination of cells by lectins has 
been used to indicate the presence of similar or identical sugars
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on the cell surface. Occasionally problems arise in this approach 
For instance Sabsin & Hart (1978) reported that lectin extracted 
from phloem exudate of the pumpkin (cucurbita maxima) agglutinated 
human erythrocytes, but that none of the saccharides that were 
tested inhibited the reaction. Haemagglutination-inhibition 
techniques have been used by Newman et al. (19.76) to study a 
phenol-extracted glycopeprotein fraction from bovine milk fat 
globules and Newman and Uhlenbruck (1977) have also used native 
and desialylated human milk fat globule membrane glycoproteins 
to inhibit peanut lectin-induced agglutination of desialylated 
erythrocytes. Hapten inhibition studies have also been used by 
Farrar & Mohanna (unpublished results) to define immunodominant 
groupings of bovine milk fat globule membrane using anti- 
(bovine MFGM) antisera.
The detailed analysis of the carbohydrate components of 
membrane glycoproteins requires the isolation of the oligo­
saccharide complexes free from protein. It is for other 
purposes sometimes desirable to remove the carbohydrate while 
keeping the protein intact. This is the situation when the 
possible contribution of carbohydrate to functional activity of 
a glycoprotein is being considered and is particularly relevant 
to consierations of the antigenic sites of membrane glycoproteins.
Carbohydrate residues can be largely cleaved (but not 
necessarily removed), depending on their linkages, by periodate 
oxidation, which, if used carefully will not affect protein 
residues (Spiro, 1964; Christensen et al., 1975).
Nevertheless the oligosaccharides are not completely removed by
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these means and there is always a danger of oxidising certain 
amino acid residues ( Spiro, 1964; Clamp & Hough, 1965), 
cysteine and tyrosine.
Mort et al. (1977) have recently reported that anhydrous 
hydrogen fluoride will remove carbohydrate from glycoproteins 
while leaving the protein intact. They claimed that " ... during 
the cleavage of glycosidic linkages by anhydrous hydrogen fluoride 
there is little or no degradation of the sugars themselves and 
no increase in the heterogeneity of the protein." Koch et al. 
(1956) and also Lenard & Hess (1964) have shown that peptide bonds 
are stable in HF at 0°C and also at room temperature for several 
hours, although Lenard et al. (1964) have reported the slow 
cleavage of methionyl peptide bonds at room temperature and 
Lenard and Hess (1964) have described an easily reversed N to 0 
acyl shift under these conditions. Within the carbohydrate 
complexes it appears that hydrogen fluoride cleaves all the glyco­
sidic linkages of neutral and acidic sugars at 0°C while leaving 
glycopeptide linkages intact. More severe treatment with 
anhydrous hydrogen fluoride for 3h at 23°C cleaves the 0- 
glycosidic linkages but not the N-glycosidic linkages.
In 1971, Moramatsu reported the isolation of an endo- 
glycosidase in the culture fluid of Diplococcus pneumoniae 
(Muramatsu, 1971) and a year later another endoglycosidase was 
reported in Streptomyces (Tarentino et al., 1972). Since their 
discovery, the enzymes have been extensively studied with regard 
to their ability as tools in glycoprotein research. Both cata­
lyse the cleavage of the core di-N-acetylchitobiose linkages of
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N-glycosidically-linked oligosaccharide complexes (Fig. 28a I & II) 
and are accordingly named as endo-g-N-acetylglucosaminidase D 
(from Diploroccus) and endo-B-N-acetylglucosaminidase H 
(from Streptomyces) or more commonly as endoglycosidase D and 
endoglycosidase H respectively (Koide & Muramatsu, 1974;
Tarentino et al., 1974). _
Endoglycosidase D can act upon glycopeptides and glyco­
proteins provided that an unsubstituted core al-»-3 linked mannose 
unit is present as in the general structure shown in Fig. 32 
(Ito et al., 1975; Tai et al., 1975).
R -*■ Man al Fuc al
6 . M  _
Man 31 Glc NAc 31 ^ 4 Glc NAc->-*- Asn 
Man al Fig. 32
If this mannose unit (underlined in Fig. 32) is substit­
uted or lacking then the oligosaccharide is not a substrate for the 
enzyme. In view of the general structures shown by ‘c o m p l e x * (Fig. 28aII) 
oligosaccharides of glycoproteins it is clear that these will 
only be cleaved by endoglycosidase D after prior * trimming* to 
the required substrate form by exoglycosidases such as 3~galac- 
tosidase and 3"N-acetylglucosaminidase. Enzyme combinations of 
this type have been used to split * complex* oligosaccharides off 
glycopeptides from thyroglobulin (Koid et al., 1974), or well 
directly off intact glycoproteins such as IgG, fetuin and trans­
ferrin (Muramatsu et al., 1977).
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Endoglycosidase D also hydrolyzes an oligosaccharide 
(Man)^ (Glc NAc>2 (Muramatsu et al., 1978) indicating that the 
peptide portion of substrates does not have much effect on 
susceptibility to the enzyme.
Endoglycosidase H is best suited to the cleavage of 
*high-mannose* type oligosaccharides (Fig. 28^1)°^ the general 
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where R, R and R" are mannose chains but can contain N-acetyl- 
glucosamine (Tarentino et al., 1974). The enzyme has been used to 
cleave oligosaccharides of this type from intact glycoproteins 
such as thyroglobulin (Turentino et al., 1973), IgM and 
invertase (Tarentino et al., 1974). Recently endoglycosidase H 
has also been used to cleave glycopeptides prepared from 
embryonal carcinoma cells (Muramatsu et al., 1980) and 
together with endoglycosidase D, by Koide et al. (1979) in 
their studies on mannosyl glycopeptides from cultured fibro­
blasts and their viral transformants. These studies concluded 
that oligosaccharides, released by digestion with endoglycosidases, 
were identical in normal cells and in virally transformed cells. 
Tarentino et al. (1975) have pointed out that (Man)^ (Glc NAc)^
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peptide is very slowly attacked by the endoglycosidase H while 
attachment of a fucosyl residue to the innermost ^-acetylglucosanine 
as in Fig. 34 completely abolishes substrate activity.
Endo-g-N-Acetylglucosaminidase (endoglycosidase C^) 
has been isolated from Clostridium perfringens (Ito et al., 1975) 
and has been found to have a specificity similar to that of 
endoglycosidase D. Other enzymes with specificity similar to 
that of endoglycosidase D have been isolated from hen oviduct 
(Tarentino et al., 1976) and from fig latex (Chien et al., 1977), 
while enzymes with specificity similar to that of endoglycosidase H 
have been isolated from Clostridium perfringens (endoglycosidase C^^) 
(Ito et al., 1975) and again from fig latex (Chien et al., 1977; 
Ogata-Arakawa et al., 1977).
A third general type of endoglycosidase, endo-g-N-acetyl- 
glucosaminidase L, has been isolated from Stroptomyces griseus 
(Tarentino & Maley, 1974). It hydrolyses the asparaginyl carbo­
hydrate (Fig. 33) to the disaccharide Man-6” (1" 4^)- GlcNac and N- 
acetylglucosaminyl-L-asparagine (Glc Nac 6 (l^N)Asn), and also, 
unlike Endo-H, (Glc NAC)^ to(Glc NAC)2 plus Glc NAc, and (Glc NAc)^ 
to 2(Glc NAc)2 at twice the rate observed for Man (Glc Nac)2 Asn 
(Trimble et al., 1979).
However none of the endoglycosidases discussed above 
is capable of hydrolysing intact complex glycopeptides of the 
type shown in Fig. 34 which are common in animal glycoproteins 
(Kornfeld & Kronfeld, 1976). Complete cleavage can, however, 
be achieved after removal of the peripheral sialic acid, 
galactose and N-acetylglucosamine residues, as described previously.
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followed by endoglycosidase D treatment (Koide et al., 1977) 
(Fig. 34), and also can be achieved by endoglycosidase H after 
removal of the core-bound L-fucose (Tarentino & Maley, 1976).
6-N-Acetylglucosaminidase
NANA -Gal -GlcNAc'Man a(l 6)
X
NANAfGal- GlcNAc-Man a (l-»3) 
6-Galactosidase 
Neuraminidase
Man 6 ( W )  GlcNAc 6 (1
L-Fuc a(l->6) 
■4)g 1cNAc e (!-*«) Asn
Endo-g-N-acetylglucosaminiolase D
Fig. 34. After Koide et al. (1977).
Removal of sugars from IgG by glycosidase digestion
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4.C.C Glycoproteins as antigens
i. Glycoproteins as antigens of ABO and Lewis blood groups
It was in the beginning of the twentieth century that
the ABO blood-group system was discovered by Landsteiner (1900), 
This system is based on the occurrence of A and B active 
materials (antigens) on human red cells.. These antigens are 
complemented by antibodies of opposite specificities in the 
blood serum as shown in Table 1.
Blood group Antigen on red cell Antibody in serum
A A Anti-B
B B Anti-A




Table 1. Antigen and antibody characteristics of the 
ABO blood group system
Red cells of group 0 carry an H antigen for which 
antibodies are present in some non-human species.
76.
The structural basis of the ABO and related Lewis
a ' b . . .
(Le X Le ) activities has been extensively discussed.
Landsteiner et al. (1924) reported that material responsible 
for ABO blood group activity could be extracted from red cells 
with ethanol. He also suggested that this material was lipid 
in nature. However it was not until the discovery of blood, 
group substances in a water-soluble form in secretions 
(Lehrs, 1930) that real progress was made towards their chemical 
characterization. The soluble substances are glycoproteins 
and their availability on a relatively large scale was of 
great advantage.
The blood group determinants on the red cell surface were 
studied indirectly by using serological techniques in which mono­
saccharides were used as inhibitors of haemagglutination. Thus 
Watkins & Morgan (1952) showed that ^-fucose alone inhibited the 
agglutination of type 0 cells by anti H lectins, whereas the N- 
acetyl-a-2rgalactosaminopyranosyl group (Morgan & Watkins, 1953) 
inhibited the agglutination of group A cells by anti A lectins.
The a-D-galactopyranosyl group (Rabat & Leskowitz, 1955) was 
similarly identified as the immunodominant structure of B blood 
group activity. Furthermore these results were later confirmed 
when a-galactosidase a-^-acetylgalactosaminidase and a-L-fuco- 
sidase were found to destroy the activities of B (Zamitz &
Rabat, 1960), A (Weissman & Hinrichsen, 1969) and H blood-groups 
(Bahl, 1970) respectively.
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The definitive chemical characterisation of blood group 
active substances followed from the isolation, purification and 
analysis of the secreted glycoproteins (Rabat, 1956; Morgan,
1959, 1960). In this way were determined the complete carbo­
hydrate structures (Fig. 35) of the blood group active complexes.
Because of the difficulties of isolating large quantities 
of erythrocyte membrane components it was not until the 1960*s 
that the ABO blood-group active substances could be obtained from 
erythrocyte membranes themselves (Fig. 36). The first compounds 
so to be isolated were glycosphingolipids with short carbohydrate 
chains composed of 5 to 10 sugar molecules (Roscielack, 1963; 
Hakomori & Strycharz, 1968; Hakomori et al., 1972, and 
Roscielack et al., 1973)% Recently it has been shown that ABH anti­
gens are also present in the form of complex poly (glycosyl) 
ceramides containing as many as 59 sugar residues (Gardas & 
Roscielak, 1976; Dejter-Juszynski, 1978).
During the last ten years glycolipid ABH antigens of 
gastrointestinal and other tissues (Hakomori, 1981, and references 
cited therein) have been identified as fucose-containing glyco­
sphingolipids with a chemical composition similar to that of 
blood group glycolipids of erythrocyte membranes (Fig. 37).
ABH blood group active glycopeptides also have recently 
been detected in erythrocyte stroma (Takasaki & Robata, 1976; 
Takasaki et al., 1978; Finne et al., 1978; Rrusius et al., 1978; 
Jarnefeldt et al. 1978).from which two types of carbohydrate 
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A* GalNAc«1




jGaldl —  4GlcNAcd1 —  3Gald1 —  4GlcNAcd1 —  3Gald1 —  4Glc —  Ceramide
l-Fuco 1 
A‘ L-Fucor 1
G^aldl —  4GlcNAcd1
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A" Similar to A' exact structure undetermined
(2) 8-active components 
B, Gakri








H, l-FucoI —  2Gaid1 —  4GlcNAcd 1 —' 3Gald1 — 4Glc —- Ceramide
Hy l-FucoI - 2Gald1 *4GlcNAcd1 ^ 3Gald1 - 4GlcNAcdl 3Gald1 —  4Glc —  Ceramide
Hj L-Fuco 1 —  2Gald1 —  4GlcNAcd1^
gGaldl — ' 4GlcNAcd1 —* 3Gald 1 —' 4Glc —  Ceramide
L-Fucal —  2Gald1 —  4GlcNAcd 1 
H* Similar to Hj, exact structure undetermined
Fig. 36. Structures of Blood group glycolipid variants isolated 
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(Fig. 38)(for a review see Hakomori, 1981). Schenkel-Brunner 
(1980) determined the proportions of ABO blood group antigenic 
sites present in glycolipids and glycoproteins. He converted 
the blood-group-H sites of native human 0-type erythrocytes 
in situ into blood-group-A determinants by transfer of labelled 
N-acetylgalactosamine residues using a-N-acetylgalactosaminyl 
transferase from blood-group-A^ individuals. After partitioning 
the red cell membranes between water and organic solvents the 
author concluded that "blood-group ABH activity of human eryth­
rocytes is determined preferenially by group-specific glyco­
proteins rather than glycolipids."
The blood group active glycolipids are constituents 
of cell membranes (Koscielak et al., 1972) and of blood plasma 
(Marcus & Cass, 1969). Only the latter glycolipids display Lewis 
(Marcus & Cass, 1969) as well as A, B or H blood group specificities 
(Schacter et al., 1972) whereas the former have high A, B or H 
(Koscielak et al., 1972) but not Lewis activities (Koscielak,
1963). It is now generally accepted that the Lewis activity of 
erythrocytes must be derived from glycolipids adsorbed from 
blood plasma (Kôscielak et al., 1973; Race & Sanger, 1975).
However an Le^-active sphingoglycolipid with the structure; 
g-galactosyl-(L+3)-[a-fucosyl-(l-4)]-2-acetamido-2-2deoxyglucosyl- 
(I+3)-galactosyl(I+4)-glucosyl-(l+I)-Ceramide has been isolated 
from human adenocarcinoma (Hakomori and Jeanloz, 1964, 1965;
Hakomori et al., 1967; Hakomori, 1967).
The biosynthesis of ABO and Lewis blood group determinants 
by gene-determined glycosyl transferases is shown in Fig. 39.
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Type 1 chain-precursor 









H and Le genes
(a 2 and a 4 fucosyl
transferases)
H gene 
(a 2 fucosyl 
transferase)
Gal 31---3 Glc NAc-
2
I
Fuc a 1 Fuc a 1
[Le'a












Gal a 1-3 Gal 3 1-3 Glc NAc 
2
Fuc a 1
Fig. 39. Biochemical pathways for the conversion of type 1 chain
endings in precursor glycoprotein into Le*, A and B active 
structures. [_ ] specific activity of structures; ( )
specificity of enzymes. Gal = D-galactose:GlcNAc = 
N-acetyl-D-glucosamine; GalNac = N-acetyl-D-galactosamine; 
Fuc = l-fucose. After Watkins (1972)
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ii. Glycoproteins as antigens of the Sd* blood group
Glycoproteins are also involved in Sd* blood group 
activity. It has been reported (Sanger et al., 1971; Bird & 
Wingham, 1971) that Sd* blood group activity resembles that of 
the A blood group in that they both depend upon a terminal N- 
acetylgalactosamine. Furthermore, Sd* positive cells from 
group 0 or A individuals which react strongly with human anti- 
Sd* sera are also agglutinated by the lectins from Dolichos 
biflorus and Helix pomatia, both specific for blood group A 
determinants (Race & Sanger, 1975).
Blood group Sd* was initially identified by Macvie et al. 
(1967) and Renton et al. (1967). This blood group is inherited 
as a dominant character and individuals are classified into two 
types, Sd (a+) and Sd (a-).
Sd*-active substances are not only expressed on red cells 
but also in most human secretions (Morton & Terry, 1970; Morton 
et al., 1970) with the greatest concentration in urine and 
meconium. Investigations of the chemical nature of the Sd*- 
active substances using urine (Morgan et al., 1978; 1979) 
suggested that Sd* activity is an integral property of the well- 
known Tamm and Horsfall urinary glycoprotein (Tamm & Horsfall,
1950, 1951; Soh et al., 1980). This glycoprotein, a constituent 
of all urines, has been extensively studied and its physical, 
chemical and immunological properties have been identified 
(Fletcher, 1972).
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iii. Glycoproteins as antigens of MNS^-blood groups
The MN blood group system was first defined by 
Landsteiner & Levine (1928a,b), and subsequent work has shown 
that receptors for the MN blood group system are located on glyco- 
prôteins of the human erythrocyte (Klenk & Uhlenbruck, 1960; 
Lisowska, 1963; Springer et al., 1966; Hamagushi & Cleve, 1972; 
Fukuda & Osawa, 1973). Glycophorin A is the glycoprotein on 
which the MN-antigens are located (Azuma et al., 1973;
Tuech & Morrison, 1974; Tomita & Marchesi, 1975), whereas the 
closely related Ss-antigens are located on glycophorin B 
(Hamaguchi & Cleve, 1972; Singer & Morrison, 1974).
MN activity of glycophorin has been shown to be dependent 
on the presence of alkali-labile oligosaccharide complexes con­
taining sialic acid (Springer & Young, 1971). These complexes 
have been analysed by Thomas & Winzler (1969) and been shown to 
be largely based on the tetrasaccharide structure shown in 
Fig. 40ii. A similar structure (Fig. 40i) was reported in the 
same year by Adamany and Kathan (1969) but this latter structure 
has been found not to be consistent with periodate oxidation 
data obtained from the intact glycoprotein (Romanowska &
Bardnowski, 1963; Lesowska & Duk, 1972; Dahr et al., 1974). In 
view of the fact that apparently identical oligosaccharides were 
obtained by treatment of either M or N glycoproteins with alkali 
(Thomas & Winzler, 1969; Adamany & Kathan, 1969) it has been con­
cluded that, while essential for MN activity, these groups do not 
carry the antigenic specificity. The role of the polypeptide 
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Fig. 40. Three structures for alkali-labile oligosaccharides
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(Lisowska & Duk, 1975; Wasniowska et al., 1977) that chemical modi­
fication of the amino groups of glycophorin abolished MN specificity 
and by demonstration of this activity on deglycosylated glyco­
proteins (Lisowska & Kordowicz, 1976). Dahr et al. (1977) 
purified MN-active sialoglycoproteins from MM, NN and MN cells 
and found that the N-terminal group of MM sialoglycoproteins 
was serine while that from NN cells was leucine. MN-active 
sialoglycoproteins carried both groups. Moreover Lisowska &
Wasnjowska (1978) have characterised cyanogen bromide-cleaved 
fragments of glycophorin that are just eight amino acids long 
and show M or N specificity. They carry apparently-identical 
carbohydrate residues and differ only in their N-terminal amino 
acids as discussed above. It is now generally accepted that MN 
specificity residues in these amino acid residues although Springer 
and coworkers maintain that alkali-labile carbohydrate complexes 
are alos involved in specificity. They find that M and N speci­
ficities can be interconverted by the removal or addions of 
sialic acid (Springer & Desai, 1974, 1975; Desai &
Springer, 1979) and Springer & Desai(1974) have proposed MN-active oligo­
saccharide structures■to explain this (Fig. 40 iii). Moreover Springer & 
Yang (1977) have reported the isolation, from human red cell MN- 
active glycopeptides, of oligosaccharides that are larger than 
a tetrasaccharide and carry low MN specificities.
A radioimmunoassay for MN on TF (see page 121) antigens 
in body fluids has been reported (King & Holburn, 1979).
iv. Glycoproteins as histocompatibility antigens
The histocompatibility system seems to be the only genetic 
system, beside the ABO system, which has major influence on human 
transplantations. Histocompatibility antigens differ from 
individual to individual and give the tissues of each individual 
their own chemical identity to be recognised as being foreign in 
graft rejection during transplantations (Fig. 41). In mice one 
set of antigens known as the H-2 system provides the strongest 
barrier to transplantation. H-2 antigens have their counterpart 
in the HLA antigens of man. The H-2 and HLA antigens are glyco­
protein molecules firmly attached to the surface of nearly all 
cells (Cunningham, 1977). These two systems have been studied 
since the 1930's and 1950*s respectively, and a picture has emerged 
from genetic mapping and population studies (Fig. 42). The region 
of the genetic material that codes for H-2 antigens in mouse has 
been studied by many workers (Snell & Stimpfling, 1966; Amos, 1964; 
Shreffer, 1966) and has been described as "a complex of genes 
located on a relatively short segment of the mouse's chromosome 
No. 17" by Cunningham (1977) who discusses the regions of the 
H-2 complex as well as gene's products such as K antigens, D 
antigens and la antigens. By the use of different methods of 
extraction, different test systems and various cell sources, it has 
been demonstrated that almost all of the histocompatibility allo- 
antigen activity is associated with membraneous cell fractions 
(Harzenberg, 1961; Davies, 1962; Manson et al., 1962; Basch & 
Stetson, 1963; Dumond et al., 1963; Hilgert et al., 1964;
Herberman & Stetson, 1965; Ozer & Wallach, 1967) and many methods 













a c ce l e r a te d REJECTION
Fig. 41. After Cunningham (1977)
Scheme illustrating the genetics of transplantation.
A) Transplantation of skin graft from one mouse (black) to
a genetically identical mouse. The graft is retained
indefinitely (a).
B) Transplantation of skin graft from one mouse (black) to
a genetically different mouse (white). The graft is
rejected within two weeks (b).
C) Injection of lymphocytes, from a mouse (white) that has 
already rejected a graft, into a genetically identical 
mouse (white) at the same time as it receives a trans­
plant from a genetically different mouse (black). The 
graft will be rejected within one week (c). This 
accelerated rejection occurs because the transferred 
lymphocytes have already been sensitized to foreign histo­










extraction by butanol (Kandutsch, 1960; Manos et al., 1964), and 
nonionic detergents (Kandutsch, 1960) and the use of chelating 
agents (Edidin, 1966), Ultrasound (Kahan, 1965), and lipases 
(Kandutsch, 1960). Solubilization by proteolytic digestion has 
also been reported using crude ficia (Nathenson & Davies, 1966a) 
or "autolysis” (Nathenson & Davies, 1966b). The above methods 
have been used to solubilize H-2 alloantigens from spleen or 
tumor cell membranes, but the resulting material was generally 
of low antigenic activity and showed considerable variation in 
reproducibility with respect to the strain of origin of the 
starting material. In order to avoid such disadvantages 
crystalline papain has been used as a solubilization agent by 
Nathenson & Shimada (1968) who found this method to be superior 
to "autolysis" with respect to absolute yield of antigen and 
reproducibility. A less detailed genetic map has been obtained 
for the human HLA gene complex. It has been reported in many 
reviews (Barnstable & Jones, 1977; Cunningham, 1977; Barnstable, 
1978; Barnstable et al., 1978; Badmar, 1978) that the HLA gene 
complex is located on human chromosome No. 6, and that three 
groups of genes are distinguished in the HLA region. They are 
firstly the B, A and C genes, secondly the D genes and thirdly 
the complement genes. The HLA-A and HLA-B genes seem to be 
closely related to the H-2D and H-2K genes of the mouse 
(Cunningham, 1977).
Considerable progress has been made in biochemical 
studies of the HLA region products (i.e. the histocompatibility 
antigens)(Crumpton & Snarry 1977). The A, B and C antigens, the
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products of the HLA-A, B and C loci, are glycosylated polypeptide 
chains that penetrate through the membrane (Fig. 43a). These 
chains are noncovalently complexed with another smaller poly­
peptide, $2"™icroglobulin, which is coded for by a gene on a 
different chromosome (Barnstable, 1978). The la or DRw antigens 
are also glycosylated polypeptide chains (Fig. 43b) which penetrate 
through to the cytoplasmic face of the membrane. Three complement 
components C^, B factor (Bf) and have been found linked to the 
major HLA region, whereas two others and are apparently not 
so linked. The major function of serum complement is to attack 
foreign organisms following their recognition by antibody.
The A, B and C antigens are thought to be present on all 
human tissues except erythrocytes, sperm and the layer of tropho- 
blast forming the barrier between foetus and mother. The function 
of the A, B and C antigens has not been clearly demonstrated yet, 
but many reviews have discussed these phenomena (see Barnstable, 
1978 and refs, therein).
la and DRw have been found on B lymphocytes and mono­
cytes (reviewed in Mol1er 1976; McDevitt, 1978) as well as T cell 
> subsets (Thorsby et al., 1978; Evans et al., 1978; Greaves et al., 
1979), granulocytic and erythroid progenitors (Winchester et al., 
1977, 1978; Janossy et al., 1978). Furthermore, Janossy & Pizzolo, 
(1979) and Rouse et al. (1979) have reported the presence of these 
antigens on thymic epithelium, while Rowden et al. (1977) have 
shown evidence of their presence on epiderms. Very recently many 
workers have demonstrated HLA-DR antigens on the surface of guinea-­
pig (Fursum et al., 1979) and human (Wiman et al., 1979; Newman 













Fig. 43. Schematic representation of membrane bound (a) HLA-A EC 
antigens and (b) HLA-DRw 
After Barnstable (1978)
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la and DRw antigens are found to be closely associated 
with many diseases and may play a role in the control of immune 
responses and in the regulation of the cellular interactions and 
antigen recognition (Pauli & Benacerraf, 1977; Mumro & Bright,
1976; Katz & Benacerraf, 1976; McDevitt et al., 1976). They are 
also involved in cell-cell interactions such as the homing of 
lymphocytes to the mammary gland during lactation (McWilliams 
et al., 1977; Roux et al., 1977).
4.d. Glycoproteins and cell-cell adhesion
Specific adhesion between cells of the same type is a 
fundamental prerequisite for morphogenesis and organogenesis. 
Experimentally, the phenomenon can be demonstrated by showing 
that dissociated single cells of embryonic organs (Moscona, 1965) 
can reaggregate and then differentiate under favourable conditions. 
It has been speculated that cell-cell adhesion occurs by specific 
recognition processes in which "lock and key" type mechanisms are 
involved. Such a mechanism occurs in the interaction between an 
enzyme and its substrate and systems involving transferases and 
their carbohydrate substrates on opposing cell surfaces have been 
proposed (Roseman, 1970; Shure & Roth, 1975). Not only enzyme- 
substrate but also hormore-receptor interactions are of this type 
(Roseman, 1970; Wiitteiberger & Glaser 1977) and the general 
suggestion has been made that components which are responsible for 
cell-adhesive specificity should always consist of a protein which 
can specifically bind to a ligand on an adjacent cell. This 
ligand could be another protein, the carbohydrate moiety of a 
glycolipid or glycoprotein, or some other as yet unidentified
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membrane component. The interaction between lectins and specific 
monosaccharides fits this requirement and recent work has in many 
cases concentrated on the involvement of lectins in cell adhesion.
The cellular slime moulds, in particular the species 
Dictyostelium discoideum, have become popular model systems for 
studies of eukaryotic development and the ease with which large 
numbers of homogeneous cells can be cultured has allowed these 
organisms to prove useful in cell adhesion studies. The mechanism 
of self-adhesion of single slime mould cells, to form a multi- 
cellular "slug" or "grex", is presently believed to involve 
proteins with lectin activity (Frazier, 1976). Proteins from 
this source have been purified to yield two lectins, discoidins I 
and II, with apparent specificities for N-acetyl-D-galactosamine 
and lactose respectively (Frazier et al. 1975). Similar lectins 
(pa-lidins) with apparently similar functions have also been 
isolated from another slime mould Polysphondelium pallidium 
(Frazier, 1976). Vith respect to higher organisms, galactose- 
binding lectins have been reported in a number of tissues 
including the electric organs of the electric eel and chick 
embryo pectoral muscle (Teichberg et al., 1975; Nowak et al., 
1976), but without strong evidence for their function. One 
possible example of a specific lectin-mediated adhesive mechanism 
comes from the chick retinotectal system. It has been reported 
(Barbera et al., 1973; Marchase, 1977) that the dorsal retina is 
rich in hexosamine-terminal carbohydrate, whereas the comple­
mentary ventral half of the tectum contains a protein that 
preferentially binds to N-acetyl-D-hexosamine. This would explain
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the mechanism in which cells from the dorsal half of the retina 
adhere to cells from the ventral half of the optic tectum and 
vice versa.
Recently attention has been directed towards the fibro- 
nectins, large extracellular proteins with subunit molecular weights 
of 200,000-250,000 believed to be involved in cellular adhesion 
(Yamada & Olden, 1978). Fibronectins from various sources 
probably represent just two specific proteins, cell surface and 
plasma fibronectins respectively. Cell surface fibronectin is 
also known as LETS (large external transformation-sensitive) 
protein (Hynes & Bye, 1974) or as CSP (cell surface protein)
(Yamada & khston, 1974). Cell surface fibronectin constitutes 
1-3% of total cellular protein of embryonic or adult fibroblasts 
cultured in vitro (Yamada et al., 1977), and has been found on 
astroglial cells (Vaheri et al., 1978) and on certain cultured 
epithelial cells (Chen et al., 1977) including blood vessel 
endothelial cells (Birdwell, 1978; Jaffe & Mosher, 1978;
Macarak et al., 1978). Cell surface fibronectin can also be 
detected (by fluorescent-labelled specific antibodies) on the 
surface of many other cultured cells (Yamada & Pastan, 1976;
Chen et al., 1976; Bornstein & Ash, 1977; Bornstein et al., 1978). 
Fibronectin is apparently only loosely associated with the cell 
membrane, being readily detached by sucrose gradient centrifugation 
(Graham et al., 1975; Marciani & Bader, 1975).
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It is believed that fibronectins function as adhesive 
proteins that bind cells to other cells or to substrate. This 
conclusion is based on the localisation of fibronectin which 
extends between cells and is also found sandwiched between cells 
and the tissue culture substratum (Yamada & Pastan, 1978; Chen et al., 
1976; Yamada, 1978; Hedman et al., 1978). This idea is supported 
by many experiments including the finding that fibronectin purified 
from cell surfaces behaves like a lectin and readily agglutinates 
fixed sheep erythrocytes (Yamada et al., 1975; Baum et al., 1977). 
Proteases and chelating agents, which are known to disrupt cell­
cell adhesion, have been found to destroy the agglutinin activity 
(Yamada et al., 1975). Purified cell surface fibronectin can also 
mediate the attachment of dissociated cells to collagen (Pearlstein, 
1976; Yamada et al., 1978). A role for fibronectin-collagen com­
plexes in cell-cell adhesion has been supported by many workers, 
kumunofluorescent staining of fibronectin shows a fibrillar net­
work of protein on both adherent cells in tissue culture and in 
connective-tissue sections. Chen & Gudor, 1977; Jaffe & Mosher,
1978). Double-staining with fluorescent antibody has demonstrated 
that fibronectin co-distributes with the collagen component of 
connective tissue, and in fibroblast cultures the stained extra­
cellular structures are superimpossible (Linder et al., 1978;
Bornstein & Ash, 1977). Recently Gold & Pearlstein (1980) have 
implicated hydrophobic interactions in fibronectin-collagen com­
plexes.
98.
Further evidence for the adhesive role of fibronectin 
is provided by the observations that during embryonic development 
fibronectin is first detectable on the cells of the blastula 
inner cell mass (Zetter & Martin, 1978) but is later lost as 
mesenchymal cells differentiate into muscle, cartilage, and 
renal tubular epithelium (Linder et al., 1975; Wartiovaara et al., 
1976). It has also been found that treatment with cellular fibro­
nectin increases the extent of attachment to plastic tissue 
culture substrata of several transformed cell lines (Yamada et al., 
1976; Willingham et al., 1977; Ali et al., 1977). Plasma fibro­
nectin [also known as Cig (cold insoluble globulin}] is a dimeric 
glycoprotein very similar to the cell surface form, and has a sub­
unit molecular weight of 20000-22000 (Mosesso & Umfleet, 1970; 
Iwanaga et al., 1978). It is present in human plasma (0.3mg/ml) 
and serum (Mosesson & Umfleet, 1970) and is believed to be the 
serum factor commonly required for the attachment of certain cells 
to collagen-coated dishes (Klebe, 1974; 1975; Hynes, 1978) or for 
cells to attach and spread on tissue culture dishes (Hook, 1977; 
Grinnell, 1976).
The nature of the immediate interaction between fibro­
nectin and the cell surface is not clear, although fibronectin has 
been shown to be relatively ineffective in mediating cell-substratum 
adhesion of mutant baby hamster kidney (BHK) (Yamada et al., 1978) 
that are deficient in cell surface carbohydrate. This would seem 
to implicate carbohydrate-fibronectin interactions in the 
adhesive process.
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5. Surface changes in cancer cells
Tumour cells have the capacity for uncontrolled growth 
(Clarkson & Baserga, 1974; Becker, 1975) and, in the case of malig­
nant cells, migration out of tissue bounds to invade and colonize 
both surrounding and distant tissue sites (metastasis)(Whiss, 1967; 
Filder, 1975; Becker, 1975). Direct study of tumour cells in situ 
presents many difficulties but a valuable experimental system for 
studying the process of malignancy (Clarkson & Baserga, 1974; 
Becker, 1975) is provided by transformed cells. These are cells, 
mainly of fibroblastic origin, that have been changed in vitro, 
either spontaneously or by an oncogenic determinant (e.g. a virus 
or chemical carcinogen) so that one or more of certain properties, 
are altered. Such properties include the loss of anchorage 
dependence (Macpherson & Montagnier, 1964; Stocker et al., 1968; 
Shin et al., 1975), decreased serum and growth factor dependence 
(Holley, 1975; Gospodarowicz & Moran, 1976) and also decreased 
density-dependent inhibition of growth (Todaro & Green, 1973; 
Aaronson & Todaro, 1968; Dulbecco, 1970). The transformed cells 
are classified as tumour cells only if they, when transplanted, 
give tumours in immunologically-impaired mice (e.g. nude mice) 
and not all transformed cells are necessarily tumour cells.
Transformed cells show alterations not only in their 
cellular properties but also in the nature of their cell surface 
components. Cellular fibronectin ^Iso known as LETS, CSP, or 
galactoprotein (see page 96)| has been shown to be decreased 
after transformation (Hynes, 1976; Yamada & Pastan, 1976;
Yamada & Olden, 1978), and several morphological and behavioural 
properties associated with transformation have been found to be
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reversed by the addition of fibronectin to the cultures (Yamada et al., 
1976; Ali et al., 1977). Treatment of untransformed cells with 
monospecific antibodies to fibronectin was demonstrated (Yamada,
1978) to mimic the morphological effects of transformation. Fibro­
nectin, however, not always decreased in transformed cells (Hynes,
1976; Pearlstein et al., 1976; Yamada & Olden, 1978) and other 
apparent contradictions have been reported. Thus reconstitution 
of fibronectin on transformed cells has been found to have no 
effect on growth rates, on levels of cyclic AMP, or on the 
increased rates of nutrient transport which are characteristic 
of transformed cells (Yamada et al., 1976; Ali et al., 1977;
Yamada, 1978). Furthermore, papain-treatment has been shown to
remove fibronectin from cells without stimulating growth, whereas 
thrombin or insulin can stimulate growth without decreasing levels 
of fibronectin (Teng & Chen, 1975; Blumberg & Robbins, 1975;
Zetter et al., 1976; Keski-Oja, 1976). Recently, Chen et al. (1978)
have suggested that decreases in cell surface fibronectin may be 
associated more with the capacity of cells to metastasize than 
with their initial capacity to form tumours after injection into 
iramunosuppressed animals.
Decreases in cell surface fibronectin after transformation 
have been shown to result from a combination of decreased biosyin- 
thesis, increased proteolytic degradation, and increased loss from 
the cell surface into culture media (Robbins et al., 1974; Vaheri 
& Ruoslahti, 1975; Hynes & Wyke, 1975; Olden & Yamada, 1977).
Decreases in cell surface fibronectin have also been found in 
normal cells after inhibition of glycosylation (Duksin & Bornstein, 
1977; Olden et al., 1978), but unlike in transformation, these
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decreases are not believed to result from altered synthesis or 
binding to cells, or to altered secretion (Olden et al., 1978) 
but rather to the increased susceptibility of unglycosylated 
fibronectin to proteolytic degradation (Olden et al., 1978).
The extracellular matrix of normal cells contains not only 
fibronectin but also glycosylaminoglycans and collagen, all of 
which may be decreased in transformed cells (for a review see 
Yahreri & Mosher, 1978). Mild trypsin treatment releases most of 
the cell-associated glycosylaminoglycans (Roblin et al., 1975), and 
significantly more heparan sulfate has been found in trypsinates 
of normal than of transformed cells (Chiarugi et al., 1974).
Decreases in the synthesis of collagen have been found 
in the transformed cells of chick and mouse fibroblasts (Green et al., 
1966; Peter Kofsky & Parther, 1974; Levinson et al., 1975), and 
these changes were considered to be secondary to the decrease in 
the procollagen messenger RNA (Adams et al., 1977). It was also 
reported (Liotta et al., 1978) that certain cells require collagenous 
substrata for growth, but lose this requirement after transformation, 
and thus decreases or alterations in collagen could be related to 
this altered growth requirement.
Fibronectin may also have an organizing role in matrix 
formation in its association with collagan, procollagan and other 
fibrillar matrix structure (Vaheri et al., 1978b), and transformed 
cells which fail to produce fibronectin matrices show a comparable 
decrease in matrix procollagan (Vaheri et al., 1978a) and collagan 
(Gold & Pearlstein, 1980). Actin and myosin have also been found 
to be decreased after transformation (WLckus et al., 1975; Shizuta
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et al., 1976), and these decreases have been suggested to be related 
to the decreased numbers of microfilament bundles detected with 
anti-actin and anti-myosin in transformed cells (McNutt et al.,
1973; Pollack et al., 1975).
With regard to cell surface glycopeptides, many workers 
have reported that transformation of cells is accompanied by an 
increase in the average size of pronase-cleaved glycopeptides.
This increase is apparently minimised by prior treatment of the 
cells with neuraminidase (for a review see Warren et al., 1977) 
indicating that transformation results in changes of amounts of 
sialic acid. Many early assays of total cellular sialic acid 
revealed no overall increases (Vfeiss, 1967; Robbins & Nicolson,
1975) suggesting that the neuraminidase-sensitive changes affect 
a limited subpopulation of oligosaccharides. Increase in glyco- 
peptide size has also been demonstrated in non-transformed cells 
during mitosis, suggesting that transformed cells may be unable 
to confine these alterations to the mitotic phase of the cell 
cycle (Warren et al., 1977; Click & Buck, li73).
Increase in size of mannose-containing glycopeptides 
have been reported in rapidly growing cells (Muramatsu et al.,
1973). Two other abnormalities were found in these glycopeptides, 
firstly that the structure of the oligosaccharide was predomin­
antly of the "high-mannose" type rather than of the "complex" 
type (Ceccarini et al., 1975) and secondly that fewer sugars 
occurred close to the glycopeptide linkage region (Muramatsu et al., 
1973; Ceccarini et al., 1975).
103.
Many other cell surface changes may also occur in 
malignant or transformed cells. Such changes include altered 
surface enzymes of cyclic AMP metabolism (Unkeless et al., 1974; 
Pastan et al., 1975), altered transport properties (Hatanaka, 1974), 
changes in glycolipids (Brady et al., 1974; Hakomori, 1975), and 
altered receptors for hormones such as growth factor (Todaro et al.,
1976), catecholamines (Sheppard, 1977), insulin (Thomopoulos, 1976) 
and prostaglandin (Davies, .1976). A reproducible change in glyco­
sylation of a protein with an apparent molecular weight of 100.000 
daltons has been reported by Bramwell & Harris (1978). In malig­
nant cells or tumours, this protein displays specific modifications 
including increased binding of the lectin Concanavalin A, whereas 
binding to wheat germ agglutinin is decreased (Bramwell & Harris, 
1978).
Chemical characterization of cell surface components 
represents one approach towards finding specific tumour cell 
markers which could not only serve a diagnositc purpose but might 
also act as targets for therapeutic measures. Cancer immunology 
represents another such approach, and in fact many tumour-specific 
transplantation antigens (TSTA) in the plasma membrane have been
defined by immunological methods. The TSTA of SV 40-transformed
cells has been studied and shown to be a glycoprotein of 58.000 
daltons that is synthesized by mRNA from an early region of the 
SV 40 genome (Luborsky et al., 1976; Schmidt-Ullrich et al.,
1977; Mora et al., 1977; ï&istev et al., 1977; Anderson et al., 1977),
and it apparently shares common peptides with one or two other
antigens such as the T antigen (MW 100.000) and the U antigen 
(Luborsky et al., 1976; Schmidt-Ullrich et al. , 1977; Robb, 1977;
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Chang et al. , 1977). Similar proteins have been found to be present 
in cells transformed by polyoma virus ( Ito et al., 1977) and 
associated with infection by feline leukemia and sarcome viruses 
(Hardy et al., 1977; Stephenson et al., 1977). The feline 
oncornavirus-associated cell membrane antigen (FOCMA) was 
suggested to be a target for immuno-surve il1a nee against tumour 
development in cats (Hardy et al., 1977) and several other TSTAs 
have been characterised (Billing & Tevasaki, 1974; Grimes et al., 
1977; Troy et al., 1977). A present hope is that, by a combination 
of both the chemical and immunological techniques, tumour antigens 
might be characterized and used in the immunotherapy and possibly 
even vaccine-based prevention of cancer.
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6. The Milk Fat Globule Membrane
6.A Origin of MFGM
Milk exists as a suspension of cream in an aqueous serum 
(skim milk). The cream consists of fat droplets (Fig. 44) ranging 
in size from O.l-lOym with an average of 3-4ym, which are 
stabilized in the milk serum, by an external membrane, generally 
known as the milk fat globule membrane (MFGM). Many reviews 
have dealt with the production of milk contents (Patton & Keenan, 
1975 and references cited therein).
The milk fat flobule membrane is derived mainly from the 
apical plasma membrane of the mammary secretory cells (The lactating 
cells) which are the basic units in the production, not only of the 
milk fat globules, but also of other milk components such as 
lactose and most of the milk proteins. The lactating cells are 
sphere-shaped units arranged around the lumen of the alveolus 
(Fig. 45) which has an arterio-venous capilliary system supplying 
it with raw materials for making the milk products. These are 
then secreted into the lumen which is connected by a duct system 
draining to the outlets at the skin surface.
6.B Mechanism of secretion of milk components
Secretion of the milk components occurs by two different 
mechanisms whereby material is lost from the apical plasma membrane 
of the lactating cell during the secretion of milk fat globules, 
and is replaced during the secretion of soluble milk components 
such as casein and lactose (Fig. 46). During the first mechanism, 
fat droplets form within the lactating cells and move to the
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Fig. 44. Electron microscopy of a single human milk fat 
globule coated with gold.
Human milk fat globules were separated from 
freshly expressed human milk by centrifugation 
(1500xg, 10 min) at 22°C and washed with phosphate- 
buffered saline by resuspending and centrifugation 
as above four times.
The sample was prepared for electron microscopy, 
according to Horisberger (1977), by J. Forsdyke and 
D. Crellin at the Electron Optical Studies Department, 
University of Bath. Globules were fixed for Ih in 2% 
osmium tetroxide in 0.05M cacodylate buffer, pH 7.0, 
and then washed four times with distilled water.
Washed globules were air dried from water suspension 
onto glass and were coated with gold in an Argon 
Sputter Coater. Photographs were observed and 












Fie. 45. The alveolus. After Patton & Keenan (1975)
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apical region where they become enveloped in the plasma lemma being 
finally expelled into the lumen entirely surrounded by apical 
plasma membrane. Evidence for such a process was first reported 
by Jeffer (1935) who noticed the enmeshing of fat droplets with 
the limiting membrane of the mammary cell during their secretion. 
This process was subsequently confirmed by electron microscopy 
lactating rat mammary tissue (Bargmann & Knoop, 1959; Bargmann 
et al., 1961). Electron micrographs (Feldman, 1961) of lactating 
bovine mammary tissue also are suggestive of this process (see 
Fig. 47). This mechanism involves the removal of membrane 
material from the plasma membrane of the lactating cell, and 
replacement of such loss is believed to be made from the Golgi 
vesicles during emptying of their contents in the secretion of 
soluble milk components (Fig. 46). This latter mechanism is 
evidently a quite different process from that involved in the 
expulsion of milk fat globules (Patton & Fowkes, 1967; Patton 
& Hood, 1969; Patton & Jenson, 1975; Morrë et al., 1979) and is 
illustrated in Fig. 2 (page 4 ).
Similarities between the milk fat globule membrane 
and the mammary cell plasma membrane have been demonstrated by 
biochemical comparison of the two membranes. Both membranes 
have a similar lipid composition (Keenan et al., 1970a) and milk 
fat globule membrane contains enzymes similar to those of plasma 
membrane preparations (Dowben et al., 1967; Patton & Trans, 1971). 
On the other hand, Keenan et al. (1971) have found differences in 
the triglyceride fatty acid composition of the plasma membrane 
and the milk fat globule membrane. They attributed this to the 
presence, on one surface of isolated milk fat globule membrane.
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Fig. 47. Electron micrograph showing the juxta position of Golgi
vesicles and intracellular fat globule prior to secretion 
from the lactating mammary cell.
Courtesy of Dr. F.B.P. Wooding, Agricultural Research Council, 
Institute of Animal Physiology, Graham, Cambridge, England.
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of an electron-dense material which they assumed to be composed of 
high melting triglycerides. This suggestion was later supported 
by Wallstra (1974).
In addition to the plasma membrane, milk fat globules 
are also surrounded by a layer of material absorbed from the 
cytoplasm prior to secretion (Brunner, 1969; Wooding, 1971b;
Bauer, 1972) and lying between the fat globule core and the plasma 
membrane layer. Stein & Stein (1967) suggested that this layer 
could be derived from endoplasmic reticulum and the same con­
clusion was reached by Martel-Pradal & Got, (1972). Another 
suggestion was made by Wboding(1971b) namely that this layer may 
in part be derived from cytoplasmic surfactant molecules.
Hood & Patton (1973) isolated intracellular milk fat globules 
from mammary tissue and found no evidence of the ordered structure 
to be expected for biological membranes and they concluded that 
the intracellular lipid droplets are stabilised by a phospho- 
lipid-cholesterol layer similar to that of chylomicrons.
Earlier ideas (Titus et al., 1928; King, 1955) that the 
outer globule membrane consists of entirely skim milk protein 
adsorbed on the surface of the fat globules have now been discarded, 
Proteins of milk fat globule membrane differ in amino acid com­
position, in physical properties (Palmer & Samuelsson, 1924;
Herald & Brunner, 1957) and in their immunological characteristics 
(Palmer & Lewis, 1933; Coulson & Jacson, 1962) from almost all 
protein component of skim milk.
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A further question concerns what attracts the fat drop­
let to the plasma membrane during the secretion process. Patton 
& Fowkes (1967) presented evidence to show that this attraction 
may derive from London-Van der Waals forces operating when the
distance between membrane and droplet is reduced to a critical
o
distance of about 20A. Wooding (1971a), on the other hand, from
his observations with electron microscopy, has shown that the
o
distance between membrane and droplets is too large (100-200A) 
to approach the critical distance of such forces. It does seem 
possible however that hydrophobic forces, generated by lipophilic 
elements of the plasma membrane end of the fat droplet, could 
assist in reducing the distance.
There may be general physical forces, within the cell, 
which govern the movement of the secretory vesicles into its 
apical region. Microtubules, for instance, which have been shown 
to exist in the apical web of lactating cells (Sandbern et al. 
1964), can regulate the intracellular movement of secretory 
vesicles. Orli et al. (1973) and Stein & Stein (1973) have 
demonstrated that drugs such as colchicin and vinblastine, which 
disassemble microtubles, interfere with the secretory process 
in liver cells, and similar results were observed in the pancreas 
by Lacy & Malaisse (1973). These two alkaloids have been shown 
also to suppress lactation in goats by inhibiting the secretion 
of milk components.
113.
6.c. Isolation of MFGM
Isolation of the milk fat globyle membrane is asimple 
process which involves both separation of the globule and isolation 
of the membrane from the separated globules. All procedures 
that are in use today depend upon that of Palmer and Samuelsson 
(1924) who were the first to describe a method for isolation of 
the milk fat globules.
Separation of the fat globules can be achieved by centri­
fugation in laboratory centrifuges, when the fat globules (cream) 
rise above the aqueous phase (skim milk). The speed of centri­
fugation is not critical and it can be performed at a few thousand 
G forces for periods as brief as 10 min. Mechanical cream 
separators have also been used, and they are recommended for 
large scale separations.
Washing of the globules, prior to dissociation of the 
membrane, is important for the removal of all entrained milk 
serum constituents. This can be done simply by dispersing the 
globules in water or isotonic solution (buffered or unbuffered) 
and then reseparating. The process is repeated several times.
The isolation of the membrane from separated globules 
can be done by churning, sonication or freeze thawing. Slow 
freezing and thawing has been particularly recommended (Huang & 
Kuksis, 1967; Cole et al., 1959). These processes destabilize 
the lipid-in-water emulsion and the core lipids coalesce or, at 
higher temperatures, rise as oil. The membrane is then obtained 
by centrifugation at about lOOO.OOOxg for 60-90 min. Released
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membrane materials can also be obtained by precipitation at lowered 
pH or by addition of ammonium sulphate and collection of the 
precipitated membrane by filtration or low speed centrifugation 
(Brunner, 1974; Kitchen, 1974),
If lysis and high speed centrifugation are performed at 
temperatures above the melting range of the globule core, then 
the resulting oil is free of phospholipids (Huang & Kuksis, 1967; 
Keenan, 1974a). However at temperatures below this, considerable 
quantities of membrane become entrained in the lipid phase and 
Brunner (1974) has shown that this material can be recovered by 
melting the solidified fat, washing with aqueous medium and 
centrifugation.
Direct extraction of membrane constituents from the 
washed globules has also been reported. Sodium dodecyl sulphate 
has been used to extract proteins for electrophoretic analysis 
(Kobylka & Carraway, 1972; Mather & Keenan, 1975),and extraction 
with chloroform/methanol has also been used for membrane phos­
pholipids (Huang & Kuksi, 1967; Patton & Keenan, 1971).
115.
6.D. Composition of the milk fat globule membrane
The only milk fat globule membranes which have been studied
extensively are those of the cow in which protein and lipids account 
for over 90% of the dry weight of the membrane (Thompson et al.,
1961 ; Huang & Kuksi, 1967; Swope & Brunner, 1970; Kobylka and
Carrawy, 1972; Brunner, 1974). The relative proportions of these
two constituents vary widely and the overall composition of the 
system is shown in tables 2, 3 and 4. Protein values ranging from 
25 to 60% of the dry weight have been reported. Many factors have 
been found to affect the analytical results, including not only the 
breed of animal but also the age, season, stage of lactation and 
the method used for isolation of the membrane. Contamination by 
triglycerides of the fat globule core can also affect the analytical 
results, and care must be taken to minimize manipulation artefacts 
and also to remove all milk serum constituents. Taking extensive 
precautions, Swope & Brunner (1970) found protein to comprise 
between 41 to 43% of the dry weight of the membrane.
Carbohydrates of the milk fat globule membrane exist in 
both lipid and protein band forms. A number of workers have reported 
about 55nmol of protein-bound sialic acid and 6nmol of ganglioside- 
bound sialic acid per mg protein (Keenan & Huang, 1972; Keenan et al., 
1973; Keenan, 1974a). Hexose and hexosamine exist at levels of 
about 0.6pmol and 0.3ymol respectively per mg protein (Swope &
Brunner, 1970). While both glucosamine and galactosamine have been 
detected in protein fractions (Swope & Brunner, 1970) only galacto­
samine has been found in ganglioside fractions (Keenan, 1974a).
Martel et al. (1973) found similar levels of carbohydrates in human
Table 2
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Constituents Amount expressed as % dry weight
Protein
Lipid
25 to 60% of dry weight 
30 to 65% of dry weight
Table 3
1
Constituents Amount expressed as % total lipids
Neutral lipids 56 to 80%
Hydrocarbons 1.2%
Sterols 0.2 to 5.2%
Sterol esters 0.1 to 0 .8%
Glycerides 53 to 74%
Free fatty acids 0.6 to 6.3%
Table 4
Constituents Amount expressed as n mol/mg total protein
Cerebrosides 3.5 n mol/mg
Gangliosides 6.0 n mol/mg
Sialic acids 6.3 n mol/mg
Hexoses 0.6 n mol/mg
Hexosamines 0.3 n mol/mg
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milk fat globule membranes in which they detected only 15yg RNA/
Mg protein and no DNA. It is not clear whether this level of RNA 
represents a true membrane constituent or results from low levels 
of endoplasmic reticulum in the fraction (Wooding et al., 1970; 
Wooding 1971a). It may be significant that Emmelot & Bos (1972) 
have found RNA and DNA in liver cell membrane to be contaminations.
Milk fat globule membrane preparations have been reported 
to show relatively high activities of several enzymes, largely 
those characteristic of plasma membranes (Solyom & Trams (1973;
De Pierre & Karnovsky, 1973; Morre et al., 1974; Trams & Lauter, 
1974). On the other hand many workers have demonstrated the 
absence, or low activity, of enzymes that are typical of the mito- 
chondrian (Bailie & Morton, 1958; Dowben et al., 1967), of the 
endoplasmic reticulum (Keenan & Huang, 1972; Plantz et al., 1973) 
or of Golgi membranes (Keenan et al., 1970b; Keenan, 1974b).
In addition to plasma membrane enzymes, glucose-6-phos- 
phatase and lactose synthetase activities have been detected in 
human milk fat globule membrane (Martel-Pradal & Got, 1972), but 
have been regarded as arising from a greater entrainment of cyto­
plasmic membranes during the secretion of the human globules.
Some enzymes known to exist on the milk fat globule 
membrane have also been detected in whole milk such as xanthine 
oxidase (Avis et al., 1955) and both acid (Bingham & Zittle, 1963) 
and alkaline (Zittle & Della Monica, 1952) phosphatases. The 
latter enzyme is stable in the presence of sodium dodecyl sulphate 
(Mather & Keenan, 1974), which, uniquely, allows its detection in 
sodium dodecyl (Mather & Keenan, 1974). Kinura (1969) reported
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the absence of NA^-ATPase in MFG, a fact which correlates with
the known presence of this enzyme in the basal and lateral, but not
2+pical, plasma membrane of mammary secretory cells. Ca -ATPase
is probably also absent from milk fat globule membrane
(Baumrucker & Keenan, 1975) consistent with the inability of the
membrane to accumulate calcium in an energy-dependent manner,
Huang & Keenan (1972) have however characterized an ATPase in
the milk fat globule membrane which is stimulated by Mg*, K*
(slightly), but not by Na*. Kitchen (1974), in contrast to
2+
Plantz and Patton (1973), was able to demonstrate Mg -ATPase 
activity in membranes of skim milk. Kitchin (1974) also 
reported that nearly all of the membrane enzymes are present 
in higher activities in the skim milk fraction.
Herald and Brunner (1957) separated proteins of 
milk fat globule membrane into two fractions "soluble" and 
"insoluble" based upon centrifugation sedimentation of a water 
or saline dispersion of defatted fat globule membrane and in the 
following years several groups partially characterized proteins 
and glycoproteins obtained from milk fat globule membranes 
(Jackson et al., 1962; Coulson & Jackson, 1962; Chein &
Richardson, 1967). Swope and Brunner in 1970 reported com­
positional characteristics of three milk fat globule membrane 
fractions obtained by differential centrifugation and later 
Banerjee et al. (1974) used the same technique to study 
defatted buffalo and cow fat globule membrane. They found 
similarities in the gross composition and the amino acid pro­
files of the two membranes.with soluble fractions showing higher 
amounts of carbohydrate than the insoluble fractions. A variety
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of reagents have been used to solubilize the proteins, but little 
selective solubilization of individual proteins has been achieved 
(Kobylka & Carraway, 1972; Cawston, 1975; Mather & Keenan, 1974; 
Mangino & Brunner, 1975). SDS has been reported to be a satis­
factory dissociating agent for membrane proteins (Bretscher,
1973) and the use of this reagent provides a good starting 
point for isolating individual proteins of milk fat globule 
membranes. Many workers have reported that all the membrane 
proteins can be solubilized by treatment of the globules with 
aqueous solutions containing SDS, EDTA and 2-mercaptoethanol 
(Anderson et al., 1972; Kobylka & Carraway, 1972; Mather &
Keenan, 1975) and 5-7 major proteins or glycoproteins have 
been observed after SDS polyacrylamide-gel (SDS-PAGE) electro­
phoresis, Cawston et al. (1976) isolated four major proteins, 
from cow MFGM by column chromatography of SDS complexes which 
were then examined by SDS-PAGE. In the same year Basch et al.
(1976) fractionated the salt soluble proteins from cow MFGM 
using Sephadex column chromatography in SDS. Three fractions 
were obtained one of which was determined to have a molecular 
weight 49,500, by SDS-PAGE.
Periodate-Schiff (PAS) staining of PAGE gels has been 
used to detect glycoproteins of the milk fat globule membrane 
and several attempts have been made to isolate glycoproteins 
from this source. A mixture of up to seven PAS-staining glyco­
proteins has been isolated by centrifugation and extraction 
(Anderson & Cawston, 1975; Kanno et al., 1975; Shimizu et al., 
1976; Newman et al. (1976a). Extraction by lithium 
diiodosalicylate was used by Keenan et al. (1977) to extract
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a high molecular weight glycoprotein fraction from bovine milk 
fat globule membrane. This fraction had three electrophoretically 
distinguishable glycosylated proteins but was free of nonglyco­
sylated proteins. The isolated final fraction was freely water 
soluble and was immunogenic when injected into rabbits. Triton- 
solubilised milk fat globule membrane has alsa been tested 
against anti (milk fat globule membrane) antisera on crossed 
immunoelectrophoresis plates (Nielson & Bjerrum, 1977) when 
four major precipitin arcs were obtained. The corresponding 
antigens were shown to be glycoproteins as the four precipitin 
arcs were inhibited by introduction of intermediate concavalin A 
gels into the system. The presence of sialic acid was shown in 
three glycoproteins by differences.in migration observed following 
neuraninidase-treatment. Harrison et al. (1975) characterized 
two major dlaloglycopeptide fractions obtained by Pronase treat­
ment of intact milk fat globules and tentatively identified a 
tetrasaccharide component of these released by alkali treatment. 
Newman et al. (1976) used phenol to extract a glycoprotein 
fraction from milk fat globule membrane and obtained evidence 
suggesting that the major alkali-labile oligosaccharide of this 
glycoprotein consisted of the disaccharide 3“2rgalactopyranosyl 
(I'+'S) N-acetyl-g-galactosamine substituted by two molecules of 
sialic acid. Farrar & Harrison (1978) released a mixture of 
glycopeptides from bovine milk fat globule membrane by pronase 
digestion and purified the glycopeptide mixture by gel filtration 
and ion-exchange chromatography. The glycopeptides were shown to 
contain two trisaccharides and one tetrasaccharide arising from 
substitution of sialic acid on the disaccharide 3”D-galactos
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pyranosyl (l*»-3) N-acetyl-D-galactosamine.
6.E. MFGM as a source of TF, HLA-DR and epithelial antigens
The core disaccharide g-D-galactopyranosyl (1-3) N-acetyl- 
D-galactosamine which has been demonstrated on bovine MFGM (Farrar 
& Harrison, 1978) and also on a number of other mammalian membranes 
(see below) has recently been the subject of considerable interest 
because of reports that it is exposed on breast epithelial cells 
of patients with mammary carcinoma but not on normal equivalents 
(Springer et al., 1975; Springer et al., 1976). In parallel 
studies, Newman and Uhlenbruch (1977) failed to find the TF anti­
gen on glycopeptides derived from normal human milk fat globules 
(themselves derived from breast epithelial membrane) when the 
glycopeptides were used to inhibit lectin-induced agglutination 
of desialylated human erythrocytes. They did, however, detect 
the TF antigen by chemical analysis of the glycopeptides 
(Glockner et al., 1976) and the presence of unsubstituted TF 
antigen exposed on human milk fat globules has been demonstrated 
by agglutination assays using peanut lectin (Farrar et al., 1979; 
Farrar et al., 1980). Direct evidence for the exposure of TF 
antigen on both normal and cancerous breast epithelial membranes 
has been obtained by the use of fluorescent-labelled peanut lectin 
(Newman et al., 1979a,b; Klein et al., 1979) and the TF antigen is 
not now generally regarded as a specific marker for breast cancer.
The TF antigen has the structure Gal 81-*-3 GalNAc which 
is the core disaccharide of the tetrasaccharide demonstrated on 
the surface of human red cells by Thomas and Winzler (1969).
Anti-T antibodies are present in normal human sera indicating that
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the antigen is normally hidden on human red cells (Uhlenbruck et al., 
1969). Evidence has been obtained for the presence of sialic 
acid-substituted TF antigen not only on the surface of bovine 
(Newman et al., 1976) and human (Glockner et al., 1976) milk fat 
globule membranes but also on the surface of erythrocytes from 
horses, sheep, pigs, humans (Glockner et al., 1976) and cows 
(Newman & Uhlenbruck, 1977) as well as on human and bovine lym­
phocytes (Newman & Uhlenbruck, 1977). Particular sialic acid 
containing tri- and tetrasaccharides based on the TF antigen core 
have been fully characterised on membranes from human erythrocytes 
(Thomas & Winzler, 1969), rat brain (Finne, 1975, Finne & Rauvala, 
1977), bovine milk fat globule (Farrar & Harrison, 1978) and 
kidney and liver cells (Krusius & Finne, 1977). Despite these 
many sources of the TF antigen, the bovine milk fat globule 
membrane together with the human erythrocyte probably represents 
the most convenient source.
Human milk fat globule membrane is known (Wiman et al., 
1979; Newman et al., 1980) to be a source of HLA-DR-like antigens 
(see glycoproteins as histocompatibility antigens section page gg ). 
Evidence has also been presented (Reiter & Brown, 1976) for 
the presence of specific gut epithelial cell membrane receptors 
for E. coli on the surface of bovine MFGM, and Ceriani et al.
(1977) were the first to describe an antiserum to defatted human 
milk fat globules (cream) which is apparently specific to mammary 
epithelium. Antisera raised in such a way and then absorbed with 
different tissues were used by Heyderman et al. (1979) to demon­
strate a new epithelial antigen on the mammary epithelial membrane 
which is the original source of MFGM (see page 105). Antisera have 
also been raised against goat MFGM (Patton et al, 1980) and
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shown to suppress milk secretion.
It is clear that MFGM of bovine and particularly . of human 
origin is a potential source of oligosaccharide and glycoprotein 
antigens of physiological significance. It is in this context 
that the human MFGM, which has been relatively little studied, 
is examined in the present thesis which describe structural and 
immunochemical investigations of the membrane glycoproteins.
SECTION A
SIALOGLYCOPEPTIDES AND OLIGOSACCHARIDES 
FROM HUMAN MFGM
124.
Materials and Methods 
Materials
The gas chromatographic columns and packings were from 
Phase Separations Ltd., Queens Ferry, Flintshire, U.K. Sephadex 
gels were from Pharmacia (OB) Ltd., London, U.K., ion exchange 
resins from Bio-Rad Laboratories Ltd., St. Albans, U.K.
L-fucose, n-mannose, fi-galactose, D-glucose, N-acetyl-D-gluco- 
samine, N-acetyl-^-galactosamine, N-acetylneuraminic acid, 
N-acetylneuramin lactose (bovine colostrum, type II),
Coomassie Brilliant Blue and the gel filtration calibration kit 
were from Sigma (London) Chemical Co., London, S.W.6, U.K.
Pronase (B grade. Streptomyces griseus proteinase) was purchased 
from Calbiochem Ltd., London, U.K. Sodium borohydride was from 
Aldrich Chemical Co., Gillingham, Kent, U.K.
All other reagents and solvents were obtained from 
BDH Chemicals Ltd., Poole, Dorset, U.K. and were of AnalaR grade 
whenever possible.
Methods
Hexose and hexosamine determinations
Total hexose was determined colourimetrically by a 
modification of the cysteine HgSO^ assay (Dische and Danilchenko, 
1967) using a calibration curve based on grgalactose.
Individual hexose and hexosamine components of the acid 
hydrolysed glycopeptide fractions were identified and determined 
quantitively as their alditol acetates by comparison with iden­
tically treated authentic standards and by using Perseitol as 
internal standard (see Gas liquid chromatography).
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Sialic acid determination
Sialic acid determination was based on the method of 
Warren (1959) as modified by Aminoff (1961). The samples 
(0.1ml) were hydrolysed at 80°C for Ih before determination of 
the freed sialic acid.
Sialic acid determination in purified oligosaccharide 
fractions was based on the method of Svennerholm (1958). The 
samples were hydrolysed as above, cooled, and then applied to a 
column (5cm x 0.5cm) of anion-exchange resin (Bio-Rad AG 1X8, 
formate form). The column was eluted with water (10ml) to 
remove neutral saccharides and then with 0.31M formic acid 
(10ml). The acid eluate was freeze-dried and redissolved in 
water before assay as described above. Commercial N-acetyl 
neuraminic acid treated identically was used as a standard.
In the case of column fractions containing pyridine 
acetate buffer, the volatile buffer was removed from the 
aliquots (0 .1ml) by freeze-drying and redissolving in distilled 
water (0 .1ml).
Protein determination
Total protein was determined colourimetrically by the 




Acid hydrolysis of aqueous solutions (approx. 1ml) 
of glycopeptides or oligosaccharides was effected by evaporating 
an aliquot (0 .1ml) of the solution to dryness in a stream of 
followed by incubation at 120°C for Ih with 2M-trifluoroacetic 
acid (50pl) in a sealed tube. Perseitol (20yg) was routinely 
added as an internal chromatographic standard prior to hydrolysis. 
The hydrolysates were freed from acid in a stream of at 50°C 
and the residual free monosaccharides were converted to their 
alditol acetates.
Alditol acetate derivatives of monosaccharides released 
by hydrolysis of either glycopeptides or oligosaccharides were 
prepared as follows. The dried, acid-free hydrolysates' (approx. 
20yg) were incubated with NaBH^ (0.5mg) in 3M-NH^0H (50yl) for Ih 
at 22°C. Glacial acetic acid was then added dropwise until 
effervescence ceased indicating the removal of excess boro­
hydride. The mixture was evaporated to dryness at 50°C in a 
stream of and borate was removed by successive addition and 
evaporation in of methanol (lOOyl), methanol/water (1:1, 
lOOyl) and dry methanol (lOOyl, three times). The residue was 
allowed to stand over KOH and PgO^ in a dessicator overnight and 
then heated in acetic anhydride (50yl) at 121°C for Ih. The 
acetylated mixture was dried in a stream of at 50°C and the 
residue was taken up in dichloromethane (50yl).
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Chromatography was performed by injection of samples 
(l.Oyl) of the dichloromethane solution onto columns (2m x 0.25cm) 
of coiled glass containing either 3% OV-17 or OV-225 on H.P. Gas 
Chrom Q in either a Pye Unicam (OV-17) or a Sigma 3 (OV 225) gas 
chromatograph. Chromatography was carried out isothermally at 
200°C (for separation of hexoses on OV-225) or at 205°C (for 
separation of hexosamines on OV-17) with flow rates of 45ml/h.
Equimolar mixtures of standard hexoses and hexosamine 
were derivatized as described above and chromatographed in order 
to determine retention times and to establish that sialic acid 
did not affect the results. Traces obtained in this way are shown 
in Figs. 48 and 49. Quantification of individual monosaccharides 
in analysis of glycopeptides and oligosaccharides was achieved 
by reference to the internal standard perseitol using the formula:
Weight of monosaccharide =
Peak area of monosaccharide x x weight perseitol 
Peak area of perseitol
where K„ is a correction factor =4
Peak area of perseitol
Peak area of equal weight of monosaccharide
Retention times and values of K for the monosaccharides
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Fig. 49. Gas chromatography of alditol acetate derivatised standards 
[L - fucose (peak I), D - mannose (peak II), ^  - galactose 
(peak III), N - acetyl-D-glucosamine (peak IV), N-acetyl-D- 
galactosamine (peak V), perseitol (peak VI)_| . Separation on 
a column of 3% OV-17 isothermally at 205°C.
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Gel filtration
All gel filtration was performed by using Sephadex gels 
that had been swollen by equilibration at 22°C with distilled water 
for 24h. The gels, when not in use, were stored in the presence of 
0.02% Hibitane (chlorhexidine) or 0.02% sodium azide as antibacterial 
agents. All elutions were performed at 22°C by using an LKB 
Varioperpex pump to maintain the flow rate. An LKB Redirak 2112 
fraction collection, fitted with an electronic timer, was used to 
collect the samples automatically.
Thin-layer chromatography
Silica gel G plates (20cm x 20cm x 0.5 mm) were used for
thin layer chromatography of oligosaccharide samples (1ml). The
bands were developed with (propan-2-ol/butan-l-ol/water)(5:3:2, by 
vol.) and positions of bands were determined from patterns of spots 
on a control plate that was sprayed with Q3% (w/v) phenol in ethanol/
cone HgSO^ (19:1, v/v)J and heated at 110°C for 10 min.
Sodium dodecyl sulphate (SDS) polycrylamide gel electrophoresis
Gels were prepared in clean glass tubes as described by 
Weber et al. (1972). Diluted acrylamide solution in O.lM-sodium 
phosphate buffer, pH 7.2, containing 1% (w/v) SDS at the required gel 
concentration (28ml) was mixed with ammonium persulphate solution 
(15mg/ml, 1.5ml) and TEMED (0.045ml), degassed for 2 min and immediately 
pipetted into glass tubes (8cm x 0.5cm) closed at the bottom with para- 
film. Distilled water (0.5ml) was layered gently on top of the gel 
solution in each tube and the gels were allowed to polymerise for Ih.
131. -
Glycopeptide and the peptide marker samples were prepared 
for electrophoresis by heating at 100°C for 4 min in 0.01 ^-sodium 
phosphate buffer, pH 7.2, containing 1.0% (w/v) SDS and 1% v/v 
2-mercaptoethanol, at a final concentration of the peptide protein 
in the solution of Img/ml. A few drops of glycerol and a suitable 
amount of Bromophenol Blue as internal marker were added and then 
aliquots (50-100yl) were loaded onto the gels which were subjected to 
electrophoresis at 6mA/gel. When the internal marker reached a 
distance of 0.5-1 cm from the bottom of the gel, the gels were removed, 
fixed in propan-2-ol/glacial acetic acid/water (25:10:65, v/v/v) and 
stained for protein with 0.25% (w/v) Coomassie Brilliant Blue in 
methanol/glacialacetic acid/water (46:5:49, v/v/v). Destaining at 
37°C was effected with methanol/glacial acetic acid/water (5:7:88 
v/v/v). The periodic acid Schiff's procedure was used to stain the 
gels for carbohydrates. Gels were fixed in ethanol/glacial acetic 
acid/water (40:5:55, v/v/v) for 12h and treated for 3h with 0.7%- 
periodic acid solution containing 5% acetic acid. 5% acetic acid 
containing 2% sodium arsenite was then added with repeated changes 
until the brown colour of iodine in the gel had cleaved. Gels were 
stained in Schiff's reagent (Fairbrank et al., 1971) for 12h and 
then washed twice with O.OIN HCl containing 0.1% sodium meta­
bisulphate.
Mobilities were calculated from the formula 
Mobility =
distance migrated by protein ^ length of gel before staining
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Isolation and proteolytic digestion of milk fat globules
Freshly-expressed human breast milk (1.5£)at 22°C was 
centrifuged (12,000 xg., 10 min). The cream layer was separated, 
resuspended in double-distilled water (20 vol.) at 22°C and re­
centrifuged (12,000 xg, 10 min). This washing process was repeated 
a further two times to give approximately 50g washed fat globules.
Sialic acid analysis (Methods section) of the aqueous sub- 
natant showed that the final washings were free from sialic acid.
Washed cream (50g) was suspended in 50mM-Tris HCl buffer, 
pH 7.8, (100ml) containing 4mM- CaCl^ at 37°C and 50mM- Tris-HCl 
buffer, pH 7.8 (50ml) containing Pronase (150pg/ml) at 37°C was added. 
The mixture was gently stirred at 37°C for Ih, cooled in ice for 
30 min. and centrifuged (6,000 xg, 30 min). The aqueous subnatant 
was separated from the milk fat globules, centrifuged (100,000 xg, 2h) 
and extensively dialysed against distilled water at 4°C. The non- 
diffusible material was freeze-dried, redissolved in water (5ml) and 
centrifuged (125,000 xg, Ih) to give a pellet, a surface layer of lipid 
and a yellow solution. The solution was separated and assayed 
(Methods section) for hexose (approx. 8mg.), and sialic acid (approx. 
1.25mg). This solution could be stored at -20°C for several months 
without apparent change. This procedure is outlined in Scheme 1.
A control experiment was done in which washed cream was 
treated exactly as described above except that Pronase was omitted 
from the incubation buffer. The final centrifugation gave as before 
a pellet, a lipid layer and a clear solution which in the case of the 
control was found to be only very faintly coloured and to be free of
134.
sialic acid.
The effect of increasing the amount of Pronase in the pro­
teolytic digestion of washed fat globules was investigated. Increasing 
the Pronase/milk fat globule ratio from 150yg/g to 450pg/g resulted in 
more extensive disruption of milk fat globules as judged by the amount 
of pellet and fat layer obtained from the final centrifugation step.
The yield of soluble bound sialic acid was, however, not increased by 
the use of more Pronase.
Fractionation of Pronase-cleaved fragments on Sephadex G50
The pale yellow solution (2ml, containing 2.5mg sialic acid) 
obtained from the final centrifugation described above was applied to 
a column (90cm x 0.5cm) of Sephadex G50 (fine) which had previously been 
equilibrated with double-distilled water at 22°C. The column was 
eluted with double -distilled water at a flow-rate of 24ml/h at 22°C 
and fractions (5ml) were collected and continuously monitored at 280nm 
by using an LKB Uvicord 2. Aliquots (0.1ml) of individual fractions 
were assayed for hexose and for sialic acid (Methods section) and the 
resulting patterns are shown in Fig.50 which also shows the trace of 
280nm-absorbing material.
Two major hexose-sialic acid peaks were obtained. Peak I* 
eluting in the void volume, contained approximately 20% of the sialic 
acid and approximately 30% of the hexose of the initial sample. Peak II 
represented an included fraction including some 80% of the sialic acid 
and 60% of the hexose of the original sample. Peak I but not peak II 
was associated with strong absorbance at 280nm.
Milk fat globules
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Fresh human milk (1500ml)
12000 xg, 10 min 
Wash 3 times
Washed cream (50g)
Digest Pronase (150pg/g cream) at 37°C 







Freeze-dry, dissolve in water (5ml)
125000 xg, Ih
Soluble glycopeptides PelletLipid
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Fig. 50. Fractionation on Sephadex G-50 (Fine) of Pronase- 
cleaved glycopeptides. The column was eluted with 
water at 22°C with a flow rate of 24ml/h. Fractions 
(5ml) were automatically collected from which aliquots 
(0 .1ml) were individually assayed for sialic acid (A^^^^)
and hexase (A.^ 2Q * Protein (A^g^----- ) was continuously







Fig. 51. Fractionation on Sephadex G-50 (Fine) of Pronase (15mg) 
incubated in the absence of the milk fat globules.
The column was eluted with water at 22°C with a flow
rate of 24ml/h. Protein (A^g^ --- ) was continuously





Fig. 52. The combination of Fig. 50 and Fig. 51.
139.
Control experiments were done in which Pronase (15mg.) was 
incubated under the conditions described in the previous section but 
in the absence of milk fat globules. Concentration as described gave 
a final solution (2ml) which was applied to the Sephadex 050 column as 
detailed above and the eluate was continuously monitored for absorbance 
at 280nm. The resulting trace is shown in Fig.51. Analysis of samples 
(0.1ml) from fractions corresponding to peaks I and II (Fig.50) showed 
no evidence of hexose or sialic acid. The combined results of Figs.50 
and 51 are shown in Fig. 52.
Carbohydrate composition of sialoglycopeptide fractions I and II
Fractions corresponding to sialoglycopeptide peaks I and II 
(Fig.50) were separately pooled and freeze-dried. The lyophilized 
fractions were redissolved in distilled water (2mg/ml) and samples 
(lOyl) were hydrolysed with 2M-trifluoroacetic acid to release mono­
saccharides which were converted to their alditol acetates as described 
in the Materials and Methods section. Gas chromatography of the 
derivatized samples gave the percentage composition of the individual 
monosaccharide components in sialoglycopeptide fractions I and II.
These are given, together with the
corresponding data for sialic acid (determined colourimetrically as 
described in Materials and Methods) in Table 6 .
Sodium dodecyl sulphate - polyacrylamide gel electrophoresis (SDS-PAGE) 
of peaks I and II (Fig.50) from Sephadex G.50
Fractions corresponding to peak I (Fig30") were combined and 
freeze-dried and samples (50pg protein) were subjected to SDS-PAGE 
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section. When the gels were stained for protein with Coomassie Blue, 
two compact bands (la and 13) were observed (Fig53a ) with mobilities 
26 and 48 respectively. Band la but not 13 stained for carbo­
hydrate with periodate-Schiffs reagent (Fig53b ).
Fractions corresponding to peak II (Fig30 ) were combined 
and freeze-dried and samples (50pg protein) were subjected to SDS-PAGE 
in 10% acrylamide gels. Staining for protein with Coomassie Blue 
showed three bands I la, 113 and Ily (Fig54d ) with mobilities 18 ,
26 , and 50 respectively. When the gels were stained for carbohydrate
using the periodate-Schiff reagent, only bandsIla and 113 could be 
detected. They appeared as a single diffuse band (Fig.54b).
Origin of SDS-PAGE bands 13 & Ily - - - .
As outlined above, incubation of Pronase in the absence of 
milk fat globules gave material absorbing at 280nm which was fraction­
ated on Sephadex G-50 (Fig.51). Fractions eluting in the position of 
peaks I & II (Fig.50) were collected, freeze-dried and analysed by 
SDS-PAGE. A single Coomassie Blue-positive band corresponding to Ily 
Figs.54a) and also to 13 (Fig.53a) was obtained. These bandsdid not 
stain for carbohydrate with periodate-Schiff reagent.
Further fractionation on Sephadex of sialoglycopeptides corresponding 
to peak II (Fig.50)
Fractions corresponding to peak II (Fig.50) were combined, 
freeze-dried and a sample (8mg) was dissolved in O.IM acetic acid 
(1ml) and applied to a column (40cm x 2.6cm) of Sephadex G-lOO which 
had been previously equilibrated with O.lM-acetic acid at 22°C. The 







Fig. 53. SDS-PAGE in 10% acrylamide gels of sialoglycopeptide
I (50yg protein) (Fig. 50). (a) Stained with Coomassie 





Fig. 54. SDS-PAGE in 10% acrylamide gels of sialoglycopeptide II 
(50yg protein) (Fig. 50). (a) stained with Coomassie 
Blue. (b) stained with periodate-Schiff reagent.
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16ml/h and fractions (5ml) were automatically collected and continuously 
monitored for absorbance at 280nm using an LKB Uvicord 2. Samples 
(0.1ml) of fractions were assayed for hexose and sialic acid (Materials 
and Methods section) and the resulting elution pattern is shown in 
Fig. 55. Two hexose-sialic acid peaks (IIA and IIB) were obtained 
together with a third peak (IIC ) containing protein but no hexose or 
sialic acid.
Fractions corresponding to each of the three peaks IIA ,
IIB and IIC (Fig. 55) were separately combined and freeze-dried to 
give residues weighing 3mg, 4.5mg and a trace respectively. SDS-PAGE 
of the fractions IIA and I I B in 10% acrylamide gels gave in each 
case a single band stainable with Coomassie Blue or with periodate- 
Schiff reagent. The positions of the bands indicated the probable 
identity of fractions IIA and I I B with material giving rise to 
bands Ila and 113 respectively (Fig. 54) [obtained when peak II (Fig.50) 
was analysed by SDS-PAGE without further fractionation on Sephadex].
Further fractionation of peak II (Fig. 50) was also achieved 
by repeat gel filtration on Sephadex G-50. Fractions corresponding 
to peak II (Fig.50) were combined, freeze-dried and a sample (5mg) 
was dissolved in O.IM acetic acid (1ml) and chromatographed on a column 
(90cm X  1.6cm) of Sephadex G-50 (fine) previously equilibrated in the 
same buffer. Elution with O.IM acetic acid at a flow rate of 21ml/h 
gave fractions (4ml), analysis of which gave the sialic acid profile 
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Fig. 56. Rechromatography on Sephadex G-50 of sialoglycopeptide II 
(Fig. 50). The column was eluted with 0.5K acetic acid 
at 22°C with a flow rate of 21ml/h. Aliquots (0.2ml) 
of fractions (4ml) were individually assayed for sialic
acid (A^^q •).
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Determination of the molecular weights of sialoglycopeptide fractions 
IIA and IIB by gel filtration
The molecular weights of the sialoglycopeptide fractions IlA 
and IIB were determined by comparison of their elution volumes from 
Sephadex GIOQ with the volumes shown by standard proteins of known 
molecular weight. Albumin C7mg), ovalbumin (7mg), chymotrypsin (3mg) 
and ribonuclease A (lOmg) were combined and dissolved in O.lM-acetic 
acid (1ml). The solution was applied to a column (40cm % 2.6cm) of
Sephadex G-lOO which had been previously equilibrated with O.lM-acetic
acid at 20°C. The column was eluted with O.lM-acetic acid at 22°C with
a flow rate of 16ml/h and the eluate was continuously monitored for
absorbance at 280nm giving the elution pattern shown in Fig.57, A 
plot of log. M.Wt versus (Fig,58) gave a straight line from which
the molecular weights of sialoglycopeptide. peaks IIA, IIB and IIC were 
calculated to be 24,000, 13,000 and 6,500 respectively (Table 7).
The two peaks obtained when material corresponding to peak II 
(Fig.5o) were chromatographed on Sephadex G-50 (Fig.56) were identified 
as fractions IlA and,IIB by molecular weight determination using protein 
standards as described above. Ovalbumin (7mg), chymotrypsin (3mg) and 
ribonuclease (lOmg) were combined and chromatographed on a column of 
Sephadex G-50 (fine) exactly as described for the elution pattern shown 
in Fig.56. Continuous monitoring of the eluate for absorbance at 280nm 
gave the elution pattern shown in Fig. 59 and the corresponding plot of 
log M.Wt versus is shown in Fig. 60. Comparison of the data shown 
in Figs.56 and 59 gives the molecular weights of the two sialic acid- 
containing peaks of Fig. 56 as 25,000 and 12,500 respectively (Table8 ) 
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Fig. 58. Calibration plot for Sephadex G-lOO column. The elution 






where = elution volume for the protein
V = column void volume = elution volume for Blue Dextran 2000 
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Fig. 60. Calibration plot for Sephadex G-50 column, the elution pattern 
of which is shown in Fig. 59.
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Preparation of alkali-labile oligosaccharides from Sialoglycopeptide II 
(Fig.50)
Fractions corresponding to peak II (Fig.5o) were pooled and 
freeze-dried. A sample (30mg) was dissolved in O.lM-acetic acid (1ml) and 
applied to a column (100cm x 1cm) of Sephadex G-25 (fine) which had been 
previously equilibrated with O.lM-acetic acid at 22°C. The column was 
eluted with O.lM-acetic acid with a flow rate of 40ml/h and fractions 
(5ml) were automatically collected and assayed for hexose and sialic acid 
(Fig. 610.
Fractions were pooled so as to exclude the tail of partially 
included material and the combined fractions were freeze-dried giving 
23mg lyophilized product. A sample (20mg) was dissolved in l.OM- 
sodium borohydride (20ml) containing 0.05M-sodium hydroxide and the 
solution was degassed in a stream of N^. The mixture was then incubated 
in a stoppered flask at 50°C for 24h in the dark, cooled in ice and 
adjusted to pH 6 by addition of Bio-Rad AG50W x 8 cation-change resin 
(H^ form) .
The resin was removed by centrifugation (3000 xg, 5 min) 
and washed with double-distilled water (3 x 10ml). Supernatant and 
washings were passed down a column (8cm x 0.7cm) of the same resin 
which was then eluted with distilled water (20ml). The combined eluates 
from the column were freeze-dried and the residue was freed from boric 
acid by repeated addition and removal by distillation of methanol.
The residue was dissolved in O.IM acetic acid (1ml) and 
applied to a column (100cm x 1cm) of Sephadex G-25 (fine) which was 
then eluted with O.lM-acetic acid at 22°C with a flow rate of 40ml/h. 
Fractions (5ml) were collected and assayed for hexose and sialic acid.
154.
The elution pattern (Fig. 62) shows two major sialic acid-containing 
hexose peaks, b and c, flanked by minor peaks (a, d, e and f) con­
taining hexose and relatively less sialic acid. Peak (a) coincides 
with the sialoglycopeptide peak excluded from an identical Sephadex 
column prior to borohydride treatment (Fig. 61). Superposition of 
the traces of Figs. 61 and 62 makes this clear (Fig. 63).
Fractions corresponding to peaks b-^ f (Fig. 62) were com­
bined, freeze-dried and dissolved in 0.05M-pyridine acetate buffer, 
pH 5.0 (1ml). The sample was applied to a column (15cm x 1.5cm) of 
DEAE Sephadex A-25 which had been previously equilibrated with the 
same buffer at 22°C. The column was eluted at a flow rate of 
40ml/h first with this buffer (100ml) and then with a linear gradient 
(0.05M-0.65M) of pyridine acetate, pH 5.0 (200ml) at 22°C. Fractions 
(5ml) were collected and aliquots (0.1ml) were assayed for hexose, 
sialic acid and protein as described in the Materials and Methods 
section. The elution profile (Fig. 64) shows three distinct hexose- 
sialic acid peaks A(II), B(II) and C(II). Only peak A(II) contained 
protein.
Carbohydrate composition of sialoglycopeptide fraction a (Fig.62 ) 
and sialoglycopeptide fraction A(II)(Fig.64 )
Fractions corresponding to sialoglycopeptide peaks a 
(Fig. 62) and A(ll)(Fig. 64) were separately pooled and freeze- 
dried. The freeze-dried residues were redissolved in distilled water 
(approx. 2mg/ml) and samples (lOyl) were hydrolysed with 2M-tri- 
fluoroacetic acid to release monosaccharides which were converted 





Fig. 61. Purification on Sephadex G-25 of the Sialoglycopeptide II 
from Sephadex G-50 (Fig. 50). The column was eluted with 
O.IK acetic acid at 22°C with a flow rate of 40ml/h. 
Fractions (50ml) were automatically collected from which 
aliquots (0 .1ml) were individually assayed for sialic 
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and Methods section. Gas chromatography of the derivatized samples 
gave the percentage composition of the individual monosaccharide 
components in each of the peaks. These are given, together with 
corresponding data for sialic acid (determined colourimetrically as 
described in the Materials and Methods section) in Table 9. 
Representative gas chromatographic traces are shown in Figs. -65 and 
66.
Purification of oligosaccharide fraction B(II) by thin layer 
chromatography
The procedure for purification of a sialic acid-containing 
oligosaccharide fraction by thin layer chromatography was established 
by using N-acetylneuraminyl lactose as a model compound. The commer­
cially supplied (Sigma Chemical Co. Ltd.) sample (5mg) was dissolved 
in 0.05M-pyridine acetate buffer, pH 5.0, (1ml) and applied to a 
column (15cm x 1.5cm) of DEAE Sephadex A-25. The column was eluted 
with the same buffer (200ml) and fractions (5ml) were collected.
Assay of samples (0.1ml) of the fractions for hexose showed a single 
peak (Fig. 67). Fractions corresponding to this peak were pooled 
and freeze-dried to give 450yg hexose. This was dissolved in water 
(1ml) and the solution was applied as a band on plates (20cm x 20cm 
X  0.5mm) of Silica gel C. The plates were developed with propan-2- 
ol/butan-l-ol/water (5:3:2, by vol) and the positions of the bands 
were established by the use of an identical control plate spotted 
with the same sample, sprayed with 3% (w/v) phenol in ethanol/conc. 
HgSO^ (19:1, v/v) and heated at 110°C for 10 min. This plate showed 
the presence of two bands (R^ 0.20, 0.28) (Fig. 68) corresponding 
to the known presence of two positional isomers (N-Acetylneuraminyl 
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Fig. 65. Representative gas chromatogram of alditol acetates 
from hydrolysis of fractions corresponding to peak a 
(Fig. 62). Peaks I and II represent N-acetylgluco- 
samine and perseitol (internal standard) respectively. 
Chromatography was performed on a column (2m x 0.25cm)
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Fig. 66. Representative gas chromatogram of alditol acetates from
~i—
25
hydrolysis of fractions corresponding to Peak A(II) 
(Fig. 64). Peaks I, II and III represent N-acetyl- 
glucosamine, îJ-acetylgalactosamine and perseitol 
(internal standard) respectively. Chromatography was 
performed on a column (2m x 0.25cm) of 3% OV-17 on PYE 















Ü • H CO
(Q 3 4-1
I—t o
i-H u . d
>> o a *
CM • H  -













1 . P i r 4











• d CO O
cfl 0) 4-1
X i d d
A • H CO
0) T3
c/3 • H 0)




Q s l l O
m I-H
C O 8o m O
O CM
>> -d -
X X CO <
A 4-1 d
(C • H o
Pi 3 •r4 0)
00 4-1 CO
o U o
4-1 0) CO X
2 4-1 P i (U
8 d P4 Xo 1-4
P i <u u
o
U 0] X 4 4
cO





u 1-4 4 4 CO
X o O cO
0) u
(U (U
d (U 44 P i
o CO (U






Fig. 68. Control thin-layer chromatogram of oligosaccharide 
fraction B(II) run on Silica Gel G. Samples 1, 2 
and 3 represent two separate batches of fraction 







ratio of 85:15 in commercial N-acetylneuraminyllactose. Silica 
gel corresponding to the position of these bands was scraped from the 
preparative plate, shaken with water (5ml) and centrifuged (3000 xg, 
10 min), The washing-centrifugation procedure was repeated twice 
more and the combined supernatants were freeze-dried and rechroma­
tographed on a column of DEAE-Sephadex exactly as described above. 
Assay of eluate fractions showed a hexose profile identical to that 
shown in Fig. 67. Fractions corresponding to this peak were pooled 
and freeze-dried to give a residue assaying for 275yg hexose which 
represents a 61% recovery from the combined thin layer and ion- 
exchange chromatographic procedures. Combination and freeze-drying 
of all the column eluate fractions in groups of five tubes showed 
that only the first five tubes contained silica gel.
Fractions corresponding to peak B(II) (Fig.64 ) were 
combined, freeze-dried and chromatographed as a band on Silica Gel G 
exactly as described for N-acetylneuraminyllactose. The control 
plate (Fig. 68) showed the presence of two bands (R^ 0.19, 0.15) 
running slower than N-acetylneuraminyllactose. Silica gel corres­
ponding to these bands was scraped from the preparation plate and 
processed as described for N-acetylneuraminyllactose to give a 
freeze-dried carbohydrate-containing residue. This was rechrom­
atographed on DEAE-Sephadex exactly as described in the legend to 
Fig. 64 and a single hexose-sialic acid peak was eluted in the 
position of peak B(II) (Fig. 64). Fractions corresponding to this 
peak were pooled and freeze-dried.
166.
Preparation of alkali-labile oligosaccharides from Sialoglycopeptide I 
(Fig. 50)
Fractions corresponding to peak I (Fig. 50) were pooled and 
freeze-dried. A sample (30mg) was chromatographed on Sephadex G-25 
exactly as described for sialoglycopeptide II (page *153) to yield 
18mg of freeze-dried sialoglycopeptide material that was excluded 
from the gel.
The excluded (from Sephadex G-25) sialoglycopeptides were 
treated with alkaline borohydride as described on page 153 and the 
borate-free residue was chromatographed on a column (15cm x 1.5cm) 
of DEAE-Sephadex A-25 as described for the alkali-labile oligo­
saccharides derived from Sialoglycopeptide peak II (Fig. 58). In 
this case ion-exchange chromatography was done without prior 
rechromatography on Sephadex G-25 (cf. page 156) . The elution 
pattern from DEAE-Sephadex A-25 is shown in Fig. 69 in which three 
hexose sialic acid peaks A(I), B(I) and C(I) can be seen to 
correspond approximately to peaks A(II), B(II) and C(II) 
respectively of Fig. 64. Peak A(I), like peak A(II) (Fig. 64) is 
the only one of the three to contain protein.
Purification of Oligosaccharide fraction B(I) (Fig.69 ) by thin 
layer chromatography
Fractions corresponding to peak B(I)(Fig. 69) were 
combined, freeze-dried and chromatographed as a band on Silica gel G 
as described (page 159) for peak B(II) (Fig. 64) from sialoglyco­
peptide II (Fig. 50). Two zones were obtained with values 
similar to those of peak B(II) (Fig. 68). Silica gel corresponding 








































































































































































































as described for N-acetylneuraminyl/lactose (page 165) to give a 
freeze-dried carbohydrate-containing residue which was then 
rechromatographed on DEAE-Sephadex exactly as described in the 
legend to Fig. 69. A single hexose-sialic acid peak was eluted 
in the position of peak B(I) (Fig. 69). Fractions corresponding 
to this peak were pooled and freeze-dried.
Carbohydrate composition of alkali-labile oligosaccharide fragments 
B(II) and C(Il)(Fig. 64)
Oligosaccharide fractions B(II) (after t.l.c. purification) 
and C(II)(Fig. 64) were freeze-dried, dissolved in water approx. 
(Img/ml) and samples (lOpl) of the aqueous solutions were evaporated 
to dryness in the s_tream of N^. 2M-Trifluoroacetic acid (50pl) and 
perseitol (20yg) were added and the samples were incubated in a 
sealed tube at 120°C for Ih. The hydrolysates were freed from acid 
in a stream of at 50°C and the residual free monosaccharides 
were converted to their alditol acetate derivatives and subjected 
to gas chromatographic analysis as described in the Materials and 
Methods section. The results of repeat analyses on different samples 
of the oligosaccharides are shown in Table 10, together with the 
contents of sialic acid (determined colourimetrically - Materials 
and Methods section). Representative g.l.c. traces are shown in 
Figs. 70, 71, 72, 73.
169.
Carbohydrate composition of alkali-labile oligosaccharide fragments 
B(I) and C(I)(Fig.69 )
Oligosaccharide fractions B(I)(after t.l.c. purification) 
and C(I)(Fig.69 ) were hydrolysed and the freed sugars were con­
verted to those alditol acetate derivatives as described for 
fractions B(II) and C(II). Gas chromatography as detailed for the 
latter fractions gave the carbohydrate compositions of B(I) and 
C(I) shown in Table 11.
170.
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Fig. 71. Representative gas chromatogram of alditol acetates
from oligosaccharide fraction B(II)(Fig. 64)
(purified by t.l.c.). Peaks 1, 2 and 3 represent 
N-acetylglucosamine, ^-acetylgalactosamine and 
perseitol (internal standard) respectively. Chroma­
tography was performed on a column (2m x 0.25cm) of 3% 
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Representative gas chromatogram of alditol acetates from
oligosaccharide fraction C(II)(Fig. 64). Peaks 1, 2 and 
3 represent N-acetylglucosamine, N-acetylgalactosamine 
and perseitol (internal standard) respectively. 
Chromatography was performed on a column (2m x 0.25cm)
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Human breast milk was stored at 4°C for not more than 24 hours 
prior to processing. Periods of storage longer than this were found 
to give rise to discolouration in the milk which in general led to 
low yields of glycopeptides. It was found that washing the 
separated cream three times with double-distilled water was sufficient 
to remove soluble milk proteins as judged by the content of sialic 
acid-containing material in the washings.
The washed cream was digested with the proteolytic enzyme 
mixture Pronase in amounts found to give optional yields of released 
glycopeptides and minimal disruption of the globules. Control 
digests carried out in the absence of Pronase established that sialic 
acid-containing material was not being simply washed off the globule 
surface during the incubation.
An average yield of soluble sialoglycopeptides from the 
proteolytic digest of 1.5& of milk contained approximately 8mg 
hexose and 1.25mg sialic acid. For further processing two such runs 
were combined and subjected to gel filtration on Sephadex G-50 when 
two major hexose-sialic acid Peaks I and II were obtained containing 
20% and 80% respectively of the sialic acid applied to the column. 
Monitoring the column by following absorption at 280nm showed a 
major peak coinciding with Peak I and a second complex set of 
peaks eluted after Peak II. These latter peaks almost certainly 
arose from the Pronase itself as similar 280nm-absorbing complexes 
were obtained when Pronase was digested and fractionated in the 
absence of milk fat globules.
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Polyacrylamide gel electrophoresis in the presence of 
sodium dodecyl sulphate of material corresponding to Peaks I and II 
gave in each case protein bands with approximate mobilities 26 and 
50 in the 10% acrylamide gels used. Peak II showed additionally 
a band with mobility 18. SDS-PAGE under identical conditions of 
the control digest containing Pronase alone gave a band with mobility 
50 for fractions corresponding to both Peak I and to Peak II, 
suggesting that this band is not derived from the milk fat 
globule membrane. This conclusion is further supported by the 
observation that the fast moving band stained for protein but not 
for carbohydrate.
The compositional pattern of Peak II as indicated by 
SDS-PAGE was supported by further gel filtration on Sephadex G-100. 
Again three components (IIA, IIB, IIC) were observed, the smallest 
of which (IIC) contained protein but no hexose. Elution of 
fractions corresponding to peaks IIA and IIB followed by analysis 
on SDS-PAGE confirmed the identity of peak IIA with the band of 
mobility 18 and of peak IIB with that of mobility 26. Calibration 
of the Sephadex column with molecular weight standards indicated 
molecular weights of 24,000 and 13,000 for Peaks IIA and IIB res­
pectively. The composition of the sialoglycopeptide mixture and 
the molecular weights of its two major components were checked and 
confirmed by gel filtration on a calibrated column of Sephadex G-50.
The molecular weights of the major sialoglycopeptide com­
ponents cleaved by Pronase from human milk fat globules are com­
parable with those similarly cleaved from bovine milk fat globules 
(25,000; Farrar, 1978) and from pig erythrocyte (12,000; D.okov, 1980)
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In the latter case it was found that extensive further Pronase 
treatment of the released fragments did not lead to the production 
of smaller polypeptide units, suggesting that the extracellular 
carbohydrate complexes protect the peptide chain from proteolytic 
attack. It may well be that 12,000 represents a limiting minimum 
molecular weight fragment in the human milk fat globule system also.
The carbohydrate compositions of Peaks I and II (Table 6) 
show the presence of all the usual monosaccharide components to be 
expected in glycoproteins, whether membrane-bound or soluble, 
although the apparently very low content of mannose in Peak I is 
unusual and difficult to reconcile with the substantial content of 
glucosamine with which mannose is commonly associated. It was of 
particular interest to examine the nature of alkali-labile oligo­
saccharide complexes on glycopeptides derived from human milk fat 
globule membrane in view of the recent characterisation of an 
0-glycosidically-linked tetrasaccharide present in relatively large 
amounts on bovine milk fat globules (Farrar & Harrison, 1978).
Peak II showed a substantial content of N-acetylgalactosamine 
which usually forms the glycopeptide linkage in alkali-labile 
carbohydrate structures and it was therefore decided to concentrate 
investigations on this fraction which contained most of the sialic 
acid of the mixture.
Material corresponding to Peak II was first subjected to 
gel filtration on Sephadex G-25 in order to remove any lower mole­
cular weight components associated with the major, excluded 
fraction. This allowed oligosaccharides subsequently cleaved from 
the sialoglycopeptide by alkaline borohydride to be clearly
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distinguished from starting material. Treatment of the excluded 
fraction with alkaline borohydride released oligosaccharide 
material that was separated from most of the protein by rechroma­
tography on Sephadex G-25 (Fig. 62). In fact, in contrast to the 
situation with bovine milk fat globule membrane which gives rise 
to essentially a single hexose-sialic acid peak included on 
Sephadex G-25, several small molecular weight peaks were shown 
after gel filtration. In view of the very limited quantities of 
material available, it was decided not to attempt to separate 
directly the individual peaks which partially overlapped on 
Sephadex G-25 but to proceed to ion-exchange chromatography in 
the hope of cleaner separations.
Accordingly all partially included peaks from Sephadex 
G-25 were combined and applied to DEAE Sephadex A-25 when elution 
with pyridine acetate gave two major protein-free carbohydrate 
fractions B(II) and C(II) (Fig. 64). It was initially considered 
that these two fractions corresponded to the trisaccharide and 
tetrasaccharide peaks respectively that were eluted under similar 
conditions from alkaline treatment of bovine milk fat globule 
membrane-derived sialoglycopeptides. There were, however, differ­
ences between the two systems in that the peak eluted at lower salt 
concentrations (BII) was, in the case of human milk, by far the 
bigger of the two, whereas in the bovine system the reverse was 
true, with the later eluted tetrasaccharide in excess.
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The larger oligosaccharide fraction (BII) was subjected to 
further purification and analysis by thin layer chromatography on 
Silica Gel which had been previously used successfully to separate 
the two trisaccharide components of bovine milk fat globule membrane 
(Farrar & Harrison, 1978). Before the limited amount of sample was 
committed to experiment, the system was examined by using N-acetyl­
neuraminyl lactose, a commercial trisaccharide mixture known to 
contain two components in the molar ratio 85:15. The commercial 
mixture was characterized by ion-exchange chromatography on DEAE 
Sephadex A-25, when a single peak was eluted with pyridine acetate, 
and chromatographed as a band on thin layer. Elution of the band 
and rechromatography on ion-exchange, as before, established that 
the material could be recovered pure in 61% overall yield from the 
combined chromatographic procedures.
Thin layer chromatography of material corresponding to 
peak BII (Fig. 64) under conditions identical to those used for 
the model oligosaccharide gave a slower-moving zone made up of two 
barely-separated components. It was considered to be impractical 
to separate the two components which were accordingly eluted 
together, rechromatographed on Sephadex A-25 to remove traces of 
silica and freeze-dried for derivatization and gas chromatographic 
analysis.
Gas chromatography of alditol acetate derivatives of four 
separate batches of purified oligosaccharides BII are shown in 
Table 10. Despite some expected variation between the batches, a 
pattern of monosaccharide ratios emerged comprising sialic acid, 
galactose, N-acetylglucosamine and N-acetylgalactosamine in the
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approximate molar ratios 3:3.5;2:1.
Fractions corresponding to CXI (Fig. 64) were combined 
and, being present in much smaller amounts than BII, were analysed 
for carbohydrate content directly without prior purification or 
thin layer chromatography. In this case the monosaccharide com­
position appeared to be even more complex than that of BII 
comprising sialic acid, fucose, mannose, galactose, N-acetyl­
glucosamine and N-acetylgalactosamine in the approximate molar 
ratios 4.5: 1.5: 1: 3: 2: 0.25.
Peak I (Fig. 50) was also treated with alkaline boro­
hydride exactly as described above for Peak II. Again oligo­
saccharides were released and this time were directly separated 
by ion-exchange without prior gel-filtration on Sephadex G-25.
Three peaks AI, BI and Cl corresponded closely in elution 
positions to those of All, BII and CII respectively. Like All, AI 
(but not BI or Cl) contained protein and clearly represented the 
residual glycopeptide from which alkali-labile oligosaccharide 
complexes had been removed. BI, like BII, was chromatographed 
on thin layer plates and showed two closely related zones in 
positions identical to those of BII.
BI (after thin layer chromatography) and Cl were both 
analysed by gas chromatography for carbohydrate content, as were 
BII and CII. The monosaccharide ratios shown in Table 11 are similar 
but not identical to those obtained for BII and CII. However 
material obtained from Peak I was available in much lower amounts 
than that from Peak II and less analyses were possible. It is 
possible that oligosaccharides B and C from either of the two major
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peaks (I and II) are essentially similar in composition.
It is instructive to compare the monosaccharide composition 
of oligosaccharide BII and CII with those published for alkali- 
labile oligosaccharide complexes from other, particularly membrane- 
bound glycoproteins.
The bovine milk fat globule membrane has been analysed 
and glycopeptides have been isolated by Pronase digestion 
(Harrison et al., 1975) and by phenol extraction (Newman et al., 
1976). Both procedures have revealed major glycoprotein fractions 
which were shown, by alkaline borohydride treatment, to carry 
relatively large amounts of the alkali labile tetrasaccharide. 
N-acetylneuraminyl a 2-3 D-galactosyl 8 1-3 [N-acetylneuraminyl a 
^“Ci N-acetyl-D-galactosamine. Farrar and Harrison (1978) iso­
lated, following Pronase treatment, a mixture of glycopeptides 
from bovine MFGM, which were shown to contain two trisaccharides 
and one tetrasaccharide in which sialic acid is substituted on 
the disaccharide 8-D-galactopyranosyl (l->-3)N-acetyl-D-galactosamine.
This tetrasaccharide was initially described by Thomas 
and Winzler (1969) as a component of human erythrocyte membranes 
and has been also detected on membranes of rat brain (Finne,
1975) liver and kidney (Krusius & Finn, 1977) and erythrocytes 
from horse and sheep (Glockner et al., 1976) .
More complex membrane-bound alkali-labile structures, on 
the other hand, have occasionally been reported. Emerson & Kornfeld 
(1976) released a major sialoglycoprotein from bovine erythrocyte 
membranes which was then digested with Pronase. Chromatography 
on Sephadex G-75 of the Pronase-digest yielded two sialoglycopeptide
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peaks I and III both of which were shown by alkaline borohydride 
treatment to contain complex structures. The oligosaccharides 
derived from peak I contained galactose, N-acetylglucosamine and 
sialic acid in the ratio 3:2:0.5^1 together with a ’partial residue 
of N^acetylgalactosaminitol’. Those from peak III contained 
galactose, N-acetylglucosamine, N-acetylgalactosamine, N-acetyl- 
galactosaminitol and sialic acid in the molar ratios 2:l:l:I+2.
De Waard et al (1976) further reported that ’the partial structure 
of two of these oligosaccharides’ are in the following forms :
SA a 2->3 Gal 3 M  Gal 3 l-»"4 Glc Nac 3 W  (Gal 3 1-M Glc NAc 3 1-»^ ) 
Gal 3-^  and SAa 2->-3 Gal 3 l-»-4 Glc NAc 3 W  (Gal 3 l-»'4 G1 Nac 
31->6) Gal 3. Further indications of the presence of complex 
alkali-labile structures on bovine erythrocyte membranes were 
found by Newman & Uhlenbruck (1977) who reported the following 
structure: N-acetylglucosamine, N-acetylgalactosamine, sialic 
acid and fucose in the molar ratio 3:2:3:3:3.
The picture presently held of alkali-labile constituents 
on membrane-bound glycoproteins tends to be dominated by the now 
well-established structures of such complexes on human erythrocyte 
membranes. As mentioned above, the tetrasaccharide N-acetylneur­
aminyl a 2-3 D-galactosyl 3 1-3 (N-acetylneuraminyl a 2-^| N-acetyl- 
Drgalactosamine has also been identified on bovine milk fat globule 
and on a range of other membranes but so far no other alkali-labile 
membrane bound oligosaccharides have been fully characterized.
The indications, discussed above, of more complex structures on 
bovine erythrocyte membranes suggest other possibilities. Indeed 
soluble glycoproteins have been shown to occasionally carry very
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complex alkali-labile carbohydrate structures. The 'blood-group 
substances soluble glycoproteins of human secretions, contain 
very complex 'megalosaccharide’ side chains of this type that 
determine ABO specificity of the glycoproteins (Kornfeld &
Kornfeld, 1976). It may well be that the range of possible 
0-glycosidically-linked carbohydrate structures of membrane- 
bound glycoproteins is wider and more complex than has previously 
been realised. Certainly the evidence presented in this thesis 
suggests that more complex sstructures exist on human milk fat 
globule membrane in which no evidence for the simple tetrasaccharide, 
discussed above, was found. The best-characterised alkali- 
labile fraction examined here is BII, a protein-free oligosaccharide 
eluting as a single peak from DEAE-Sephadex. It is clear from the 
further analysis of this fraction on thin-layer chromatograms that 
it comprises at least two molecular components which go to make up 
the determined molar ratios of individual monosaccharides. In 
principle further separation of these components by thin-layer 
chromatography or by very careful gel filtration is possible.
However, the present work was constrained by limited quantities of 
human milk which was only available in quantity for a limited 
period of time and as much information as possible had to be 
gleaned from this supply. The content of glucosamine, clearly 
demonstrated both in fraction B (II) and C(II) is strongly 
indicative of the presence of complex structures not previously 
characterised in alkali-labile membrane fractions and certainly 
points to parallels with similar data reported for bovine 
erythrocytes. Fractions B(I) and C(I), while not so thoroughly 
examined here, appear to be very similar to B(II) and C(II) 
respectively.
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The function of these oligosaccharide-structures exposed 
on membrane surfaces is still not clear, as has been discussed at 
some length in the Introduction section to this thesis. Part of 
the reason for this uncertainty is clearly the present state of 
relative ignorance concerning their detailed structures and the 
work in this section may serve to point towards the types of 
molecular complexes that exist and towards techniques for their 
study.
SECTION B
S lALO: GLYCOPEPTIDE S FROM HUMAN MILK FAT GLOBULE MEMBRANE 




125Na I was from The Radiochemical Centre, Amersham,
Bucks., U.K. Sepharose 4B, DEAE Sepharose cl-6B, DEAE 52 
Sephadex were from Pharmacia (OB) Ltd., London, W.5., U.K.
Staphylococcus aureus protein A bound to Sepharose 4B, 
was prepared by the method of March et al. (1974) and was kindly 
supplied by Dr. D. Hough, Biochemistry Department, University of 
Bath. Crude "EMA" (Epithelial membrane antigen), absorbed rabbit 
anti-(defatted human milk fat globule membrane) antiserum and 
crude rabbit anti-(defatted human milk fat globule membrane) 
antiserum were kindly supplied by Dr. M.G. Ormerod, Ludwig 
Institute for Cancer Research, Sutton, U.K. Remova-strips 
(the immunoassay wells) were from Dynatech Labs. Ltd., Daux Road, 
Billingshurst, Sussex RH14 9SJ, U.K., and cyanogen bromide from 




Immunodiffusion plates were made by pouring a suspension 
of 1% (w/v) Agarase in 0.019M Tris buffer, pH 8.9-9.2, containing 
0.05M glycine, 0.002M calcium lactate and 1% (v/v) Triton X-100 
at 22°C onto glass plates (85mm x 95mm x 1mm) and allowing the 
gel to set at 4°C,
Double diffusion was performed as described by 
Ouchterlony (1967). A central well and six surrounding wells in 
a circular array were punched in the gel. Antiserum (20yl) was 
placed in the central well and serial two fold dilations of 
antigen (20yl) were arranged with a single dilution in each of 
the surrounding wells. The gels were incubated for 24h at 22°C 
in a humid environment, freed from soluble protein by washing 
with saline, dried and stained with 0.25% (w/v) Coomassie Brilliant 
Blue in methanol;glacial acetic acidrwater (46:5:49, v:v:v) 
after which the gels were destained with methanol : glacial acetic 
acid:water (5:7:88, v:v:v).
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Milk fat globule agglutination assay
Fresh human milk (10ml) was centrifuged (1500 xg, lOmin) 
at 22°C and the separated fat globules were resuspended in phos­
phate-buffered saline, pH 7.3 (10ml) and recentrifuged under the 
same conditions. The washing procedure was repeated a further 
three times after which the milk fat globules were suspended in 
phosphate-buffered saline, pH 7.3, so as to give an optical 
density of approximately 1.70.D. when read against water at 
700nm.
The suspension of washed milk fat globules (20yl), 
phosphate buffered saline, pH 7.3, (20yl) and diluted (2^ fold) 
rabbit anti-(defatted human milk fat globule membrane) antiserum 
(20yl) were mixed in a recessed microscope slide well and 
agglutination was allowed to proceed at 22°C for Ih in a humid 
environment. The fat globules were examined at lOOx magnification 
using a light microscope and agglutination (3ç) was scored as 
+++ (x > 60%); ++ (60% > X > 30%); + (x < 30%); - (x < 10%).
The agglutination titre is expressed as the minimum dilution 
of antiserum giving an agglutination score of -. Control experi­
ments in which rabbit antiserum was replaced by buffer alone con­
sistently showed agglutinations rated as -.
Inhibition of the milk fat globule agglutination assay 
was assessed in the following manner. Serial two-fold dilutions 
of inhibitor (20yl) were mixed with a 2* ^ fold dilution of anti- 
(defatted human milk fat globule membrane) antiserum (20yl)(where
X  ' • •2 is the agglutination titre as defined above) in a recessed 
microscope slide well. The mixture was incubated at 22°C for
189.
15 min. after which a standard suspension of milk fat globules 
(20yl) was added and agglutination was allowed to proceed at 22°C 
for Ih. The minimum dilution of inhibitor required to inhibit 
completely the agglutination of the globules is defined as the 
inhibition titre. Control experiments were run in which the 
inhibitor was replaced by buffer alone.
Figs. 74B; 75A &B and 76A & B show electron micrographs 
of human milk fat globules at agglutination values of (+++).
Fig. 74a shows a control experiment in which rabbit antisera was 
replaced by buffer alone.
Preparation of human milk fat globule membranes
Freshly expressed human breast milk (1.5t) was waxmed 
to room temperature and centrifuged (12000xg, lOmin.). The 
cream layer was separated, resuspended in phosphate buffered 
saline, pH 7.3, (5 volumes) and recentrifuged (12000xg, 10 min). 
The washing procedure was repeated 3-4 times.
Washed cream was suspended (to 33% w/v) in phosphate- 
buffered saline, pH 7.3, containing O.linM phenylmethy 1 sulphonyl 
fluoride (as a protease inhibitor). The suspension was cooled 
to 4°C and shaken at room temperature until butter formed. The 
mixture was then warmed to 37°C and centrifuged (lOOOOOxg, Ih).
The resulting membrane pellet was resuspended in lOmM Tris-HCl 
buffer, pH 8.1, and recentrifuged (lOOOOOxg, Ih). This washing 
procedure was repeated a further 2-3 times to give washed 
membrane.
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Fig. 74. Scanning electron micrographs of gold-coated human 
milk fat globules following agglutination by rabbit 
anti- (defatted human milk fat globule membrane) anti- 
aera (Fig. 74B). Fig. 74À is a Control obtained by 
using phosphate buffered saline in place of antisera.
Agglutination of washed globules was performed as 
described on p.188 and samples were prepared and 
photographed as described in the legend to Fig. 44. 
Magnification 3,4000 X and 850 X for Fig. 74a and b 
respectively.
25KV 0 7 1 0  1 0 . 0U B A T H U
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Fig. 7-5A,B. As Fig. 74B except at magnifications 5,000 X and 
25,000.
J1 .0 U  B A T H U0 7 0 625KV
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Fig. 76. Comparison of scanning electron micrographs of
unlabelled human milk fat globules (A) and gold- 
labelled human milk fat glpbules(B>. Magnification 
6,000 X and 10,000 X respectively.
1 ,0U B A T H U0 7 0 7
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Preparation of defatted human milk fat globule membranes
Freshly expressed human breast milk (1.5&) at 22°C was 
centrifuged 12,000xg, 10 min). The cream layer was separated, 
resuspended in 0.05M Tris-HCl buffer, pH 7.5, (5 volumes), con­
taining 0.25M-sucrose and l.OmM MgClg and recentrifuged (12000xg,
10 min). The washing procedure was repeated 3-4 times.
The washed cream (lOg) was resuspended in 50mM Tris-HCl 
buffer, pH 7.5 (35ml) containing 0.25M sucrose and l.OmM MgCl2 and 
stirred vigorously with chloroform (60ml) at 22°C for 30 min.
The fat-containing organic phase was separated and discarded.
The aqueous phase was re-extracted with chloroform as above and 
then stirred vigorously with ether (1 volume) for 30 min. at 
22°C. The aqueous suspension of milk fat globule membranes was 
separated, re-extracted with ether and centrifuged (4000xg, 15 min) 
Anyremaining organic solvent was removed by evaporation under 
reduced pressure in a rotary evaporator and the residual aqueous 
suspension was dialysed against distilled water for 12h. at 4°C.
The non-diffusible material was freeze-dried to give a residue 
(approx. 6mg) containing 58% protein, 23% hexose and 3% sialic 
acid.
Isolated milk fat globule membranes were also extracted 
with organic solvents. In this case washed membranes (p.189) were 
suspended (lOmg protein/ml) in 50m Tris-HCl buffer, pH 7,5, con­
taining 0.25M sucrose and l.OmM Mg Cl^ as above and extracted as 
described for intact fat globules.
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The antigenicity of the defatted membrane fragments was 
assessed in terms of their interaction with anti-(defatted human 
milk fat globule) antiserum (kindly supplied by Dr. M.G. Ormerod, 
Ludwig Institute for Cancer Research) in two ways.
Firstly the membrane fraction was used to inhibit the 
agglutination of human milk fat globules by the standard anti­
serum. Agglutination of human milk fat globules performed as 
described earlier gave an agglutination titre of 2^ (Table 12).
A 2^ fold dilution of antiserum was accordingly used in the 
determination of the inhibition titre of the membrane fraction 
which was found to be 2^ using an initial membrane suspension con­
taining 6mg/ml (Table 12).
Secondly the antigenicity of the defatted milk fat 
globule membrane fraction was checked by immunodiffusion against 
standard antiserum. Defatted membrane (2mg protein/ml) in phosphate- 
buffered saline, pH 7.3, was arranged in serial two fold dilutions 
in the outer wells of an immunodiffusion plate as described above. 
The end point (minimum dilution of antigen showing no precipitin 
line) was obtained at a dilution of 2^ indicating a strong anti­
genic response to the defatted membrane preparation (Fig. 77).
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Preparation of rabbit anti-(defatted human milk fat globule membrane) 
antiserum
Defatted human milk fat globule membranes (lOOyg protein) 
were suspended in phosphate-buffered saline, pH 7.3, (1.0ml) and 
emulsified with Freund’s adjuvant ('complete* for the first 
injection, ’incomplete* for subsequent injections)(1ml). The 
emulsion was injected subcutaneously at four intramuscular sites 
of a rabbit at four-weekly intervals. Seven days after the second 
and subsequent injections blood was taken from the peripheral veins 
of the rabbit’s ear, allowed to stand at 37°C for Ih and then at 
4°C for several hours. The resulting clotted blood was centri­
fuged (7000xg, 15 min) and the supernatant antiserum was separated 
and stored at -20°C.
After each bleeding, the titre of the antiserum was 
assessed in terms of its ability to agglutinate human milk fat 
globules and also of its ability to form a precipitin line in the 
immunodiffusion plates. Table 12 shows that after the 4th 
injection of membranes the antiserum showed an agglutination 
titre of 2^, i.e. four times that of the standard anti-(defatted 
human milk fat globule membrane) antiserum supplied by 
Dr. M.G. Ormerod, When the antiserum was examined by immuno­
diffusion against serial dilutions 2x of defatted membrane 
(2mg protein/ml in phosphate-buffer saline, pH 7.3) an end point
(minimum dilution of antigen showing no precipitin line) was
3obtained at a dilution of 2 (Fig. 77) i.e. twice that shown 
by the antisera supplied by Dr. Ormerod.
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Table 12
Titres obtained by agglutination of human milk fat 
globules by serial dilutions of different preparations of 
rabbit anti-(defatted human milk fat globule membrane) anti­
serum. Agglutination was carried out as described in page 188 
using I, crude antiserum supplied by Dr. M.G. Ormerod; II 
crude antiserum prepared by the author; II absorbed antiserum.
I II Ill
2° ++ + +++ ++ +
2^ +++ +++ +++
2^ +++ (+++) ( +++)
2^ ++ + ++ + ++
2^ (+++) ++ +
2^ + + - -
2 \ + - -
2^ - - -
2» - - -
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Fig. 77. Comparison of rabbit anti-(defatted human milk fat globule 
membrane) antiserum preparations by double-diffusion 
against defatted human milk fat globule membrane. 
Experiments performed as described earlier (page 187) 
were arranged so as to contain serial two-fold 
dilutions of defatted membrane antigen in wells 1-5 
and buffer alone in well 6. The central well contained 
A, and B, crude antisera supplied by Dr. Ormerod;
C, crude antisera prepared by the author; D normal 
rabbit serum as a control.
' f W '
6 1 .
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Preparation of absorbed rabbit anti-(defatted human milk fat globule 
membrane) antiserum
Anti-(defatted human milk fat globule membrane) antiserum 
was absorbed with plasma, extracts of kidney and liver, non­
specific cross-reacting antigen and lactoferrin. These operations 
were carried out by Dr. M.G. Ormerod and Mrs. K. Steele at the 
Ludwig Institute for Cancer Research, Sutton, according to the 
procedure described in Heyderman et al. (1979). The agglutination 
titre of absorbed antisera is shown in Table 12.
Purification of rabbit IgG
a) Normal rabbit serum (20ml) was mixed with saturated aqueous 
ammonium sulphate solution (12ml) and the resulting precipitate was 
removed by centrifugation (3000xg, 15 miti) and dialysed against 
0.03M-sodium phosphate buffer, pH 7.3, at 4°C for 12h. The 
non-diffusible material was applied to a column (20cm x 1.5cm) of 
DEAE 52 Sephadex which had been equilibrated with 0.03M-sodium 
phosphate buffer, pH 7.3 at 22°C. The column was eluted with the 
same buffer with a flow rate of 60ml/h, and the absorption of the 
eluate at 280nm was continuously monitored using an LKB Uvicord 2. 
Fractions corresponding to the first peak of 280nm absorbing 
material were combined and dialysed against O.IM sodium hydrogen 
carbonate buffer, pH 8.3 containing 0.5M sodium chloride.
b) Alternatively rabbit IgG was purified by affinity chroma­
tography on protein A. Normal rabbit serum (10ml) was applied
to a column (10cm x 1cm) of Staphyloccus aureus Protein A 
covalently linked to Sepharose 4B (see Materials p.186).
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The column was washed with phosphate buffered saline, pH 7.3 until 
the eluate showed no ^2S0 following which purified rabbit IgG was 
eluted with O.IM sodium citrate buffer, pH 3.0
The eluates showing Aggg were collected and dialysed 
against O.IM sodium hydrogen carbonate buffer, Ph 8.3, containing 
0.5M sodium chloride.
Covalent attachment of purified rabbit IgG to Sepharose 4B
The procedure for cyanogen bromide activation of Sepharose 
4B is based on that described by March et al. (1974). Sepharose 4B 
(Pharmacia Ltd.), distilled water and 2M sodium carbonate were mixed 
in the ratio 1:1:2 (v:v:v) and a solution of cyanogen bromide in 
acetonitrile (0.1 volume, Ig/ml) was added with vigorous stirring. 
Stirring was continued for 1-2 min after which the slurry was 
filtered on a coarse sintered glass funnel. The gel was washed 
successively with O.IM sodium hydrogen carbonate, pH 9.5,
(10 volumes), distilled water (10 volumes) and O.IM sodium hydro­
gen carbonate, pH 8.3, containing 0.5M sodium chloride (10 volumes) 
and transferred to a plastic bottle containing purified rabbit 
IgG (p.198)(approx. 4mg/ml) in O.IM sodium hydrogen carbonate, 
pH 8.3 (1 volume). The mixture was allowed to stand at 4°C for 20h 
following which the gel was washed with O.IM sodium hydrogen 
carbonate, pH 8.3 containing 0.5M sodium chloride (20 volumes).
The washed gel was then incubated with IM glycine in the latter 
bicarbonate buffer for 4h at 24°C in order to mask unreacted 
groups in the gel and washed successively with O.IM sodium acetate, 
pH 4.0, (20 volumes), 2M urea (20 volumes) and O.IM sodium hydrogen
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carbonate, pH 10.0 (20 volumes) all of which solutions contained 
additionally 0.5M sodium chloride.
The washed Sepharose 4B-IgG conjugate was finally 
suspended in phosphate buffered saline.
Purification of sheep anti-(rabbit IgG) antibodies
Sheep anti-(rabbit gamma globulin) antiserum (10ml) 
(kindly supplied by Dr. M.G. Ormerod, Ludwig Institute for Cancer 
Research) was mixed with saturated aqueous ammonium sulphate 
solution (6ml) and the resulting precipitate was separated by 
centrifugation (3000xg, 15 min) and dialysed against phosphate 
buffered saline, pH 7.3, for 12h at 4°C. The non-diffusible 
material was applied to a column (15cm x 0.7cm) of purified 
rabbit IgG covalently linked to Sepharose 4B (p.199). The 
column was washed with phosphate buffered saline, pH 7.3, (75ml) 
and the anti-(rabbit IgG) antibodies were then eluted with O.IM 
sodium citrate buffer, pH 3.0. Protein (A2qq)-containing 
fractions were combined and dialysed against O.lM-sodium phosphate 
buffer, pH 7.0 and the non-diffusible material was concentrated 
(to approx. lOmg/ml) by using a Minicon-B concentrator.
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125I-iodination of sheep anti-(rabbit IgG) antibodies
The iodination procedure is based on that described by
Urbaniak et al. (1973). A solution of purified sheep anti-(rabbit
IgG) antibodies (p.200) in O.IM sodium phosphate buffer, pH 7.0,
(lOyl, lOmg/ml) was mixed with O.IM sodium phosphate buffer,
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pH 7.0 (lOyl), Na I (Radiochemical Centre, Amersham, solution 
in NaoH, specific activity l3-17mCi/ygI. (lOyl) and freshly pre­
pared Chloromine T in O.IM sodium phosphate buffer, pH 7.0 
(25yl, 4mg/ml). The mixture was stirred slowly at 22°C for 
3 min following which sodium metabisulphite (25yl, 4mg/ml in 
phosphate buffered saline, pH 7.3) and potassium iodide (lOOyl, 
lOOyg/ml) in phosphate buffered saline, pH 7.3, containing 0.5%
(w/v) bovine serum albumin were added and the mixture was applied 
to a column (20cm x 0.75cm) of Sephadex G-25 (fine) previously 
equilibrated with phosphate buffered saline, pH 7.3 containing 
0.5% (w/v) bovine serum albumin. The column was eluted with the 
same buffer with a flow rate of 50ml/h and fractions (1ml) were 
automatically collected from which samples were counted for 
radioactivity) in an LKB Ultrogamma counter. Fractions corresponding 
to the peak of radioactive protein were combined and stored at -20°C.
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Radioimmunoassay for epithelial membrane antigenic activity
The radioimmunoassay was developed by Dr. M.G. Ormerod 
and co-workers at the Ludwig Institute for Cancer Research, Sutton.
Crude epithelial membrane antigen (EMA) (kindly supplied
by Dr. Ormerod) was diluted (1:500) in 0.05M sodium carbonate,
pH 9.7, and a sample (SOyl) was incubated in a plastic immunoassay
well (Remova-rstrip,. Dynatech Labs. Ltd. )for 12h at 22°C.
The well was washed four times with phosphate buffered saline,
pH 7.3, containing 0.5% (w/v) bovine serum albumin and absorbed
rabbit anti-(defatted human milk fat globule membrane) antiserum
(p.198)(50yl, diluted 1:500 in the latter buffer) was added to the
well and allowed to stand for 3h at 22^C. The well was then washed
three times with phosphate buffered saline, pH 7.3 containing
125
0.5% (w/v) bovine serum albumin as above, and I-labelled sheep 
anti-(rabbit IgG) antibodies (p.201)(50yl, diluted in the same 
buffer to give 2 x 10^ c.p.m.) were added to the well and allowed 
to stand at 22°C for Ih. The well was finally washed four times 
as described above and bound radioactivity was counted in an 
LKB Ultrogamma counter to give the control value of bound counts.
The antigenicity of a putative epithelial membrane anti­
gen was assessed by incubation of the test sample (lOOyl, in 
phosphate-buffered saline, Ph 7.3, containing 0.5% bovine serum 
albumin) with the absorbed rabbit anti-(defatted human milk fat 
globule membrane) antiserum (25yl, at a final concentration of 
1:500 in the latter buffer) for 12h at 22°C prior to the addition 
of the latter to the immunoassay well. The incubation and 
washing sequence was then followed as described above and the
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inhibition of control bound radioactivity was determined. In 
practice, serial dilutions of test sample were assayed and that 
concentration of putative antigen giving 50% inhibition of the 
control value was used as a measure of its antigenicity.
Maximum binding of radioactive counts, equivalent to 
the value obtained by the control procedure described above could 
also be obtained when buffer alone was incubated with the first 
antibodies prior to their addition to the well.
































































































































Fractionation of Glycopeptides corresponding to peaks I and II (Fig. 50) 
on DEAE Sepharose cl-6B
Fractions corresponding to each of the two peaks I and II 
from Fig. 50 were separately pooled and freeze-dried to give 
residues weighing approximately lOmg (peak I) and 25mg (peak II).
Each combined sample was dissolved in 5mM pyridine acetate 
buffer, pH 5.0 (1 ml) and applied to a column (25cm x 1.5cm) of DEAE- 
Sepharose cl-6B which had been previously equilibrated with the same 
buffer at 22°C.
The column was eluted with the above buffer (100ml) followed 
by a linear gradient (Q.05-1.OM) of pyridine acetate, pH 5.0 (200ml) 
with a flow rate of 40ml/h and fractions (5ml) were automatically 
collected. Samples (0.1ml) of fractions were assayed for hexose and 
for sialic acid giving the elution patterns shown in Figs. 79 and 80.
In each case two distinct groups of hexose-sialic acid peaks 
were obtained, a sialic acid - poor group (P) eluted with 0.05M 
pyridine acetate and a sialic acid - rich group (R) eluted with 
approximately 0.5M pyridine acetate. Fraction IIR constituted a 
single sharp peak (Fig. 80).
Fractions corresponding to each of the groups of peaks IP, IR, 
IIP and IIR (Figs. 79 & 80) were separately combined and freeze-dried. 
Samples (50yg protein) of each were subjected to SDS-PAGE in 10% acryl- 
amide gels. All fractions showed Coomassie-Schiffs positive bands 
with mobility similar to that of bands Ila and 113 (Fig. 54). The 
sialic acid - poor fractions (IP and IIP) showed in addition the lower
206.
molecular weight band (II; ^  ) which has been identified as a pronase- 
derived fragment, free of hexose and sialic acid. This band was absent 
from the sialic acid-rich fractions IR and IIR.
Carbohydrate composition of sialoglycopeptides
Eluate fractions corresponding to each of the sialoglyco- 
peptide peaks IP, IR, IIP and IIR were separately pooled and
freeze-dried. The lyophilised fractions were redissolved in distilled 
water (2mg/ml) and samples were hydrolysed and the released mono­
saccharides were analysed by gas liquid chromatography of their alditol 
acetate derivatives.
Aliquots (lOyl) of the aqueous sialoglycopeptide solutions were 
evaporated to dryness in a stream of . 2M-Trifluoroacetic acid (50yl) 
and perseitol (20yg) were added and the samples were incubated in a 
sealed tube at 120°C for Ih. The hydrolysates were freed from acid in 
a stream of at 50°C and the residual free monosaccharides were 
converted to their alditol acetate derivatives as described in the 
Materials and Methods (section ^  Gas chromatography of the derivatized 
samples allowed the percentage composition of the individual monosaccharides 
components to be determined* These are shown and the corresponding data 
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Papain digestion of human milk fat globule membranes
Washed human milk fat globule membranes (260mg, obtained 
from 50g washed cream (see Materials and Methods section) were 
suspended in lOmM Tris-HCl buffer, pH 8.1 giving a final protein 
concentration of lOmg/ml. The suspension was then mixed with 
papain (2mg to lOmg membrane protein) and 5mM-cystein and 
incubated with gentle agitation for 30 min at 37°C. Proteolytic 
action was then terminated by addition of sodium iodoacetate to 
a final concentration of 6.5mM and the mixture was centrifuged 
(lOOjOOOxg, Ih) at 4°C. The supernatant was separated and stored 
and the pellet was resuspended in lOmM Tris-HCl buffer, pH 8.1 
and centrifuged (100,000xg, Ih) at 4°C. The two supernatants 
were combined and dialysed against 5mM-sodium phosphate buffer, 
pH 6.0, at 4°C for 12h. The non-diffusible material was freeze- 
dried to give a residue containing 2mg hexose and 0.8mg sialic 
acid (Table 14). This procedure is outlined in Scheme 2.
A control experiment in which papain (28mg) was incubated 
in lOmM Tris-HCl buffer, pH 8.1, containing 5mM-cystein under 
the conditions described above demonstrated that no significant 
hexose or sialic acid was present in the supernatant (Table 14).
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cream (50g)
churning and centrifugation (lOOOOOxg) 
at .room temperature for Ih.
membrane (260mg)
Papain digestion 
(2mg papain/lOmg protein) 
Centrifugation (lOO.OOOxg), & wash 
Dialyse.
papain digested fragments(12mg)
containing 2mg hexose 
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Epithelial membrane antigenic activity of Sialoglycopeptide fractions 
from human milk fat globule membrane
Freeze dried material corresponding to peaks I and II 
(Fig. 50), peaks IP and IR (Fig. 79) and peaks IIP and H R  
(Fig. 80) was assayed for epithelial membrane antigenic activity 
as -described in the Materials and Methods section. In addition, 
the soluble hexose-sialic acid fraction prepared by papain treat­
ment of human milk fat globule membranes (p.210) was similarly 
assayed.
Plots of the percentage inhibition of control bound 
counts versus concentration of test sample are shown in 
Figs. 81-85. The concentrations of samples that caused 50% 
reduction in maximum bound radioactivity are listed in Table 15.
Fractions corresponding to peaks I and II (Fig. 50) 
from the control digest containing pronase alone (Fig. 51) were 
separately freeze dried, dissolved in distilled water (1ml) and 
then assayed for epithelial membrane antigenic activity at 
concentrations corresponding to approximately 5mg and 8mg of 
glycopeptides I and II respectively. At these concentrations 
















Fig. 81. Plots of the percentage inhibition of control bound
counts versus concentration of antigen. A: Skim milk, 
B: Epithelial membrane antigen (EMA).
Concentrations of antigen are expressed as ml 














Fig. 82. Percentage inhibition of control bound counts 
versus concentration of four different batches 






Fig. 83. Percentage inhibition of control bound counts 
versus concentration of two different batches 
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Fig. 84. Percentage inhibition of control bound counts
versus concentration of two different batches
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Fig. 85. Percentage inhibition of control bound counts
versus concentration of sialic acid rich sialo­
glycopeptide IIR (Fig. 80)(•-•-•) and concentration 
of sialic acid poor sialoglycopeptide IP (Fig. 79) 
(-o-o-o).
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Table 15. Epithelial membrane antigenic activities of Sialoglyco­
peptide fractions I & II (Fig. 50), IP & IR (Fig. 79), IIP & IIR 
(Fig, 80) and crude papain digest page 210. Antigenic activities 
are expressed as the concentration of peptide (yg/ml) giving rise 
to 50% inhibition in the radioimmunoassay described on page202 •
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Discussion
The presence of an antigen, apparently specific for 
epithelial membranes, has recently been demonstrated by Heyderman 
et al. (1979) using immunohistological techniques in which absorbed 
rabbit anti-(defatted human milk fat globule membrane) antisera 
were used to detect the above antigen in a number of human tissues 
(see Introduction section page 22^ * The latter antisera were 
found also to be specific for a soluble component of milk serum 
("EMA") the structure of which is presently unknown 
(Dr. M.G. Ormerod - personal communication).
The absorbed antisera were found, not surprisingly, to
agglutinate human milk fat globules (see Methods section page198)
and this agglutination was, in fact, used here to assay the antisera,
In view of this agglutination and of the origin of the antisera it
was logical to search for the true epithelial membrane antigen on
the surface of the milk fat globule membrane itself. Ormerod &
Steele (unpublished) have developed an antigenicity assay which
involves the use of 'EMA', absorbed rabbit anti-(epithelial
125membrane antigen) antiserum and I-labelled sheep anti-(rabbit- 
19 G ) antibodies (see Methods section page 202) • Inhibition 
of this assay, by serial dilutions of test sample, gives a quan­
titative assessment of the activity of the test samples as 
epithelial antigens.
Sialoglycopeptides were prepared from the outer surface 
of human milk fat globule membrane by pronase digestion and chroma­
tography on Sephadex G50 after which two peaks (I & II) were 
obtained (see Section A, page 134) •
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The antigenicity of these two fractions was checked 
by inhibition of the above assay and both sialoglycopeptides were 
found to be strong inhibitors (Table 15). Antigenicity assay 
under identical conditions of the control digest containing 
pronase alone showed no inhibitory activity. Further fraction­
ation of the sialoglycopeptide fraction I (Fig. 50), using ion- 
exchange chromatography on DEAE-Sepharose cl-6B led to the 
separation of two distinct groups of hexose/sialic acid con­
taining peaks. They are the sialoglycopeptide fractions IP 
(sialic acid poor) and IR (sialic acid rich)(Fig. 79).
Similar ion-exchange fractionation of peak II (Fig. 80) gave again 
a group (possibly only 2) of early eluting sialic acid poor 
peaks (IIP) but the sialic acid-rich material eluted as a single 
sialoglycopeptide peak IIR (Fig. 80).
Polyacrylamide gel electrophoresis in the presence of 
sodium dodecyl sulphate of material corresponding to peaks IP,
IR, IIP and IIR gave in each case Coomassie-Schiff's positive 
bands with mobilities similar to thoseof bands IIci and Ilg 
(Fig.54 ). The sialic acid-poor fractions (IP and IIP), but not 
the sialic acid-rich fractions (IR and IIR), contained in addition 
the lower molecular weight band (Ily .) which has been identified 
as a pronase-derived fragment (see Section A, page 143).
Human milk fat globule membrane was also digested with
I
papain when a mixture of larger molecular weight glycopeptides 
was obtained. This mixture of glycopeptides contained 2mg hexose 
and 0.8mg sialic acid. A control digest containing papain alone, 
but not milk fat globule membrane, was shown not to contain sig-
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nificant hexose or sialic acid.
Fraction IP, IR, IIP, IIR and the crude "papain digest" 
were assayed for epithelial membrane antigenic activity when all 
of which, except IR and IIP, showed antigenic activity (Table 15), 
It is of interest that antigenicity can be retained in such glyco- 
peptide fractions which while retaining most, (Table 13), of the 
carbohydrate of the original membrane glycoproteins almost 
certainly represent severely curtailed polypeptide chains. This 
might be taken to imply that carbohydrate plays a major role in 
the antigenic expression of the membrane bound glycoproteins, 
an idea which is studied extensively in Section C. With regard 
to the pronase-cleaved fragments, fractions I and IP both show 
antigenic activity but the ion-exchange purification has clearly 
not brought about a purification of the antigenic component 
(Table 15). Fraction IIR, on the other hand, shows higher 
activity than does fraction II and so represents a purification 
of antigenic material. Fraction IIR is also of interest in that 
it comprises an apparently homogeneous sialoglycopeptide peak 
(Fig. 80) and, in contrast to peaks I, II, IP and IIP is free 
from pronase-derived contaminating fragments as shown by SDS-PAGE,
The relatively high antigenic activity shown by the 
crude papain digest is of some interest. Papain has 
been used to cleave glycopeptide fragments from the extracellular 
surfaces of a number of cells (Nathenson & Shimada, 1968) and has 
been used in particular to release glycopeptide molecules with 
H-2 and HLA antigenic activities from mouse and human cells 
respectively (Cunningham, 1977). The crude papain digest from
223.
human milk fat globules prepared as described in this thesis was 
in fact shown by Dr. R. Newman (Imperial Cancer Research Fund) to 
have HLA DRw (la) antigenic activity whereas the corresponding 
crude Pronase digest was totally inactive in this respect. It 
may be that, in general, the larger extracellular glycopeptides 
obtained by papain digestion are more likely to retain the anti­
genicity of the native membrane than are the more extensively 
fragmented products of Pronase attack. Further investigation 
of papain-derived glycopeptides was not, however, possible in 
the present work because the original large stocks of human 
milk had all been treated with Pronase immediately following 
delivery and only limited samples of fresh milk were available 
for papain digestion. However the above points should be 
borne in mind for further studies.
SECTION C
CARBOHYDRATES AS EPITHELAIL MEMBRANE ANTIGENS?
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Materials and Methods 
Materials
Molecular weight markers for SDS-PAGE were from BDH 
Chemicals Ltd., Poole, Dorset, U.K. Donkey anti-goat IgG antisera 
and goat anti-rabbit IgG antisera were from Miles Biochemicals Ltd., 
Slough, U.K. Hydrogen fluoride in pyridine was purchased from 
the Aldrich Chemical Co., Gillingham, Kent, U.K. Glycosidases 
extracted from Trichomonas foetus were kindly supplied by 
Dr. J.H. Westwood, Ludwig Institute for Cancer Research, Sutton,
U.K. Mixed Glycosidase D from Diplococcus pneumoniae were from
Seikagaku Kogyo Co. Ltd. and were kindly supplied by
Dr. S. Wonnacott, Biochemistry Department, University of Bath.
Methods
Purification of Rabbit IgG on Sephadex G25
Rabbit IgG (Section B, p.l98)(4mg) in OJ.M sodium 
citrate buffer, pH 3.0, (2ml) was applied to a column (150cx x 1cm) 
of Sephadex G25 (fine) which had been previously equilibrated with 
distilled water at 22°C. The column was eluted with distilled water 
at 22°C with a flow rate of 40ml/h and fractions were automatically 
collected and continuously monitored by using an LKB Uvicord 2. 
Fractions corresponding to the excluded peak (Fig. 86) were 
collected and freeze-dried.
225A
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Fig. 86. Purification on Sephadex G-25 (fine) of normal rabbit IgG.
The column was eluted with distilled water at 22°C with
a flow rate of 40ml/h. Fractions (5ml) were automatically
collected and continuously monitored (A^gQ) by using an
LKB Uvicord 2.
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125I-iodination of goat-anti-(rabbit IgG) antibodies
Goat anti-(rabbit IgG) antibodies (Miles Biochemicals) 
125were labelled with I exactly as described for iodination of 
sheep anti-(rabbit IgG) antibodies (Section B, p.201).
Purification of goat IgG
Normal goat serum was purified by ammonium sulphate 
fractionation and ion-exchange chromatography exactly as described 
for the purification of rabbit IgG (Section B, pj;89)*
Covalent attachment of purified goat IgG to Sepharose 4B
Purified goat IgG was linked to cyanogen bromide-activated
Sepharose 4B exactly as described for immobilization of purified
■?
rabbit IgG (Section B, p.,199).
Purification of donkey anti-(goat IgG) antibodies
Donkey anti-(goat IgG) antiserum was purified by affinity 
chromatography on goat IgG linked to Sepharose 4B (above) as 
detailed for the purification of sheep anti-(rabbit IgG) 
antibodies (Section B, p.200).
125I-iodination of donkey anti-(goat IgG) antibodies
Purified donkey anti-(goat IgG) antibodies were labelled
125with I as described for the iodination of sheep anti-(rabbit IgG) 
antibodies (Section B, p.201).
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Experimental and results
Deglycosylation of fetuin by hydrogen fluoride in pyridine
Commercial fetuin (Sigma London Chemical Co.. Poole, 
Dorset- U.K.)(2mg) was added to a solution of hydrogen fluoride 
in a plastic test tube (10ml) which was sealed with parafilm.
The test tube was incubated for 3h either at 0°C or at 40-50°C 
following which the tube contents were poured into double distilled 
water (50ml) at 4°C. The tube was rinsed three times with water 
and the combined aqueous solutions were dialysed against several 
changes of double-distilled water at 4°C for 24h. The non-diffusible 
material was freeze-dried and the residue was re-dissolved in 
double-distilled water (2ml) and assayed for protein, sialic acid 
and individual hexoses and hexosamines as described in the Materials 
and Methods section (p.124). Control experiments were carried out 
in which either the sample or hydrogen fluoride/pyridine was 
replaced by distilled water and the overall procedure was performed 
as described above. The results are shown in Tables 16 and 17.
Development of a radioimmunoassay for the antigenicity of rabbit IgG
The radioimmunoassay is based on that (p.202) used to
determine epithelial membrane antigenic activity and initially
involves binding of rabbit IgG to an immunoassay well. Goat anti-
(rabbit IgG) antibodies are then allowed to bind to the immobilised
125
rabbit IgG and radiolabelled second antibodies, I-labelled 
donkey anti-(goat IgG) antibodies finally bind to the complex.
The bound radioactivity then represents a control value. The 
antigenicity of a test sample is assayed by pre-incubating the 
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application to the immunoassay well and continuing the assay as 
described above. The reduction in bound counts relative to the 
control value then represents a measure of the antigenicity of 
the sample.
In developing thé radioimmunoassay procedure it was 
necessary to define the optimum concentration of reagents for 
routine operation.
Optimum amounts of rabbit IgG and goat anti-(rabbit IgG) antibodies. 
Rabbit IgG was purified on Sephadex G-25 and material corresponding 
to the excluded peak (Fig. 86) was dissolved (120yg/ml) in 0.05M 
sodium hydrogen carbonate buffer, pH 9.7. Serial two-fold 
dilutions of stock solution were made up in the same buffer and 
aliquots (50y1) of each dilutëd sample were separately incubated 
in immunoassay wells at 22°C for 12h. The wells were washed four 
times with phosphate-buffered saline, pH 7.3, containing 0.5%
(w/v) bovine serum albumin.
125
I-labelled goat anti-(rabbit IgG) antibodies (Materials 
and Methods section) were diluted with phosphate buffered saline, 
pH 7.3, containing 0.5% (w/v) bovine serum albumin to give
5
2 X 10 c.p.m./50yl. Aliquots (50y1) were added to the above
washed wells and incubated for 3h at 22°C. The wells were washed 
four times with buffer as above and counted in an LKB Ultrogarama 
counter. The bound counts are plotted against concentration of 
rabbit IgG in Fig. 87 from which it can be seen that maximal 
bound counts are obtained at a rabbit IgG concentration of 30yg/ml. 
A control experiment in which rabbit IgG was replaced by 0.05M 
sodium carbonate buffer, pH 9.7, led to zero bound counts.
231.
The optimal concentration of goat anti-(rabbit IgG)
antibodies was determined by repeating the above binding assays
but using rabbit IgG at a fixed concentration of 30yg/ml and
serial two fold dilutions of a stock solution (120pg/ml) of 
125I-labelled goat anti-(rabbit IgG) antibodies. The variation 
of bound counts with concentration of antibody is shown in 
Fig. 88 from which it can be seen that the minimum concentration 
causing maximum binding is ISyg/ml.
125
Optimal amount of donkey anti-(goat IgG) antibodies. I-labelled
donkey anti-(goat IgG) antibodies (Materials and Methods) were 
diluted with phosphate buffered saline, pH 7.3, containing 0.5%
(w/v) bovine serum albumin to give 8 x 10^ c.p.m. in 50yl.
Serial two fold dilutions of the stock solution in the same buffer 
were prepared and aliquots (50yl) were used in the overall radio­
immunoassay procedure as follows.
Purified rabbit IgG excluded from Sephadex G-25 (Fig. 86) 
was dissolved (30yg/ml) in 0.05M sodium hydrogen carbonate buffer, 
pH 7.9, and a sample (50yl) was incubated in a plastic immunoassay 
well for 12h at 22°C. The well was washed four times with phos­
phate buffered saline, pH 7.3, containing 0.5% (w/v) bovine serum 
albumin and affinity purified goat anti-(rabbit IgG) antibodies 
(Materials and Methods section)(15yg/ml in the same buffer) were 
added to the well. The well was allowed to stand for 3h at 22°C,
washed three times with phosphate buffered saline containing bovine
125
serum albumin as above and I-labelled donkey anti-(goat IgG) 
antibodies (50yl) at various dilutions (see above) were added.
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above and bound radioactivity was counted in an LKB Ultrogamma
125counter. A plot of bound counts versus dilution of I- 
labelled donkey anti- (goat ]gG) antibodies is shown in Fig. 89 
from which it can be seen that a four-fold dilution of stock 
solution gave essentially maximum bound counts. This concentration 
of labelled antibodies was accordingly used in all subsequent 
applications of this assay.
Antigenicity of purified rabbit IgG. Purified rabbit IgG excluded 
from Sephadex G-25 (Fig. 86) was dissolved (87yg/ml) in phosphate 
buffered saline, pH 7.3, containing 0.5% (w/v) bovine serum 
albumin. Serial dilutions of the stock solution were prepared in 
the same buffer and samples (lOOyl) were incubated for 12h at 22°C 
with the goat anti-(rabbit IgG) antibodies (at a final concentration 
of 15yg/ml) prior to their use in the radioimmunoassay described 
above. A plot of the bound radioactive counts versus concentration 
of rabbit IgG is shown in Fig. 90 from which it can be seen that 
1.8yg/ml rabbit IgG causes 50% inhibition of maximum bound counts. 
This concentration is taken as a measure of the antigenicity of 
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Effect of hydrogen fluoride in pyridine on the antigenicity of 
rabbit IgG
Purified rabbit IgG was excluded from Sephadex G-25 
as described in the Materials and Methods section (Section C, 
p.224)* Material corresponding to the excluded fraction (2mg) 
was dissolved in hydrogen fluoride in pyridine (10ml), incubated 
in a sealed plastic test tube for 3h at 40-45°C and tube contents 
were poured into double-distilled water (50ml) at 4°C. The tube 
was rinsed three times with water, thetcombined aqueous solutions 
were extensively dialysed against double-distilled water and the 
non-diffusible material was freeze-dried. The residue was re­
dissolved in double-distilled water (1ml) and assayed for anti­
genic activity by the radioimmunoassay procedure described on 
page 234 when 50% inhibition of bound radioactivity was not 
achieved by concentrations less than 2000yg/ml,
A control sample of purified IgG was taken through the 
entire procedure described above except that the hydrogen fluoride/ 
pyridine solution was replaced by distilled water. 50% 
inhibition of bound radioactivity in the radioimmunoassay was 
achieved at concentrations of IgG of 3.7yg/ml.
238.
Deglycosylation of fetuin by a glycosidase mixture from T. foetus 
Fetuin (Sigma London Chemical Co. Ltd., Poole, Dorset, 
U.K.)(2mg) in O.IM citrate-phosphate buffer, pH 6.0, (0.4ml) was 
incubated for 4h at 37°C with a freeze-dried extract of glyco- 
sidases from Trichomonas foetus (Materials and Methods section). 
The mixture was poured into double-distilled water (2ml) at 4°C 
and the incubation vial was rinsed out three times with double­
distilled water. The combined aqueous solutions were dialysed 
against distilled water for 12h at 4°C and the non-diffusible 
material was freeze-dried. The residue was taken up in distilled 
water (2ml) and assayed for protein, sialic acid and for 
individual hexoses and hexosamines as described in the Materials 
and Methods (Section A). Control experiments were performed in 
which either the enzyme or fetuin was replaced by buffer alone. 
The results are shown in Table 18.
Effect of glycosidase mixture from T. foetus on the antigenicity 
of rabbit IgG
Purified rabbit IgG excluded from Sephadex G-25 
(Fig. 86)(2mg) in O.IM citrate-phosphate buffer, pH 6.0, (0.4ml) 
was mixed with a glycosidase extract from Trichomonas foetus 
(Materials and Methods, Section C)(2mg) in O.IM citrate-phosphate 
buffer, pH 6.0, (0.4ml) and the'mixture was incubated at 37°C 
for 4h, cooled to 4°C and assayed for antigenicity by the radio­
immunoassay procedure described on page 234. 50% inhibition of 
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A control experiment in which enzyme was replaced by 
buffer alone was performed as above. 50% inhibition of bound 
counts was obtained by using concentrations of treated IgG of 
3.7yg/ml. The control lacking IgG showed no inhibition at any 
concentration.
Deglycosylation of fetuin by mixed glycosidases D from 
Diplococcus Pneumoniae
Fetuin (2mg) in O.IM citrate-phosphate buffer, pH 6.0, 
(0.2ml) was incubated at 37°C with a mixture of exoglycosidases 
plus endoglycosidase D (Materials)(20 milllunits) in the above 
buffer (0.2ml). The mixture was cooled to 4°C and applied to a 
column (150cm x lcm)of Sephadex G 25 (fine) which had been 
equilibrated at 22°C with O.IM acetic acid buffer. The column 
was eluted with the same buffer at 22°C with a flow rate of 
40ml/h. Fractions (5ml) were automatically collected from which 
aliquots (0.2ml) were individually assayed for sialic acid, 
hexose and protein as described in the Materials and Methods 
section (Section A, page 124) and the resulting patterns are shown 
in Fig. 91. Fractions corresponding to the excluded peak were 
pooled, freeze dried and the residue was dissolved in distilled 
water (2ml) and assayed for protein, sialic acid and for 
individual hexoses and hexosamines as described in the Materials 
and Method section (Section A). The results are shown in Table 19
Control experiments were done in which either enzyme 
or sample was replaced by buffer alone and the overall procedure 
was performed as above. Fractions of these controls corresponding 
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were dissolved in distilled water (2ml) and assayed for protein, 
sialic acid and for individual hexoses and hexosamines as 
described in the Materials and Methods section. The results are 
shown in Table 19.
SDS gel electrophoresis of deglycosylated fetuin
Fractions corresponding to the excluded peak (Fig. 91) 
were pooled, freeze-dried and samples (50yg protein) were sub­
jected to SDS-PAGE in 10% acrylamide gels as described in the 
Materials and Methods section (Section A). The sample stained 
as a single major protein band with mobility 54 (Fig. 92b) but 
no bands were obtained when the gels were stained for carbo­
hydrate with periodate-Schiff’s reagent.
Samples of fetuin (50 g protein) were also subjected 
to SDS-PAGE in 10% acrylamide gels. Staining for protein with 
Coomassie Blue showed a single major diffuse band at a mobility 
of 34 (Fig. 92a). This band was obtained also when the gels were 
stained for carbohydrate with periodate-Schiff's reagent. Table 20 
gives the mobility values for protein standards (Fig. 92c).(The 
mobilities are the average of five experiments), fetuin and 
deglycosylated fetuin. A plot of log. mol. wt versus mobility 
for the standards is shown in Fig. 93 from which the molecular 
weights of fetuin and deglycosylated fetuin were estimated to be 
50.000 and 33.000 respectively.
244.
Fig. 92a. SDS-PAGE in 10% acrylamide gel of fetuin (50yg protein) 
stained with Coomassie Blue.
Fig. 92b. SDS-PAGE in 10% acrylamide of deglycosylated fetuin (50yg 
protein) stained with Coomassie Blue.
245.
Fig. 92C. S.D.S. gel electrophoresis of protein standards, 






F ig . 93 . P lo t o f m o b il it ie s  versus lo g . m olecular weights o f
P ro te in  Standards subjected to SDS-PAGE in  10% acrylam ide  
gels.
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Desialylation of fetuin
Fetuin (2mg) was dissolved in 0.OSK^sulphuric acid (1ml) 
and incubated at 80°C for Ih after which the hydrolysate was 
cooled to room temperature and then applied to a column (150cm 
X  1cm) of Sephadex G-25 previously equilibrated at 22°C with 
O.lM-acetic acid. The column was eluted with the same buffer 
at 22°C with a flow rate of 40ml/h. Fractions (5ml) were auto­
matically collected from which aliquots (0.2ml) were assayed for 
sialic acid, hexose and protein as described in the Materials and 
Methods section (Section A, page 124). Fig. 95 shows that the 
above column was able to separate the desialylated glycopeptide 
from sialic acid. The elution pattern was similar to that obtained 
when a mixture of fetuin (5mg) and sialic acid (2mg) in 0.1M~ 
acetic acid (1ml) was applied to the same column and chromatographed 
under the same conditions (Fig. 94).
Deglycosylation of Sialoglycopeptide II (Fig. 50) by mixed 
endoglycosidase D
Sialoglycopeptide II (Fig. 50)(2mg) in O.IM citrate-phosphate 
buffer, pH 6.0 (0.2ml) was incubated for 26h at 37°C with mixed 
Glycosidases D (Seikagaku Kogyo Co. Ltd.)(50 milliunits) in the 
same buffer (0.2ml). The mixture was cooled to 4°C and applied 
to a column (150cm x 1cm) of Sephadex G-25 (fine) which had been 
previously equilibrated at 22°C with O.IM acetic acid buffer. The 
column was eluted with the same buffer at 22°C with a flow rate 
of 40ml/h. Fractions (5ml) were automatically collected from which 
aliquots (0.1ml) were individually assayed for sialic acid, 


























































































































































































A control experiment was performed in which the enzyme was 
replaced by buffer alone. The resulting elution pattern is shown 
in Fig. 97.
Fractions comprising the excluded peaks from Figs.96 
and 77 were separately pooled, freeze-dried and assayed for protein, 
sialic acid and individual hexoses and hexosamines (Materials and 
Methods, section A). The results are shown in Table 21.
Desialylation of Sialoglycopeptide II (Fig. 50)
Sialoglycopeptide II (Fig. 50)(5mg) was dissolved in
0.05M sulphuric acid (2ml) and incubated at 80°C for Ih after 
which the hydrolysate was cooled to 22°C and applied directly to 
a column (150cm x 1cm) of Sephadex G-25 previously equilibrated 
with O.IM acetic acid at 22°C. The column was eluted with the 
latter buffer at 22°C with a flow rate of 40ml/h. Fractions 
(5ml) were automatically collected from which aliquots (0.1ml) 
were individually assayed for sialic acid, hexose and protein 
(Fig. 98). Fractions corresponding to the excluded peak were 
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Fig. 98. Purification of desialylated sialoglycopeptide II, 
after mild acid hydrolysis, on Sephadex G-25. The 
column was eluted with 0.1^-acetic acid at 22°C 
with a flow rate of 40ml/h. Aliquots (0.1ml) of 
fractions (5ml) were individually assayed for sialic 






Fig. 99. SDS-PAGE in 10% acrylamide of desialylated
Sialoglycopeptide II in Fig. 98 (50yg protein) 
stained with Coomassie Blue.
257.
S.D.S gel electrophoresis of desialylated sialoglycopeptide II 
(Fig. 98)
Fractions corresponding to the excluded peak in Fig. 96 
were combined and freeze dried and samples(50yg protein) were 
subjected to SDS-PAGE in 10% acrylamide gels as described in the 
Materials and Methods section (Section A ). Staining for protein 
with Coomassie Blue showed two bands (Ila and II3Ï at mobilities 
of 20 and 32 (Fig. 99). Comparison with the bands obtained when 
sialoglycopeptide II itself was analysed (Fig. 54) shows a greater 
separation between Hot and 113 in the desialylated sialoglyco­
peptide II with the absence of the third band Ily indicating that 
this band was removed by the purification on Sephadex G25.
Neither band Ila or 113 stained for carbohydrate with 
the Periodate-Schiff reagent.
Effect of desialylation and of mixed glycosidase D treatment on the 
epithelial membrane antigenic activity of Sialoglycopeptide II 
Freeze-dried fractions corresponding to the following 
peaks were assayed for epithelial membrane antigenic activity as 
described in the Material and Methods section (Section B). 
Sialoglycopeptide peak II (Fig. 50)
Desialylated glycopeptide II (Fig. 98)
Deglycosylated peptide II (Fig. 96)
Control for deglycosylation (Fig. 9 7)
Table 22 shows the concentrations of samples giving 50% reduction 
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Discussion
In view of the demonstrated activity of Sialoglycopeptide II 
from human milk fat globule membrane as an epithelial membrane antigen 
(Section B), it was of interest to investigate the relative con­
tributions of peptide chain and carbohydrate complexes to this 
activity. What was needed was- a technique by which carbohydrate 
residues could be partially or completely removed without affecting 
the polypeptide chain, and a number of procedures were examined 
with this in mind. Mort et al. (1977) have described the use of 
anhydrous hydrogen fluoride which, they claim, is capable of 
removing carbohydrate residues from glycoproteins while retaining 
the structure and even the function of the remaining polypeptide 
chain. Procedures involving gaseous hydrogen fluoride have 
obvious and serious disadvantages in that special apparatus and 
precautions are necessary and it was decided to investigate the 
possibility of using a solution of hydrogen fluoride in pyridine 
which was commercially available. The use of such a solution, if 
successful, would have the advantages of easy handling in conven­
tional apparatus at relatively little expense.
Fetuin was used as a model glycoprotein with which to 
examine deglycosylation techniques and was treated with hydrogen 
fluoride in pyridine both at 0°C and at 45°C. Treatment of 
fetuin at 0°C led to very little removal of carbohydrate as 
judged by gas chromatographic analysis of the treated fetuin.
Treatment at 45°C on the other hand was found to be successful 
in removing some 67% of the total carbohydrate of the glycoprotein.
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It was important to determine what effects, if any, 
hydrogen fluoride in pyridine had on the polypeptide chains of 
glycoproteins and a test system was established. IjgG is known to 
contain a low level (3.6%) of carbohydrate (Clamp & Johnson, 1972) 
and it was considered that its antigenic properties might well be 
determined largely by the polypeptide chain. A radioimmunoassay 
for the antigenicity of rabbit IgG was accordingly developed in 
order that the effect of HF/pyridine on the structure and con­
formation of the polypeptide chain might be assessed.
The radioimmunoassay was based upon that used by
Ormerod and coworkers to determine epithelial membrane antigenic
activity (Heyderman.et al., 1979) and described in Section B.
Rabbit IgG was allowed to stick to the wells of a plastic immuno-
assay plate which was then exposed in succession to affinity-purified
125goat anti-(rabbit IgG) antibodies and to I-labelled donkey anti- 
(goat IgG) antibodies. The extent of binding of second antibody 
could be conveniently determined from the plate-bound radioactive 
counts. The antigenicity of modified rabbit IgG coùld then be 
determined by inhibiting the radioimmunoassay by preincubation 
of the test antigen with goat anti-(rabbit IgG) antibodies prior 
to their use and comparison of the resulting inhibition of bound 
counts with that brought about by similar preincubation with the 
native rabbit IgG. In developing the assay it was necessary to 
establish the optimal values of a number of variable factors.
Thus preliminary experiments were carried out to determine the 
best times of incubation at the various stages of the assay, the 
maximum amount of rabbit IgG that could stick to the assay well
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and the minimum concentration of goat anti-(rabbit IgG) antibodies 
consistent with maximum binding to the immobilized rabbit IgG. 
Optimal concentrations of second antibody were similarly 
established.
After establishment of the radioimmunoassay for anti­
genicity of rabbit IgG, this molecule was treated with hydrogen 
fluoride in pyridine at 45°C under conditions shown to be 
successful in removing carbohydrate from fetuin,and was assayed 
for antigenicity. Comparison with both native rabbit IgG, and 
with a control sample taken through the deglycosylation procedure 
but without HF/pyridine, showed that the antigenic properties of 
rabbit IgG had been essentially altered by exposure to HF/pyridine 
This suggested that the structure and/or the conformation of the 
polypeptide chain of rabbit IgG had been radically changed by the 
hydrogen fluoride treatment. It was, however, considered to be 
just possible that the loss of antigenicity might result from the 
removal of the carbohydrate residues from the immunoglobulin and 
this was checked by a further experiment.
An exoglycosidase mixture from Trichiomanos foetus is 
known to contain little protease activity and has been used 
successfully to remove oligosaccharide components from ABO blood 
group determinants (Watkins, 1966), carcino embryonic antigen 
(Westword et al., 1976; Ormerod, 1978) and acetylcholine 
receptor (Wonnacott et al., 1980). The use of these enzymes was 
accordingly examined with fetuin, again used as a model glyco­
protein, and was found to remove a total of 63.4% of the carbo­
hydrate, being less effective^in the removal of mannose and
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galactos amine than in the removal of galactose glucosamine or 
sialic acid in which it was particularly active. Once the 
efficacy of the T. foetus enzyme mixture in removing carbohydrate 
had been established it was possible to use the mixture to 
clarify the results of the experiments involving IgG. Thus 
rabbit IgG was treated with the T. foetus enzymes, under conditions 
identical to those used with fetuin, and the antigenicity of the 
treated IgG was examined in the radioimmunoassay. Rabbit IgG, 
deglycosylated by treatment with the T. foetus enzymes was 
found to have retained all its antigenicity as judged by the 
radioimmunoassay. This confirmed that the demonstrated loss of 
antigenic activity following HF/pyridine treatment of IgG must 
have resulted from changes in the polypeptide chain and not 
directly from the loss of carbohydrate residues.
In view of this demonstration of the non-specific 
effects of hydrogen fluoride in pyridine on glycoprotein molecules, 
deglycosylation by enzymic procedures was further investigated. 
Following the isolation and examination of endoglycosidase D 
from Diplococcus pneumoniae by Muramatsu and coworkers 
(Muramatsu, 1971), the Seikagaku Kogyo Co. of Japan has produced 
an enzyme mixture containing endoglycosidase D together with the 
exoglycosidases galactosidase, N-acetylglucosaminidase and 
neuraminidose; the exoglycosidases being designed to reduce a 
glycoprotein oligosaccharide complex to the limiting structure 
which is a substrate for the endo-enzyme. This mixture, mixed 
glycosidases D, was used to deglycosylate fetuin in the first 
instance. The treated fetuin^was separated from released sugars
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by gel filtration on a column of Sephadex G-25 and carbohydrate 
analysis of the excluded peak established that approximately 
80% of the carbohydrate had been removed from the polypeptide 
chain by the enzyme mixture. Galactosamine was less effectively 
removed than the other monosaccharides suggesting that 0-glyco- 
sidically-linked oligosaccharide complexes, commonly rich in 
galactosamine might be remaining attached to the polypeptide 
chain. Polyacrylamide gel electrophoresis of the deglycosylated 
fetuin in the presence of sodium dodecyl sulphate showed a single 
band staining for protein but not for carbohydrate. Comparison 
of the SDS-PAGE gel with those run including a range of molecular 
weight standards indicated a molecular weight of approximately 
33000 for the deglycosylated fetuin. This figure can be compared 
with that of 50000 obtained using native fetuin and is consistent 
with reported values of the molecular weight (43360-49700, Green 
& Kay, 1963 and Spiro, 1960 respectively) and carbohydrate 
content of 24.3% [8.3% hexoses, 6.3% hexosamines and 8.7% sialic 
acid, (Spiro, I960)] of native fetuin.
Conditions were also established for the removal of 
sialic acid from glycoproteins again by using fetuin as a model 
system. Preliminary experiments established that fetuin and 
sialic acid could be conveniently separated by gel filtration 
on Sephadex G-25. Similar conditions were then employed to 
separate sialic acid released from fetuin by mild acid treatment 
giving desialylated fetuin as a discrete peak excluded from the 
gel.
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Following the successful deglycosylation and dis- 
ialylation of fetuin, these procedures were applied to Sialo­
glycopeptide II from human milk fat globule in order to determine 
the effects of these treatments on the epithelial antigenic 
activity of the glycopeptide. Treatment of Sialoglycopeptide II 
with the glycosidase mixture under identical conditions to those 
employed for fetuin released carbohydrate material which was 
separated by gel filtration on Sephadex G-25. Carbohydrate 
analysis of the residual deglycosylated peptide showed an overall 
removal of 57% of the carbohydrate as opposed to 80% from fetuin. 
Compared with the results from fetuin the main differences were 
apparent in reduced removal of galactose and glucosamine together 
with a relatively low loss of fucose in the case of Sialoglyco­
peptide II. It is difficult to relate these differences to 
specific oligosaccharide structures, although it is possible 
that residual fucose and glucosamine residues in Sialoglycopeptide 
II might reflect the presence of the groupings Fuc a l->6 Glc NAc 
6 l-»-N Asn known to be resistant to further endoglycosidase attack.
Desialylation of Sialoglycopeptide II also proceeded 
essentially as shown for the model compound fetuin and a sialic 
acid-free peak was obtained by gel filtration on Sephadex G-25 
following acid treatment of the native glycopeptide. SDS-PAGE 
of the desialylated material was consistent with a reduced 
molecular weight following desialylation.
265.
Sialoglycopeptide II, its desialylated derivative, 
the partially deglycosylated peptide and a control to the deglycosy­
lated sample was all assayed for epithelial antigenic activity 
by the assay of Ormerod and coworkers described in Section B. 
Desialylation of the sialoglycopeptide was found to have little 
affect on its antigenic activity in the assay indicating that the 
terminal sialic acid residues of the glycopeptide are not 
important in this respect. Deglycosylation, on the other hand, 
was found to decrease the antigenicity by approximately five 
fold. This result is to some extent ambiguous in that the anti­
genicity is not totally lost. It could be argued that the 
residual carbohydrate (approximately 40% of the total) is 
responsible for the remaining antigenic activity. Alternatively 
it is possible that removal of 60% of the original carbohydrate 
residues allowed a conformational change that resulted in loss 
of antigenicity carried basically by the polypeptide chain. I 
This latter explanation seems to be unlikely in view of the 
lack of effect of desialylation on antigenicity and the probable 
influence of charged sialic acid groupings on the conformation 
of the molecule as a whole. The overall conclusion must 
accordingly be that the epithelial membrane antigenic activity 
of Sialoglycopeptide II probably arises from carbohydrate deter­
minants some of which are resistant to the endoglycosidase 
mixture employed in this work. Such a conclusion is supported 
by recent findings of Ormerod and Steele (personal communication) 
that rigorous purification of the epithelial membrane antigen 
present in milk serum (not Sialoglycopeptide II) led to an active 
fraction containing very little, if any, protein. This antigen 
certainly contains carbohydrate and could be a glycolipid.
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Suggestions for further work
1. Further characterization of the cleaved oligosaccharide 
fractions B(II) and C(II) to establish their complete 
structure and carbohydrate linkages. This could be done 
by using méthylation and periodate oxidation followed by 
gas liquid chromatography and mass-spectrometric analysis.
2. Further purification of the sialoglycopeptide II.R and of the 
crude "papain digest" with a view to isolating the epithelial 
membrane antigen. This could be done by affinity chromatography 
using lectin columns (e.g. Con. A) and more particularly anti^ 
*EMA' antibodies generated according to system devised in the 
Ludwig Institute for Cancer Research.
3. Further studies on the role of carbohydrate in the antigenic 
expression of the epithelial membrane antigen. This could 
involve complete removal of the sugars from purified antigenic 
components Qsec. 2 above] followed by analysis for epithelial 
membrane antigen. Complete deglycosylation might be effected 
by using alkaline borohydride treatment coupled with deglyco­
sylation by using a mixture of exo- and endoglycosidases from 
Diplococcus pneumoniae. Deglycosylation procedures would be 
worked out by using fetuin, and rabbit IgG, as models in a 
similar way to that described in this thesis.
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